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“In the South Seas there is a cargo cult of people. During the war they saw 
airplanes land with lots of good materials, and they want the same thing to 
happen now. So they've arranged to imitate things like runways, to put fires 
along the sides of the runways, to make a wooden hut for a man to sit in, with 
two wooden pieces on his head like headphones and bars of bamboo sticking 
out like antennas—he's the controller—and they wait for the airplanes to land. 
They're doing everything right. The form is perfect. It looks exactly the way it 
looked before. But it doesn't work. No airplanes land. So I call these things 
cargo cult science, because they follow all the apparent precepts and forms of 
scientific investigation, but they're missing something essential, because the 
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Incentive stimuli and environmental stressors are encoded at the level of the prefrontal cortex 
(PFC) circuits, which send their glutamatergic excitatory projections to several neuromodulatory 
regions, including the Locus Coeruleus (LC), the major source of noradrenaline (NA) for the entire 
forebrain. Despite the potential implications for NA-mediated regulation of action control and for 
the etiology of stress-related neuropsychiatric conditions, it remains to be established how LC 
neuronal activity is shaped by impinging PFC inputs (PFC→LC) to affect behavior, and whether 
these inputs are modulated by in-vivo experience.  
By combining neurophysiological and optogenetic approaches together with behavioral paradigms 
in mice, we found that PFC →LC stimulation supports learning and retrieval of contextual memory 
associations. Consistent with the occurrence of plasticity processes at LC synapses, long-lasting 
modulation of PFC→LC projections relies on the endocannabinoid (eCB)-mediated signaling 
capacity, which is dynamically shaped by context adaptations and stress salience experiences. We 
also found that eCB-plasticity at PFC → LC synapses is regulated during the adolescence to 
adulthood transition.  
In summary, our results not only dissect the behavioral implications of neuromodulated plasticity 
at PFC inputs to the LC, but also unveil divergent synaptic substrates during postnatal 
development, which might be relevant to explain some of the different noradrenergic-mediated 






The Locus Coeruleus (LC): organization and function 
The Locus Coeruleus (LC) is a compact cluster of noradrenergic neurons situated in the pontine 
region of the brainstem (Amaral and Sinnamon, 1977) (Figure 1). In the adult rat brain, the LC 
contains ≈3000 neurons (Descarries and Saucier, 1972; Aston-Jones, 2004) out of total 
≈330,000,000 neurons (Herculano-Houzel and Lent, 2005), and roughly half of the overall number 
of central noradrenergic neurons; the remaining central noradrenergic neurons are organized in 
compact nuclei (A1-A7; A stands for Adrenergic (Dahlstroem and Fuxe, 1964)) located in the 
brainstem. Through their branched axons, LC noradrenergic cells (also called norepinephrine (NE)-
LC neurons) project extensively throughout the entire neuroaxis (Figure 2). The diffuse and 
ubiquitous projections of LC have been identified since 1971 (Ungerstedt, 1971). In the light of 
their widespread projections and postulated synchronous activity, the main physiological role 
ascribed to LC-NE neurons has been the broad control of arousal levels and brain states, including 
sleep-wake transitions (Berridge and Waterhouse, 2003; Carter et al., 2010; Lee and Dan, 2012; 
Sara and Bouret, 2012). It is now well  established that LC projections, through NE release, provide 
fine control of various brain regions, thereby modulating diverse brain functions: noradrenergic 
action in cortex and thalamus strongly impacts arousal and behavioral state (Berridge and 
Waterhouse, 2003); LC-NE afferents to  thalamic nuclei and sensory cortices provide gating and 
tuning of sensory processing (Bouret & Sara, 2002; Devilbiss & Waterhouse, 2010; Eckmeier & 
Shea, 2014; Rodenkirch et al., 2019);  LC projections to the hippocampus regulate synaptic 
plasticity (Dahl and Sarvey, 1989; Maity et al., 2015; Kempadoo et al., 2016); LC projections to the 
amygdala play an important role in memory consolidation (Schiff et al., 2017; Uematsu et al., 
2017); in the frontal cortex, NE is essential for working memory and attention (Rossetti and 
Carboni, 2005; Hvoslef-Eide et al., 2015). The LC  also  projects to midbrain neuromodulatory 
systems such as the Dorsal Raphe Nucleus (DRN) (Kim et al., 2004), the dopaminergic  ventral 
tegmental area (VTA) and substantia nigra pars compacta (SNc) (Mejías-Aponte, Drouin and Aston-
Jones, 2009), and to  cholinergic nuclei of the brainstem (lateral dorsal tegmental nucleus, 
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pedunculopontine nucleus [LDT/PPN]) (Semba and Fibiger, 1992; Khanday et al., 2016). The role 
of LC projections towards these neuromodulatory nuclei remains poorly investigated.  
Even though the LC is not the only noradrenergic nucleus of the brain, it provides the sole source 
of NE for the neocortex, hippocampus, cerebellum and most of the thalamus; this highlights its 
importance in the modulation of higher-order cognitive functions (Sara and Bouret, 2012).  
Accordingly, dysfunctions in LC-NE system have been observed in neurodegenerative disorders 
and psychiatric conditions characterized by cognitive deficits.  
Figure 1 Location of Locus Coeruleus in the brainstem of (A, B Human and (C, D) Rodent brain. (A) Nuclear magnetic 
resonance image showing the loci coerulei. The loci coerulei are shown by the white areas close to the 4th ventricle 
(yellow arrows). Neuromelanin-related signal has been used to visualize the LC. (B) Horizontal section of the upper 
pons. The loci coerulei are circled in red. (C) Expression of fluorophore in the right LC. A Cre-dependent recombinant 
adeno-associated virus (AAV) expressing a fluorophore was injected into the mouse LC as an anterograde tracer. The 
mice were from a Cre-driver line in which Cre recombinase is under the tyrosine hydroxylase (TH) promoter (Allen 
Brain Atlas Connectivity Project Experiment 511971714, TH-Cre_Fl172 mouse). (D) Bright-field photomicrographs of a 
rat LC section. The section was processed for dopamine β-hydroxylase (DBH) immunohistochemistry to visualize 
noradrenergic neurons. (A, B) Modified from Szabadi et al. (2013). (C) Modified from Chandler et al. (2019). (D) 
Modified from Aston-Jones (2004). 
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LC neuronal degeneration has been observed in both Alzheimer's and Parkinson’s disease as well 
as in other forms of neurodegeneration (for reviews: (Vermeiren and De Deyn, 2017; Weinshenker, 
2018). In Alzheimer's disease, the LC shows intraneuronal fibrillary tangles of Tau protein, a 
hallmark of the pathology, alongside with LC-NE neuronal cell loss (Mann and Yates, 1983). Most 
importantly, decreased LC neuronal density has been demonstrated to correlate with cognitive 
decline (Wilson et al., 2013). LC neurons degeneration plays an important role also in the 
progression of Parkinson’s disease. Whilst degeneration of substantia nigra pars compacta (SNc) 
is the most studied neuropathological trait of the disease, post-mortem studies in human patients 
demonstrated the presence of α-synuclein aggregates (e.g. Lewy bodies) in LC neurons (Braak et 
al., 2003), which is associated with a loss of noradrenergic cells (Zarow et al., 2003). Interestingly, 
degeneration of NE-neurons has been shown to precede SNc dopaminergic cell death, suggesting 
that LC degeneration is involved in the initial stages of the disease progression (Braak et al., 2003). 
Collectively, these observations indicate that LC-NE neurons can degenerate both in Parkinson and 
Alzheimer’s disease (Zarow et al., 2003), and this neurodegeneration might lead to depression and 
vigilance loss associated with the pathologies (Solopchuk et al., 2018). Nevertheless, the causal 
link between cell loss in LC and specific pathological symptoms has not been fully established yet. 
In psychiatric conditions, the LC-NE system might be deregulated, rather than experience cell 
degeneration. Indeed, many studies point at a hyperactivation of the noradrenergic system in 
patients with Post-traumatic stress disorder (PTSD) (reviewed in Yamamoto, Shinba and Yoshii, 
2014; Hendrickson and Raskind, 2016). The supposedly increased LC activity can induce 
hyperarousal states, especially following mildly stressful stimuli that strongly characterize and 
Figure 2 (A) Cre-dependent recombinant adeno-associated virus (AAV) expressing eYFP was injected into the mouse 
LC as an anterograde tracer. The mice were from a Cre-driver line in which Cre recombinase is under the tyrosine 
hydroxylase (TH) promoter (Allen Brain Atlas Connectivity Project Experiment 511971714, TH-Cre_Fl172 mouse). After 
2-photon serial tomography, the LC axonal projections were reconstructed in 3D. (B) Assignation of projection axons 
by target region highlights the widespread projection pattern of LC neurons. Modified from Chandler et al. (2019). 
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define this psychiatric disease. The hyperarousal state is correlated with high NE levels in the 
plasma and in the cerebrospinal fluid (CSF), which are elevated in patients suffering from PTSD. 
Moreover, the concentration of NE has been shown to positively correlate with the severity of 
PTSD symptoms (Geracioti et al., 2001, 2008), while adrenergic antagonists are able to ameliorate 
the disease symptoms (Berardis et al., 2015; Remy Simon and Rousseau, 2017). 
In summary, the LC is a small brain structure that can profoundly modulate different aspects of 
animal behavior. Emerging evidence indicates that the key behavioral role played by the LC is 
dependent on its connectivity profile and functional properties of its neurons. 
Cytoarchitecture and molecular organization 
In the rodent brain, the LC nucleus is easily recognizable in stained sections as a densely packed 
group of cells lying on the ventrolateral side of the 4th ventricle, a region known as the 
rhomboencephalic tegmentum (Aston-Jones, 2004) (Figure 1 C-D). The LC is virtually only 
composed of noradrenergic neurons, as indicated by immunolabeling for Tyrosine Hydroxylases 
(TH) or for Dopamine Beta Hydroxylases (DBH), which are two key enzymes for the biosynthesis of 
Norepinephrine (NE) (Axelrod, 1971). Nevertheless, few findings demonstrated the existence of 
two pools of inhibitory GABAergic interneurons laying within or in close proximity to the LC. One 
group of interneurons is intermingled within NE neurons in the LC itself (Ijima and Ohtomo, 1988; 
Breton-Provencher and Sur, 2019). The second is a large reservoir of grouped inhibitory neurons, 
called dorsomedial(dm)LC (Jin et al., 2016), which is laying on the medial side of the LC in the 
mouse brain. These GABAergic cells are morphologically distinguishable from the noradrenergic 
neurons by their small circular cell bodies. Moreover, LC GABAergic neurons showed 
electrophysiological characteristics distinguishable from those of LC-NE neurons: high input 
resistance ( ≈ 500 MΩ), small membrane capacitance ( ≈ 20 pF), a prominent sag in response to 
cell hyperpolarization, and high firing rate ( ≈ 10 Hz) (Jin et al., 2016). These interneurons could 
regulate LC-NE neurons activity through feedback and feedforward inhibitory mechanisms (Jin et 
al., 2016; Breton-Provencher and Sur, 2019). 
Using the Golgi staining method, LC-NE neurons have been classified based on their morphology 
(Figure 3 A). Work conducted by different independent groups between the end of the seventies 
and the beginning of the eighties showed the existence of morphologically distinguishable LC-NE 
cells: large multipolar neurons ( ≈ 35µm), medium-sized elongated neurons ( ≈ 20µm) (Swanson 
and Hartman, 1975) and ovoid-shaped cells (Cintra, Kemper and Morgane, 1982). The different 
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shape of these noradrenergic neurons is linked to the orientation of their dendrites; small fusiform 
cells extend their dendrites along the sagittal and horizontal plane, while multipolar neurons 
extend their arborization more towards the frontal plane (Sievers et al., 1981).  
In addition to the morphological differences, LC-NE neurons are neurochemically diverse regarding 
their neuropeptide content (Schwarz and Luo, 2015) (Figure 3 C).  80% of LC-NE neurons produce 
the Galanin (Gal) peptide. Gal regulates different behavioral aspects: sleep/wake cycle, 
nociception, feeding, and parental behavior (Crawley, 1999; Wu et al., 2014; Li et al., 2017; Kroeger 
et al., 2018). Neurons positive for both NE and Gal are mainly located in the dorsal and central 
parts of the LC. Another neuropeptide synthesized in a LC subpopulation of cells is the 
neuropeptide Y. NPY is produced in ≈ 20% of LC cells, which are preferentially distributed in the 
dorsal part of the LC (for Gal and NPY neurons in the LC see Holets, Hokfelt and Rokaeus, 1988). 
NPY is a stress-relieving, anxiolytic, orexinergic peptide (Reichmann and Holzer, 2016; Comeras, 
Herzog and Tasan, 2019). The co-release role of NE with these two different peptides and the 
distribution of axon-terminals in target brain region positive for NE and Gal or NPY has not been 
thoroughly investigated so far.  
Another class of molecules that are differentially expressed at the LC level are the adrenergic 
receptors (AR) (Schwarz and Luo, 2015) (Figure 3 C). NE autoreceptors expressed in LC-NE neurons, 
Figure 3 (A) Camera lucida reconstructions of the 3 cell types in the Locus Coeruleus (LC) stained with the Golgi method: 
multipolar M; fusiform F; ovoid O neurons. (B) Schematic of the biased location of LC neurons along the dorso-ventral axis 
based on their morphology. (C) Schematic representing the LC molecular composition; although all LC cells produce 
Norepinephrine (NE), subsets of neurons co-release neuropeptides such as NPY and galanin (Gal). Moreover, subsets of 
LC neurons express neurotransmitter receptors differentially such as α-adrenergic receptors. (A) Modified from Cintra, 
Kemper and Morgane, 1982. (B-C) Modified from Schwarz and Luo, 2015. 
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for instance, show a rostrocaudal gradient of distribution within the LC. The α2 G-protein coupled 
receptor (ARα2) is the most abundantly expressed adrenergic receptor in the LC (Young and Kuhar, 
1980). α2 receptors are coupled to Gi/o-protein system, thus their activation inhibits cAMP 
production, leading to an autoinhibition of LC-NE neurons. α2 receptor distribution follows a 
rostrocaudal gradient of expression within the LC (Chamba et al., 1991), with higher caudal 
expression. On the other hand, α1 receptors (ARα1) are coupled to Gq signaling cascade. Gq is a 
modulatory G protein and induces Ca2+ release from the stores. Opposite to α2, α1 receptor is 
most abundant in the anterior part of the LC (Chamba et al., 1991). This distribution pattern of 
autoreceptors raises the possibility that NE released from the LC itself, or from other adrenergic 
nuclei, can induce different responses in different LC cells based on their rostrocaudal position, 
with stronger autoinhibition of the most caudal part and strong anterior activation.  Another 
example of receptors that show patterned expression within the LC is the ionotropic Nicotinic 
acetylcholine receptor (nAChRs). Single-cell RT-PCR experiments revealed differential expression 
of nAChRs in multipolar large cells compared to the medium-sized fusiform ones. The large cells 
showed α6 and β3 and often α4 mRNAs whereas the elongated fusiform cells showed α3 and β4 
mRNAs (but also α6, β3, α5 and α4 mRNAs, although at a lower level). This differential nAChRs 
mRNAs expression resulted in different sensitivity to nAChRs agonists in large multipolar compared 
to the smaller fusiform cells, with larger currents observed in the latter (Léna et al., 1999).  
LC-NE neurons express many other neurotransmitters and neuropeptide receptors such as GluR, 
GABA receptors, CRF receptors, orexin receptors, opioid receptors, and endocannabinoid 
receptors (Luque, Malherbe and Richards, 1994, 1995; Marcus et al., 2001; Reyes et al., 2006; 
Scavone and Van Bockstaele, 2009; Scavone, Mackie and Van Bockstaele, 2010), but it is not known 
if they are expressed differentially within the LC.  
In light of the aforementioned evidence, the Locus Coeruleus should not be considered only as a 
homogeneous group of NE producing neurons as initially believed; their morphological and 
molecular heterogeneity suggests that within the LC itself there are clusters of cells possibly 
involved in different functions. This hypothesis, however,  has not been demonstrated yet 
(Chandler et al., 2019). 
Adrenergic receptors and signaling in the brain 
As mentioned in the previous paragraph, the LC is nowadays considered as a complex and 
differentiated neuromodulatory nucleus. However, the effects of NE on target brain regions 
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depend largely on the receptor subtype activated, the downstream signaling cascade engaged, 
and the cell type expressing the NE-receptor. Therefore hereafter, I will briefly discuss Adrenergic 
receptors, their expression profile in the brain and their functions.   
The adrenoceptors are part of the large family of seven transmembrane domain receptors or G-
protein coupled receptors. The nine adrenergic receptors identified have been divided into three 
main groups: α1 adrenergic receptors, α2 adrenergic receptors, and β adrenergic receptors 
(reviewed in Strosberg, 1993; Insel, 1996) (Figure 4).  
α1 adrenergic receptors  
Three different α1 adrenoreceptors proteins have been cloned, namely: α1A, α1B, α1D (Zhong 
and Minneman, 1999). The three α1 are encoded by three different genes and they show a 
differential distribution in the brain (Scofield, Deupree and Bylund, 2002). In-situ hybridization 
studies (Day et al., 1997) showed that: 
-α1A mRNA is mainly present in the olfactory bulbs, many hypothalamic nuclei, and the brainstem.  
-α1B is expressed in the pineal gland, in the thalamus, in the amygdala, and in the raphe nuclei.  
-α1D mRNA levels are higher in the olfactory bulb, cortical layers II–V, the hippocampus, the 
reticular thalamic nucleus, the amygdala and motor nuclei of the brainstem.  
Figure 4 (A) The adrenoceptor family subdivision. The division in subfamilies is based on pharmacological properties and 
structural homology of the G-protein coupled receptors (GPCR). Some of the adrenoreceptors shown here can be also 
coupled to different G proteins, for instance, β2 and β3 can be bound to Gi/o signaling cascade. (B) β2 adrenoreceptor 
structure in the presence of the β antagonist carazolol (yellow) bound on its extracellular site. The membrane is shown 
as a gray stripe. (A) Modified from (Zhong and Minneman, 1999. (B) Adapted from “Protein Data Bank: 2rh1”. 
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All three α1 receptors subtypes are known to be linked to the modulatory Gq/11 protein that 
activates phospholipase C (PLC) and phosphatidylinositol signaling, resulting in activation of 
protein kinase C (PKC) on one side and in the 1,4,5 inositol-triphosphate followed by Ca2+ release 
from the stores on the other (Wu et al., 1992).  
The work on recombinant systems showed that the three different α1 receptors have different 
subcellular localizations and regulatory properties. α1B is mainly localized at the plasma 
membrane level and it undergoes rapid desensitization and internalization following adrenergic 
agonist binding. α1A is localized both on plasma membranes and intracellularly and shows a slower 
internalization rate. Finally, α1D is mainly present on intracellular vesicles, this localization might 
be due to its continuous internalization (Chalothorn et al., 2002). Since most available drugs are 
not receptor subtype-specific it is difficult to determine which subtype is involved in modulating a 
specific behavior in-vivo. 
More generally, α1 receptors are involved in some symptoms of depression (Stone et al., 2007; 
Nalepa et al., 2013). It has been shown that antidepressant drugs and treatments increase the α1 
receptor mRNA level and density, nonetheless, the mechanism by which α1 receptors mediate 
antidepressant effects is poorly understood (Deupree, Reed and Bylund, 2007). α1 are also 
involved in learning and memory although their role is controversial: some studies have shown 
that their stimulation impairs spatial  working  memory (Birnbaum et al., 1999), while others point 
at a facilitating action of α1 in Long term potentiation (LTP) and long-term depression (LTD) 
induction in the hippocampus (Doze et al., 2011; Dyer-reaves et al., 2019; Scheiderer et al., 2019). 
In these studies long-term stimulation of α1 improved memory in Morris and T-maze tests, while 
α1-KO animals displayed worsened cognitive abilities (Spreng, Cotecchia and Schenk, 2001; Doze 
et al., 2011).    
α2 adrenergic receptors  
Three different genes have been identified which codify for different α2 receptors: α2A, α2B, α2C 
(Bylund et al., 1994).  They are known to be linked to an inhibitory Gi/o signaling cascade, therefore 
the activation of α2 generally leads to the inhibition of the adenylyl cyclase (Kurose et al., 1991; 
Remaury et al., 1993). The mRNA of all three subtypes is present at the brain level (Scheinin et al., 
1994). 
- α2A is widely distributed in the cerebral cortex, LC, amygdala, paraventricular nucleus, nucleus 
tractus solitarii, reticular formation. 
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- α2B mRNA has been found almost exclusively in the thalamus. 
- α2C is found in the olfactory bulb, cerebral and cerebellar neocortex, hippocampus and basal 
ganglia.  
Amongst α2 adrenergic receptors, α2A and α2C were identified as the main auto-receptors that 
negatively regulate via a feedback inhibition the release of NE (Starke, 1987; Hein, Altman and 
Kobilka, 1999; Bücheler, Hadamek and Hein, 2002). Although the main function of the α2 
adrenoreceptor was assigned to its presynaptic location, it has been shown that these receptors 
can also display a postsynaptic localization (Ricardo, 1981). α2 adrenoreceptors are also suited to 
control the release of other neurotransmitters in addition to NE, it has been shown that these 
receptors can dampen dopamine (Bücheler, Hadamek and Hein, 2002) and serotonin release 
acting presynaptically (Scheibner et al., 2001). 
α2 receptors are crucial in analgesia and sedation (Hayashi and Maze, 1993; Buerkle and Yaksh, 
1998; Giovannoni et al., 2009). α2 agonists are considered strong analgesics since their activation 
increases the effect of opioids and they are involved in pain perception (Sullivan, Dashwood and 
Dickenson, 1987; Wilcox et al., 1987; Kawasaki et al., 2003; Sonohata et al., 2004). Other than 
being potent analgesics, α2 agonists have hypnotic properties, most likely through the inhibition 
of the LC. α2 agonists reduce LC firing leading to decreased NE levels in target brain regions. In 
turn, low levels of NE are associated with a decrease in arousal levels (Mizobe et al., 1996; Carter 
et al., 2010; Giovannitti, Thoms and Crawford, 2015).  
β adrenergic receptors  
β adrenergic receptors comprise three receptor subtypes each of which is codified by a different 
gene, the three proteins are named β1, β2, and β3 (Emorine et al., 1987, 1989; Frielle et al., 1987; 
Machida et al., 1990). The three receptors have been well characterized from a pharmacological 
point of view; specific agonists and antagonists have been indeed produced and used to determine 
the presence of specific receptor subtypes in given tissues (reviewed in Minneman, Pittman and 
Molinofj, 1981; Velmurugan, Baskaran and Huang, 2019).   
Most of the cellular effects of β adrenergic receptors activation are mediated by excitatory Gs 
protein signaling cascade. Gs protein activates the adenylate cyclase that, in turn, brings to an 
increase of intracellular cyclic adenosine monophosphate (cAMP) and to the activation of protein 
kinase A (PKA) (Hekman et al., 1984). The binding of agonists to β2 and β3 can also lead to the 
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activation of a Gi/o signaling cascade, inducing inhibition of the adenylate cyclase (Daaka, Luttrell 
and Lefkowitz, 1997; Soeder et al., 1999; Xiao, 2001). 
The mRNA for β1 adrenergic receptor is widely distributed within the rodents’ brain, while 
radioligand assay demonstrated its presence mainly in forebrain structures. β2 adrenoreceptor 
mRNA is mostly present in the olfactory bulbs, the hippocampus, the piriform cortex, and the 
cerebellum. However, radioligand assays have shown a dense localization of this receptor subtype 
especially in the cerebellar cortex (Rainbow, Parsons and Wolfe, 1984; Booze, Crisostomo and 
Davis, 1989). β3 adrenergic receptor seems to be expressed in the hippocampus, cortex, and 
striatum (Summers et al., 1995). Interestingly, within the hippocampus, the expression of this 
adrenoreceptor seems to be restricted in a specific hippocampal neuronal precursor in the 
subgranular zone (SGZ) of the dentate gyrus (DG), in this region NE acting on β3 increases the 
number of proliferating cells, de-facto activating a niche of self-renewing multipotent cells  (Jhaveri 
et al., 2010).  
β adrenergic receptors in the hippocampus are crucial in modulating synaptic plasticity acting on 
both long term potentiation (LTP) and depression (LTD) (reviewed in Dell et al., 2015; Hagena, 
Hansen and Manahan-Vaughan, 2016). β adrenergic receptors activation promotes LTP at mossy 
fibers to CA3 and at CA3 to CA1 synapses (Hopkins and Johnston, 1984, 1988; Thomas et al., 1996; 
Hagena and Manahan-Vaughan, 2012; Qian et al., 2012). Studies with β receptors agonists in the 
DG, on the other hand, suggested a dual role of this receptor in this hippocampal region: low 
concentration of β agonist induces an LTD, while higher concentration of the same agonist is able 
to induce LTP (Lethbridge, Walling and Harley, 2014). 
Since NE, through the activation of β receptors, has such a profound effect on hippocampal 
plasticity, it is not surprising that it plays a pivotal role in the retrieval of spatial and associative 
memory. Izquierdo et al. (Izquierdo et al., 1998) showed that the infusion of NE in  CA1 improved 
long term memory in an avoidance task. In the same task, mice KO for DBH, which are unable to 
produce NE, displayed impaired contextual fear memory retrieval. Memory retrieval could be 
rescued by injections of NE before the memory testing. Moreover, this restoration was dependent 
on β adrenergic receptor, since the infusion of isoproterenol (ISO), a strong β receptor agonist was 




Classical tract tracing studies have been crucial for the understanding of LC input-output profile  
(Steindler, 1981; Luppi et al., 1995; Aston-Jones, 2004; Szabadi, 2013). However, these techniques 
have some limitations: classical tracers cannot be used to target specific neuronal populations and 
they can be uptaken by en-passant fibers (Saleeba et al., 2019). More recent viral tracing 
techniques allowed for more precise and sophisticated connectivity studies of the LC-NE system. 
In particular, Schwarz and colleagues’ recent work (Schwarz and Luo, 2015; Schwarz et al., 2015) 
demonstrated that LC output is highly divergent. LC-NE neurons have strong collateralizations, 
allowing them to project broadly to many brain regions. Nonetheless, this broad collateralization 
is inhomogeneous; subsets of LC neurons display more biased projections towards selective target 
areas. In the same study, rabies retrograde tracing revealed that LC receives direct inputs from 
more than 111 different brain regions, suggesting the strong integrative role of the LC-NE system. 
Schwarz also introduced a new viral tracing methods, named ‘tracing the relationship between 
input and output’ (TRIO) and cell-type-specific TRIO (cTRIO); these techniques allowed to restrict 
trans-synaptic rabies viruses infection based on the neurons output profile (TRIO), or to their 
output profile and their cell type (c-TRIO), respectively (Figure 5). By using these viral tracing 
approaches, the authors demonstrated that NE-neurons projecting to different brain regions 
receive fairly similar inputs. However, subsets of LC-NE neurons showed specific biases in their 
input-output organization. For instance, LC neurons projecting to the medulla received 
significantly fewer inputs from the Central Amygdala (CeA) compared to LC neurons projecting 
anywhere else. This suggests that LC neurons engaged by CeA, involved in anxiety and stress 
response (McCall et al., 2015), do not directly influence NE-release in the medulla. Altogether 
these findings provide the anatomical substrate to explain the heavily integrative function of LC-
NE neurons and how they broadly modulate many brain regions simultaneously in order to, 
eventually, regulate brain states. At the same time, this study showed that LC neurons are not 
completely homogeneous in their connectivity profile; this would ultimately contribute to an 
ensemble organization within the LC which would allow the generation of the diverse behavioral 




NE release in target brain regions can occur via “wiring”- or -“volume” transmission. LC terminal 
fields can either end in close proximity with single neurons, allowing for NE synaptic release (wiring 
transmission), or in interstitial spaces, forming varicosities (volume transmission) (Descarries and 
Mechawar, 2000; Szabadi, 2013).  
Nearly all brain regions contain NE positive terminals (Swanson and Hartman, 1975). This finding 
makes the LC a central neuromodulatory hub for the whole brain.  
Olfactory Bulbs 
The Olfactory structures receive dense noradrenergic connections. Notably, it has been 
estimated that a big portion of LC neurons (≈40%) project to the bulbs (Shipley, Halloran and De 
La Torre, 1985); roughly 10 times more than NE projections to any other cortical areas. The first 
evidence obtained with retrograde tracing was later confirmed by anterograde tracing methods. 
Figure 5 Schematics of TRIO and c-TRIO trans-synaptic viral-genetic tracing techniques. (A) TRIO does not distinguish 
between region different cell types in region B projecting to the selected C region (grey outlined circles and blue 
outlined circles in region B represent two different cell types). (B) cTRIO avoids labeling promiscuous projections from 
Cre– cells (blue). Open and filled triangles, incompatible loxP sites; open and filled half-circles, incompatible FRT sites. 
Modified from Schwarz et al. 2015. 
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It has been shown that both the main and the accessory olfactory bulb receive LC projections 
(Mclean et al., 1989). NE-axons are believed to contact mainly granule cells, with minor but 
important connections with mitral cells (Aston-Jones, 2004). These synaptic connections to both 
granule and mitral cells allow to finely regulate the olfactory signal to noise (S/N) ratio (Escanilla 
et al., 2010; Linster, Nai and Ennis, 2011; Linster and Cleland, 2016; Manella, Petersen and Linster, 
2017). NE, through modulation of the inhibitory granule cells, helps to reduce the noise in the 
system (Linster, Nai and Ennis, 2011; Manella, Petersen and Linster, 2017). Moreover, NE 
modulates the responsiveness of the olfactory bulb by directly increasing the excitability of mitral 
cells (Jiang et al., 1996; Hayar et al., 2001). This fine regulation of the S/N ratio in the olfactory 
bulb lowers odor detection threshold and increases the ability to discriminate between similar 
odors (Linster, Nai and Ennis, 2011). 
Neocortex 
The LC projects to the cortex through the dorsal noradrenergic bundle, a connection known as 
the coeruleo-cortical pathway (Szabadi, 2013). Morrison and colleagues proposed that the 
coeruleo-cortical axons enter the cortex frontally and then they travel caudally towards the 
occipital lobe, creating a layer of noradrenergic fibers that extends mainly tangentially across the 
whole cortex (Morrison et al., 1981). The LC projects to all areas and to all layers of the cortex, 
although not indiscriminately. Layer I contains a meshwork of axons tangential to the cortical 
surface. Layer II/III is characterized by fibers innervating radially this layer. Layer IV contains 
convoluted axon fibers. Finally, Layer V and VI contain NE axons arranged along the 
anteroposterior axis (Morrison et al., 1978). LC neurons project mainly ipsilaterally; it has been 
indeed estimated that only 5-10% of noradrenergic neurons project to the contralateral cortex 
(Adèr et al., 1980; Waterhouse et al., 1993; Aston-Jones, 2004). Notably, it has been recently 
demonstrated how LC neurons projecting to different cortical areas show different 
electrophysiological characteristics. Single LC neurons project preferentially to either the medial 
Prefrontal Cortex (mPFC), the Anterior-Cingulate Cortex (ACC), the OrbitoFrontal Cortex (OFC) or 
the primary motor cortex (M1), with minor overlapping. In other words, virtually no neurons 
project to more than one of these cortical regions (Waterhouse and Chandler, 2012; Chandler, Gao 
and Waterhouse, 2014). Remarkably, LC neurons projecting to OFC and mPFC were biochemically 
and electrophysiologically different from the ones projecting to M1. OFC and mPFC projecting LC-
neurons showed higher mRNA levels for synaptic excitability markers (GLUR1 and NMDA R1 
subunit), higher spontaneous firing rate and were more responsive to glutamate than neurons 
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projecting to M1. The increased excitability of these neurons is probably due to the higher 
requirements for NE in associative cortices related to cognition such as the OFC and the mPFC 
(Chandler, Gao and Waterhouse, 2014). From a behavioral standpoint, it has been demonstrated 
that increasing the activation of LC neurons projecting to the PFC through the use of 
chemogenetics results in an anxiogenic and aversive response (Hirschberg et al., 2017). This finding 
suggests that the fine regulation of NE concentration at the PFC level is crucial to maintain optimal 
behavioral responses. Indeed, high NE concentration in the PFC promotes maladaptations and 
attention impairment (Suto, Eisenach and Hayashida, 2015). Therefore, although virtually all 
cortical areas receive NE afferents, the functional properties of the LC cells projecting in specific 
cortical areas are different, making possible a heterogeneous NE release in different cortical areas. 
This organization, in turn, might support a variety of diverse behavioral functions.  
Hippocampus 
LC neurons are the sole source of NE for the whole hippocampus (Loughlin, Foote and Grzanna, 
1986). The role of adrenergic receptors activation in the hippocampus has been well studied, 
indeed the LC projections in this region have been implicated in memory consolidation and 
retrieval (Hansen, 2017). Interestingly, it has been demonstrated that LC terminals in the 
hippocampus are able to release not only NE but also dopamine (DA) (Kempadoo et al., 2016). 
However, although it is known that DA has to be synthesized in LC neurons since it is a biochemical 
precursor of NE (Axelrod, 1971), the mechanism responsible for the co-release NE and DA in LC 
has not been elucidated yet (Kempadoo et al., 2016). DA released from the LC increased attention, 
enhanced spatial object recognition and memory persistence acting through the D1/D5 receptor 
(Kempadoo et al., 2016; Takeuchi et al., 2016). 
Thalamus 
The LC projects profusely to the thalamus (Lindvall, Bjorklund and Nobin, 1973; Jones and Yang, 
1985; Aston-Jones, 2004; Szabadi, 2013). This noradrenergic projection has been involved in 
sleep/wake cycle regulation, (Mccormick, Pape and Williamson, 1991) and in pain modulation 
(Westlund et al., 1991; Zhang et al., 1998). The NE modulation of thalamic circuits has been 
recently re-investigated. Rodenkirch and colleagues (Rodenkirch et al., 2019) studied the role of 
LC stimulation in thalamus-based sensory processing. LC activation increased thalamic based 
feature selectivity and improved information transmission acting through an α receptor mediated 
mechanism. These effects were shown to be mediated by a modulatory effect of NE on both the 
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ventral posteromedial nucleus (VPm) and on the thalamic reticular nucleus (TRN). Moreover, the 
LC stimulation led to an increase in the perceptual performance of animals in a tactile 
discrimination task (Rodenkirch et al., 2019). Since the thalamus is a structure involved in a 
multitude of brain functions, it is not surprising that LC→Thalamus projections have been also 
involved in stress responsivity. In this case, LC promotes the enhancing effects on the formation of 
aversive memories by disinhibiting the midline thalamus. This disinhibition occurs through the 
activation of D2 receptors by LC-dopamine release (Beas et al., 2018). 
Striatum 
Most areas of the striatum, especially its dorsal portion, have been considered for a long time 
to be devoid of NE containing terminals (Berridge and Waterhouse, 2003; Aston-Jones, 2004). 
Nonetheless, this notion has been recently challenged by a new study in which a retrograde viral 
tracing approach allowed to unveil LC-NE neurons sparsely projecting to the dorsal striatum (Zerbi 
et al., 2019). On the other hand, within the ventral striatum, in particular in the nucleus 
accumbens, there is a considerable noradrenergic innervation (Delfs et al., 1998). This NE 
containing terminals originates mainly from the A1-noradrenergic nucleus and only a minority of 
LC cells send projections to the accumbens (Delfs et al., 1998).  
Basal Forebrain 
The basal forebrain comprises different subcortical nuclei that are known to control arousal, 
attention and sleep/wake cycle (Ballinger and Ananth, 2016; Mena-Segovia, 2016). Notably, the 
medial septal area, the medial preoptic area, and the substantia imnominata all receive LC-NE 
projections (Berridge and Espana, 2006).  It has been shown that the LC and Basal Forebrain are 
intimately linked in the regulation of sleep/wake cycle. Cholinergic neurons of the basal forebrain 
are known to promote wakefulness, while somatostatin-positive GABAergic interneurons (SOM+) 
promote non-REM sleep (Xu et al., 2015). The NE released by LC inputs in the nucleus basalis of 
the substantia imonminata is able to modulate both cholinergic and GABAergic interneurons. In 
particular, NE positively modulates wakefulness-promoting cholinergic interneurons by an α1 
adrenoreceptor mediated mechanism (Fort et al., 1995). At the same time, NE decreases the firing 
rate of GABAergic interneurons by acting on α2 receptors (Manns et al., 2003). The LC released NE 




LC projects strongly to the Amygdala. Notably, both the central nucleus (CeA) and the 
basolateral nucleus (BLA) of the Amygdala are profusely innervated by LC-NE terminals (Asan, 
1998; Szabadi, 2013; Zhang, Muller and Mcdonald, 2013). NE released by LC terminals in the BLA 
promotes anxiety-like behavior. These effects are mediated by β-receptor signaling. Indeed, it has 
been shown that β-antagonism is sufficient to reduce the anxiety behavior induced by the opto-
stimulation of LC fibers in the BLA. Moreover, the optogenetic activation of LC→BLA inputs 
induced not only a real-time place-aversion but also a conditioned aversion, suggesting a 
facilitating role for NE released by LC in the formation of new associative memories with a negative 
valence (McCall et al., 2017). This finding goes in line with the known effect of NE in modulating 
amygdala plasticity and in promoting amygdala-dependent memory-consolidation (McGaugh, 
2002; Tully et al., 2007; Tully and Bolshakov, 2010).  
The role of NE in regulating the central Amygdala (CeA) function has been less investigated. 
Nonetheless, recently it has been hypothesized that LC→CeA projections are required for the 
expression of defensive responses elicited by conditioned stimuli (Gu et al., 2019).  
Hypothalamus and Midbrain 
The majority of NE terminals in the hypothalamus derive from the A1/A5 nuclei, however, the 
LC partially contributes to the noradrenergic innervation of this brain region (Cunningham and 
Sawchenko, 1988). The role that NE plays in modulating the activity of the hypothalamic neurons 
is still unclear. The hypothalamic nuclei collectively regulate many behavioral aspects: sleep and 
circadian rhythm, endocrine system, stress response, autonomic functions, just to cite few of 
them. Not surprisingly, the LC-NE system is interconnected with the hypothalamus, probably to 
allow better coordination during their overlapping processes, namely sleep and stress response 
regulation (Aston-Jones, 2004; Szabadi, 2013; Flak et al., 2014). 
LC axons have been found in the periaqueductal gray (PAG) (Fritschy and Grzanna, 1990) and two 
neuromodulatory structures: the dorsal raphe nucleus (DRN) (Peyron et al., 1996) and the ventral 
tegmental area (VTA) (Mejías-Aponte, Drouin and Aston-Jones, 2009; Isingrini et al., 2016; Mejias-
Aponte, 2016; Park, Bhimani and Park, 2017). The understanding of the mechanisms and functions 
of the crosstalk between neuromodulatory systems remains fragmented. Pudovkina and 
colleagues demonstrated that NE activates DRN cells via α1- receptor (Pudovkina, Cremers and 
Westerink, 2003) but the functions of such connections are unknown. On the other hand, the 
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mechanism of action of LC→>VTA remains elusive but it has been postulated that NE released in 
the VTA inhibits dopaminergic neurons. (Isingrini et al., 2016), The LC→VTA projection plays an 
important role in the behavioral coping strategy adopted by animals previously subjected to 
repeated/chronic stress (Isingrini et al., 2016). Animals subjected to chronic stress, especially 
exposed to repeated social defeat, show different anxiety levels (Bosch-Bouju et al., 2016) and can 
be divided into susceptible and resilient subgroups based on their social avoidance behavior 
(Golden et al., 2011). In susceptible animals displaying a high level of social avoidance, chronic 
optogenetic entrainment of LC→VTA projections was sufficient to convert the susceptible 
phenotype into the resilient one. The direct connection from the LC to DRN and VTA is a piece of 
important evidence to support the strong integration and inter-dependence between these sub-
cortical neuromodulatory nuclei. However, the possible behavioral implications of these pathways 
activation still need to be investigated.  
Cerebellum 
The Cerebellum, specifically the cerebellar cortex, receives dense noradrenergic projection 
from the LC (Olson and Fuxe, 1971). All three types of adrenoreceptors have been found in the 
cerebellar cortex:  α1, α2, and β receptors (Szabadi, 2013). NE, through these different 
adrenoreceptors, plays an important role in modulating cerebellar synaptic plasticity (Hoxha et al., 
2016). From a behavioral standpoint, NE is crucial in orchestrating the cerebellar-mediated 
acquisition of new motor skills. Animals depleted of NE in the cerebellum showed motor 
impairments when they had to learn new motor tasks (Watson and Mcelligott, 1984).  
Pons and Medulla Oblongata 
The entire brainstem receives dense NE containing axons. Notably, LC projects primarily to 
sensory and associative nuclei of this caudal brain region, while nuclei associated with autonomic 
and motor nuclei are richly contacted by non-LC NE-fibers (Levitt and Moore, 1979). Suggesting 
segregating functions for NE coming from different noradrenergic nuclei in this brain area.  
Afferent projections 
Classic studies aiming at investigating the structures sending projections to the LC were 
controversial. By injecting retrograde tracing into the LC certain groups reported that several brain 
regions projects to the LC (Cedarbaum and Aghajanian, 1978; Clavier, 1979), while others claimed 
that the number of areas projecting to the LC is extremely limited (Aston-Jones et al., 1986). In the 
first studies (Cedarbaum and Aghajanian, 1978; Clavier, 1979), the unconjugated-HRP technique 
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allowed to identify as primary forebrain inputs of the LC the central nucleus of the amygdala (CeA), 
the Bed Nucleus of the Stria Terminalis (BNST), the medial preoptic area, and the dorsomedial and 
paraventricular nuclei of the hypothalamus. Other relevant inputs were found in the brainstem, 
including the contralateral LC, midbrain central gray, vestibular nuclei, lateral reticular nucleus, 
and nucleus tractus solitarius (NTS). Significant inputs were also reported from the fastigial nucleus 
of the cerebellum. On the other hand, the succeeding Aston-Jones’ study (Aston-Jones et al., 
1986), using the WGA-HRP iontophoresis technique, identified as the major contributor for the 
bulk of fibers innervating the LC two medullary nuclei: the nucleus paragigantocellularis (PGi) and 
the nucleus posterior hypoglossi (PrH). The findings by Aston-Jones (Aston-Jones et al., 1986) were 
later confirmed by using the cholera toxin (CTb) retrograde tracing technique (Luppi et al., 1995). 
By using this technique, other regions were found to consistently project to the LC itself: the 
Kölliker- Fuse nucleus (noradrenergic A7 area), noradrenergic A5 area, median raphe (B9 area), 
and caudal and lateral hypothalamus.  These studies differed in the retrograde labeling technique 
used. The former studies (Cedarbaum and Aghajanian, 1978; Clavier, 1979) took advantage of the 
retrograde neuronal transport of the unconjugated horseradish peroxidase (HRP) to mark inputs 
of the LC, the inputs to the LC were then visualized with diaminobenzidine (DAB). This method, 
however, presents several limitations: 1) HRP diffuses substantially, allowing labeling of areas 
projecting adjacently to and not into the LC itself; 2) unconjugated-HRP is uptaken by en-passant 
fibers, possibly leading to the labeling of regions projecting through and not to the LC. Subsequent 
works  (Aston-Jones et al., 1986) used more sensitive and selective techniques: the iontophoretic 
deposition of wheat germ–agglutinin-conjugated HRP (WGA–HRP) in the LC, revealed by the 
tetramethylbenzidine (TMB) reaction. This method allowed to obtain restricted injection sites and 
made the uptake and the transport by neurons more efficient than the transport of unconjugated-
HRP. The discrepancies found in these initial studies can be partially due to the anatomical 
characteristic of the LC. LC neurites broadly extend outside LC borders in a region known as peri-
LC (Shipley et al., 1996). Therefore, the diffusion of the retrograde tracers (either unconjugated-
HRP, WGA-HRP, or CTb) in the peri-LC not only trace regions directly projecting into the LC but also 
regions forming synapses at distal dendrites of LC-NE neurons, in the peri-LC region.  At the same 
time, the unspecific diffusion of the tract-tracer outside LC borders represents a major drawback 
of these techniques since inputs to regions anatomically close to the LC (such as the Barrington’s 
nucleus) can be labeled, leading to possibly misleading results.  
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Recently, the controversial anatomical characterization of LC afferents has been more definitely 
addressed thanks to the trans-synaptic rabies viral tracing method (Schwarz and Luo, 2015; 
Breton-Provencher and Sur, 2019). These studies used a mouse line in which the Cre recombinase 
is expressed under the Dopamine Beta Hydroxylase promoter (DBH-Cre), to restrict to LC-NE 
neurons the cells from which the retrograde tracing occurs. Only DBH+ starter-cells can be virally 
infected; within these cells then the rabies virions replicate and then spread retrogradely to the 
mono-synaptically connected pre-synaptic neurons (Saleeba et al., 2019). Contrary to previous 
techniques, rabies viral tracing allowed to reach neuronal subtype specificity and to label LC input 
regions regardless of their preference to synapse with LC neurons soma or dendrites. Remarkably, 
in both studies, an array of different brain regions has been consistently shown to directly synapse 
to LC-NE neurons (Figure 6).  
Neocortex 
Retrograde studies showed that most areas of the cortex project to the LC (Luppi et al., 1995; 
Szabadi, 2013; Schwarz et al., 2015; Breton-Provencher and Sur, 2019). Amongst the different 
cortical areas, the prefrontal cortex (PFC) has one of the strongest connections to the LC. PFC 
projects mainly to the peri-LC area, where the LC neurons extend their dendritic arborization 
(Arnsten and Goldman-Rakic, 1984; Luppi et al., 1995). Although the PFC input is relatively sparse, 
indeed only a limited number of cortical pyramidal neurons are connected to the LC, it exerts a 
Figure 6 (A) Schematic for targeting delta G-protein Rabies virus (RVdg) to LC-NE neurons (LC-NE). (B) Transynaptically 
labeled neurons in different brain regions following injection of RVdG in LC of Dbh-Cre mice. LC receives projections 
from multiple brain regions. BNST, bed nucleus of the stria terminalis; Cb, cerebellum; CbN, cerebellar nuclei; CnF, 
cuneiform nucleus; DB, diagonal band; DpMe, deep mesencephalic nucleus; Gi, gigantocellular nucleus; IC, inferior 
colliculus; IPL, interpeduncular nucleus; LH, lateral hypothalamus; LHb, lateral habenular nucleus; MC, motor cortex; 
PAG, periaqueductal gray; PaV, paraventricular nucleus; PH, posterior hypothalamus; PnO, pontine nucleus; PO, 
preoptic nucleus; Pr, prepositus nucleus; PSTh, parasubthalamic nucleus; Rt, reticular nucleus; SC, superior colliculus; 
SN, substantia nigra; Sp5, spinal trigeminal tract; SPF, subparafascicular thalamic nucleus; SuM, supramammillary 
nucleus; ZI, zona incerta. Modified from Breton-Provencher and Sur, 2019). 
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potent drive on LC-NE neurons (Jodo, Chiang and Aston-Jones, 1998; Sara and Bouret, 2012). 
Counterintuitively, this connection has been shown to produce both an excitatory and an 
inhibitory effect on LC (Sara and Hervé-Minvielle, 1995; Jodo, Chiang and Aston-Jones, 1998). This 
discrepancy might be explained by the technical differences in the anesthesia method used in the 
two different studies (ketamine, which has been used in Sara and Hervé-Minvielle study, is a 
known NMDA receptor blocker and it probably affected the glutamatergic connection between 
the PFC→LC connection). More interestingly, the recent finding by Breton-Provencher (Breton-
Provencher and Sur, 2019) demonstrating a direct synaptic connection between the PFC and both 
the LC-NE neurons and the LC-GABAergic interneurons, can account for the previously observed 
incongruity on the role of PFC connection to the LC. In this scenario, the PFC can either inhibit LC-
NE neurons by activating local LC-GABAergic interneurons or, through a mono-synaptic 
connection, directly excite LC-NE neurons. 
 The strong reciprocal connection between PFC and LC activity is further supported by the phase-
locking between the LC spiking and the cortical excitability fluctuations. In non-anesthetized rats, 
during NREM sleep, about 50% of LC units are phase-locked and they fire during the cortical 
transition from “down” to “up” states (Eschenko et al., 2012; Sara and Bouret, 2012). These 
findings suggest the involvement of the LC in the cortical state transition and imply an interaction 
between the PFC and the LC during slow-wave oscillations, moreover, they are compatible with a 
possible PFC-LC excitatory loop. These results, however, do not rule out whether is the LC that 
drives PFC oscillations or vice-versa if the PFC drives LC firing.  
Amygdala 
The LC receives a relevant projection from the primary output nucleus of the amygdala: the 
Central Amygdala (CeA) (Wallace, Magnuson and Gray, 1989; Van Bockstaele, Colago and 
Valentino, 1998; Reyes, Drolet and Van Bockstaele, 2008; McCall et al., 2015; Schwarz et al., 2015; 
Breton-Provencher and Sur, 2019). This nucleus sends corticotropin-releasing factor (CRF) 
projections to the LC (Van Bockstaele, Colago and Valentino, 1998; Reyes, Drolet and Van 
Bockstaele, 2008; McCall et al., 2015) (see the paragraph in this dissertation: “LC, stress and the 
role of Corticotropin-Releasing Factor (CRF): between acute effects and long-lasting adaptations” 
for an explanation regarding the CRF effects on LC-NE neurons). Recently it has been shown that 
CeA terminals projecting to the LC contain the opioid peptide Dynorphin (DYN) in addition to CRF 
(Reyes, Drolet and Van Bockstaele, 2008). DYN released from CeA neurons promotes anxiety 
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(Pomrenze et al., 2019), but the exact role of DYN released from the CeA into the LC is not 
established yet. Interestingly, CeA→LC axon terminals do not release fast neurotransmitters, 
indeed optogenetic activation of CeA-CRF+ terminals in the LC does not evoke any inhibitory or 
excitatory postsynaptic current (McCall et al., 2015). 
Hypothalamus  
Different hypothalamic nuclei involved in sleep/wake regulation project to the LC. These nuclei 
are known to release different neurotransmitters and/or neuromodulators that ultimately affect 
LC activity. For instance, the sleep-promoting Ventrolateral preoptic nucleus (VLPO) contains 
GABAergic projecting neurons that send axons to the LC. This connection, through a GABAergic 
mediated inhibition of LC-NE neurons, is possibly involved in sleep promotion (Steininger et al., 
2001; Szymusiak and McGinty, 2008). Conversely, the wake-promoting Lateral Hypothalamus (LH) 
and Tuberomammillary nucleus (TMN) send respectively an orexinergic and a histaminergic 
projection to the LC (Horvath et al., 1999; Korotkova et al., 2005; Lee, Lee and Waterhouse, 2005; 
Cid-Pellitero and Garzón, 2011). Both neuromodulators activate LC neurons facilitating 
wakefulness (Horvath et al., 1999; Korotkova et al., 2005). 
The LC receives inputs from another hypothalamic structure: the Paraventricular Nucleus (PVN). 
The PVN is a part of the Hypothalamic–pituitary–adrenal (HPA) axis and it is therefore intimately 
related to stress response. Corticotropin-releasing factor (CRF) is released from PVN neurons to 
initiate HPA axis activation, ultimately leading to the secretion of corticosteroids from the adrenal 
glands (reviewed in Herman et al., 2016). The PVN sends CRF containing terminals to the LC. The 
PVN→LC terminals form a substantial proportion of asymmetric synapses, suggesting that CRF can 
be co-released together with glutamate in the Locus Coeruleus (Reyes et al., 2005). Remarkably, 
Reyes' work supports the existence of two populations of PVN-CRF+ cells with a distinct output 
profile. One group of neurons projects to the median eminence (ME; the structure, devoid of a 
blood-brain barrier, where hormones produced by the hypothalamus are collected before entering 
general circulation) and is, hence, part of the HPA axis; the second non-overlapping population of 
cells, on the other hand, sends projections to the LC (Reyes et al., 2005). Therefore, stress, through 
PVN-CRF+ neurons, might differentially affect the HPA axis and LC activation. This can potentially 




Ventral Tegmental Area (VTA) 
The LC receives a connection from the VTA (Beckstead, Domesick and Nauta, 1979; Ornstein et 
al., 1987). This pathway is comprised mainly of non-dopaminergic (DA) fibers, although a small 
portion of VTA-DA-fibers is present within the LC  (Swanson, 1982). Indirect evidence points at an 
excitatory drive exerted by the VTA connection on LC neurons. Indeed, local delivery of 
glutamatergic agonists (kainite) in the VTA increases the levels of the norepinephrine (NE) 
metabolite 3-methoxy-4-hydroxyphenolglycol (MHPG) in LC target brain regions (Deutch, 
Goldstein and Roth, 1986).  
Dorsal Raphe Nucleus (DRN) 
The DRN and the LC are reciprocally connected. The DRN→LC projection comprises both 
serotonergic and non-serotonergic terminals. Furthermore, DRN→LC has been shown to be more 
robust than the connection in the opposite direction (LC→DRN) (Segal, 1979; Kim et al., 2004). 
Serotonin (5-HT) in the LC has been proposed to have an inhibitory role (Segal, 1979), acting 
primarily via 5-HT1A  (Pudovkina et al., 2001; Pudovkina, Cremers and Westerink, 2002) and 5-HT2 
(Gorea et al., 1991) receptors. However, a detailed dissection of the behavioral role of this 
neuromodulatory regulation has not been addressed yet.   
Periaqueductal Gray (PAG) 
The PAG is a heterogeneous group of cells surrounding the cerebral aqueduct within the 
midbrain. PAG activity has been associated with a variety of different behavioral functions such as 
stress response, pain modulation, vocalization and sleep regulation (reviewed in Benarroch, 2012; 
Keay and Bandler, 2015). A conspicuous number of PAG neurons send projections to the LC (Bajic 
and Proudfit, 1999; Bockstaele et al., 2001; Schwarz et al., 2015; Kim et al., 2018). PAG terminals 
within the LC form mainly symmetric synapses; consistently PAG electrical stimulation has an 
inhibitory effect on LC-NE neurons (Ennis et al., 1991; Bockstaele et al., 2001).  It has been recently 
demonstrated that PAG→LC projection plays an important role in opioid-induced analgesia (Kim 
et al., 2018). 
Lateral Dorsal Tegmental and Pedunculopontine nuclei (LDT/PPN) 
LDT/PPN cholinergic neurons project to the LC (Jones and Yang, 1985; Jones, 1990). No studies 
directly addressed how the activity of LC-NE neurons is modulated by cholinergic afferents, 
however, acetylcholine is known to exert an excitatory effect on LC neurons acting through both 
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muscarinic and nicotinic receptors (Engberg and Svensson, 1980; Egan and North, 1985; Léna et 
al., 1999).  
Nucleus Paragigantocellularis (PGi) 
The PGi is a nucleus located in the rostral ventrolateral medulla. This nucleus provides an 
excitatory/glutamatergic input to LC cells (Ennis and Aston-Jones, 1988) and it is one of the 
strongest projections to the noradrenergic nucleus (Aston-Jones et al., 1986; Aston-Jones, 2004; 
Schwarz et al., 2015). PGi neurons are involved in the regulation of autonomic functions such as 
cardiovascular and respiratory control (Van Bockstaele and Aston-Jones, 1995). Consequently, it 
has been suggested that the LC might broadcast the autonomic information conveyed from the 
PGi to the rest of the brain thanks to LC- NE neurons' widespread projections.  
Nucleus Prepositus Hypoglossi (PrH) 
PrH is a nucleus situated in the dorsomedial rostral medulla, it is part of the horizontal gaze 
holding system, that is involved in the horizontal positioning of the eye in the ocular orbit 
(Mcfarland and Fuchs, 1992; Kim, Zee and Lac, 2016). GABAergic PrH neurons of the dorsomedial 
rostral medulla send an inhibitory projection to the LC (Ennis and Aston-Jones, 1989a, 1989b). This 
inhibitory PrH→LC projection has been involved in the regulation of REM sleep, since stimulation 
of PrH increased the duration of REM sleep episode in an LC activity-dependent manner (Kaur, 
Saxena and Mallick, 1997, 2001).  
Functional properties of a LC-NE neuron 
Typical LC-NE neurons show resting membrane potential ranging between -55 and -65 mV, a 
fairly high input resistance (≈200 MΩ) and action potential threshold around -55mV (Williams et 
al., 1984). They display slow and moderately regular spontaneous discharge (≈0.5-10 Hz) (Graham 
and Aghajanian, 1971) with relatively broad action potentials (≈1-2ms (Williams et al., 1984; 
Berridge and Waterhouse, 2003)). LC-NE spontaneous discharge has been consistently recorded 
in in-vivo (both in awake and anesthetized animals) (Sugiyama et al., 2012), ex-vivo (Williams et 
al., 1984; Zhang et al., 2010) and in primary cultured LC neurons (Masuko et al., 1986). Because in 
primary cultured LC neurons synaptic connections with afferent regions are lost, these studies 
suggest that spontaneous discharge of NE-neurons results from a cell-autonomous peacemaking 
mechanism. Accordingly, blocking fast excitatory transmission in LC brain slices does not prevent 
LC tonic discharge (Sanchez-Padilla et al., 2014). LC neuron peacemaking activity relies on a 
combination of a TTX sensitive Na+ current, a high TEA-sensitive most likely Ca2+ activated K+ 
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conductance, and a persistent Ca2+ current (Williams et al., 1984; Oliveira and Howlett, 2010; 
Sanchez-Padilla et al., 2014). Moreover, it has been proposed that cAMP might drive or modulate 
LC tonic firing (Alreja and Aghajanian, 1991).  
LC-NE tonic firing is linked to the arousal level and sleep/wake cycle (Hobson, McCarley and 
Wyzinski, 1975; Foote, Aston-Jones and Bloom, 1980; Carter et al., 2010; Swift et al., 2018; Breton-
Provencher and Sur, 2019). Locus Coeruleus neurons fire tonically during wakefulness, their 
activity strongly decreases during non-Rapid Eye Movement (REM) sleep and they are virtually 
silent during REM (G. Aston-Jones and Bloom, 1981; Carter et al., 2010; Takahashi et al., 2010).  
Recent optogenetic studies have demonstrated that neural activity in the LC not only correlates 
with sleep/wake cycle but it is instrumental to maintain wakefulness. It is sufficient to increase LC 
activity to promote awakening and to increase locomotor arousal (Carter et al., 2010). During 
sleep, especially during REM, LC tonic activity is silenced thanks to a mechanism involving an 
inhibitory GABAergic control exerted by the projections from the nucleus Prepositus Hypoglossi 
(PrH) (Kaur, Saxena and Mallick, 1997, 2001). The fine regulation of LC tonic activity during sleep 
and the complete spectrum of neuromodulators that shape LC activity, however, remain to be 
elucidated.  
During wakefulness, the level of LC tonic activity and the performance in a given behavioral task 
follow an inverted-U relationship (also called Yerkes-Dodson relationship (Yerkes and Dodson, 
1908; Teigen, 1994)) (Figure 7). For instance, performance in a discrimination task is low at low 
levels of LC tonic firing. This low level of LC activity is associated with drowsiness and non-alertness. 
On the opposite side of the spectrum, a very high level of LC tonic activity is related to poor 
performance; subjects show a labile attentiveness that doesn’t allow them to focus optimally in a 
given task. At the same time, high tonic firing is linked with increased behavioral flexibility that 
might be required when animals are exposed to a new environment. To ensure optimal 
performance under stable conditions subjects must be attentive and focused this condition 
correlates with a moderate level of LC tonic firing. LC activity is therefore crucial in finely regulating 
the trade-off between focused-optimal and flexible behavior (Aston-Jones, Rajkowski and Cohen, 
1999; Aston-Jones and J. D. Cohen, 2005) (Figure 7).  
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While the tonic activity of LC neurons results from the intrinsic properties of its neurons, LC phasic 
activity results from the integration of sensory inputs of different modalities. Novel or salient 
multimodal-stimuli, as well as top-down decision-making processes, are able to elicit phasic 
discharge of LC-NE neurons (Foote, Aston-Jones and Bloom, 1980; Gary Aston-Jones and Bloom, 
1981; Berridge and Waterhouse, 2003; Clayton et al., 2004). These bursts of activity, superimposed 
to the tonic firing, are composed of few action potentials, usually 2-3, at 10-20 Hz. Often, these 
phasic bursts are followed by a suppression of the firing rate lasting 300-700ms (Berridge and 
Waterhouse, 2003; Devilbiss and Waterhouse, 2010). Phasic and tonic discharge modalities are 
interdependent in that phasic responses are correlated with the underlying tonic activity. 
Moderate tonic discharge allows optimal phasic responses when a salient stimulus is presented to 
the subject. In-contrast, phasic responses are weaker when tonic firing is too low for instance 
during drowsiness, or when tonic firing is too high, as in stressful situations (Valentino and Foote, 
1987; Berridge and Waterhouse, 2003; Aston-Jones and J. D. Cohen, 2005).   
The LC neurons post-activation inhibition is, at least partially, dependent on autocrine and 
paracrine NE release. The autoreceptor α2 is thought to play a primary role in this auto-inhibitory 
effect. Accordingly, iontophoretic local application of NE causes inhibition of LC firing, which is 
Figure 7 Inverted U-shape relationship between Locus Coeruleus (LC) activity and performance on a task that requires 
focused attention. Performance is poor at very low levels of LC tonic discharge (depicted by the peri-stimulus histogram 
(PSTH) in black). Performance is optimal with moderate LC tonic activity and prominent phasic LC activation when 
exposed to salient stimuli (black arrow). Adapted from Aston-Jones and J. D. Cohen, 2005. 
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prevented by the antagonism of the α2 receptor (Kimura and Nakamura, 1987). Moreover, the α2-
receptor agonist clonidine suppresses LC-NE firing  (Svensson, Bunney and Aghajanian, 1975; 
Svensson and Usdin, 1978).  
From a network perspective, the LC has been long considered to be an undifferentiated “state 
controller” of the brain as for many other neuromodulatory nuclei (Lee and Dan, 2012). Supporting 
this view, extracellular recordings of spiking and field potentials indirectly suggested widespread 
network synchronicity within the LC (Gary Aston-Jones and Bloom, 1981; Akaike, 1982; Sakaguchi 
and Nakamura, 1987; Ishimatsu and Williams, 1996; Alvarez et al., 2002). Recent evidence, 
however, supports an ensemble-based organization of the noradrenergic nucleus. This new model 
envisages that subsets of LC-neurons are not necessarily firing synchronously. This would allow for 
more fine control of NE release in different brain regions targeted by different ensembles 
(Chandler, Gao and Waterhouse, 2014; Schwarz et al., 2015; Hirschberg et al., 2017; Uematsu et 
al., 2017; Totah et al., 2018). Consistently with this view, single-unit large-scale population 
recordings of the LC demonstrated the existence of an ensemble code in this brain region (Totah 
et al., 2018). In anesthetized rats, LC population activity was not characterized by correlations 
amongst all the single units. However, sparse and everchanging correlations among networks of 
LC cells were found on a broad range of timescales amongst different subsets of single-units. 
Moreover, spiking was not found to be a population event involving the whole LC structure even 
when nociceptive stimuli, which are thought to evoked synchronous discharge in many LC cells 
(Gary Aston-Jones and Bloom, 1981), were delivered to the animal. In this context, the reported 
presence of gap-junctions amongst neurons in the developing and adult LC (Christie and Jelinek, 
1993; Travagli, Dunwiddie and Williams, 1995; Ishimatsu and Williams, 1996; Bockstaele et al., 
2004; Rash et al., 2007) might be possibly involved in the sharp sub-milliseconds correlations that 
were found between small neural-networks. This type of sharp synchronicity was found only in 
neuronal pairs, suggesting that this form of activity-correlation is limited and spatially confined 
(Totah et al., 2018). Correlations over longer time scales (up to tens of milliseconds), on the other 
hand, are possibly caused by shared synaptic inputs among LC neurons and modulation of the 
synchrony timing by lateral inhibition (Totah et al., 2018). These findings advocate against LC as an 
undifferentiated state controller of the brain and suggest that LC is a complex nucleus with 
heterogeneous network dynamics among different ensembles.  
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The understanding of the functional properties of LC neurons was -and still is- essential to 
postulate hypotheses regarding the potential behavioral functions of this important 
neuromodulatory hub. Recent findings point to a new scenario in which the diversity in functional 
and physiological properties of LC-NE neurons allows for a nuanced and finely tuned 
neuromodulation. Nonetheless, these studies are not in opposition to the notion of LC-mediated 
global neuromodulatory changes in brain states (i.e. regulation of arousal or sleep/wake cycle) but 
they rather contribute to its refinement. 
Plasticity in the LC 
In the previous paragraphs, I described some of the “steady-state” properties of LC-NE neurons. 
However, the brain can rapidly adapt to changes in the environment by virtue of its plastic 
properties (Kandel, Dudai and Mayford, 2014). Although the effects of NE in gating and modulating 
plasticity in numerous LC target brain regions is well established, very few studies have been 
performed trying to address whether and how plasticity occurs in the LC itself.  
LC developmental plasticity 
Nakamura and Sakaguchi (Nakamura and Sakaguchi, 1990) have systematically recorded the in-
vivo tonic and sensory-evoked responses in rat LC neurons at different developmental stages. In 
their pioneering studies, they have shown a dramatic change in the spontaneous activity of LC 
neurons extracellularly recorded activity from the prenatal period to adulthood.  Conversely to 
what has been shown in adults, most LC cells in fetal and neonatal rats show no spontaneous 
activity, the fewer LC neurons showing tonic firing displayed sporadic discharge spaced by periods 
of long-lasting inactivity. During development, the firing pattern became more regular, with rats 
at postnatal day 20 (P20) showing tonic firing in most LC cells.  
Given their higher chance of being silent, one can speculate that LC neurons during perinatal 
development are not functional yet. As a matter of fact, even at prenatal stages, LC neurons 
responded strongly to tactile stimulations like air-puffs (Sakaguchi and Nakamura, 1987), 
suggesting that they are already functional but still undergoing a maturation process. LC neurons 
of adult awake animals are able to respond to multimodal sensory stimulation, this feature, 
however, is lost in adult anesthetized animals. In this condition, only noxious stimuli are able to 
phasically entrain the noradrenergic cells (Korf, S. Bunney and K. Aghajanian, 1974), while non-
noxious and non-tactile stimuli are ineffective. Surprisingly, in LC cells of neonatal rats, tactile 
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noxious and non-noxious stimuli but also visual and auditory ones were effective in activating 
noradrenergic neurons. This suggests that in younger rats LC evoked activity is more tightly linked 
to the peripheral sensory system compared to adult subjects. Moreover, the response latency to 
sensory stimulation was shown to decrease along different developmental stages, underlining how 
LC neurons are still under development at the different time-points inspected.   
Sakaguchi also estimated the conduction velocity of LC-NE axons by using the antidromic 
stimulation technique at different developmental stages. In his studies, he showed how LC axons 
are able to conduct action potential in cortical areas already at prenatal stages. To evaluate 
possible developmental changes in the conduction efficiency of LC neurons, Sakaguchi measured 
the latency between the stimulation in the frontal cortex and the antidromic spikes recorded in 
the LC demonstrating a strong consistency of the antidromic latency amongst different 
developmental stages (≈40ms). On the other hand, the estimated mean conduction velocity has 
been shown to increase to keep up with the increase in brain size, which allows the maintenance 
of constant conduction time in an expanding brain. It is worth noting that the conduction time 
from the LC to the frontal cortex has been shown to be similar not only amongst different ages but 
also amongst different animal models, such as in rodents and monkeys (Aston-Jones, Foote and 
Segal, 1985; Nakamura, Kimura and Sakaguchi, 1987). This evidence suggests that the conduction 
time from the LC to target brain regions is a crucial feature for the correct physiological function 
of the noradrenergic nucleus.  
The pioneering studies of Nakamura and Sakaguchi first showed how LC neurons undergo 
profound developmental plastic changes. Up to now, it is not yet understood which internal and 
external factors shape this developmental trajectory and how the observed differences in the LC 
tonic firing pattern and in the sensory-evoked responses shape animal behavior.  
LC, stress and the role of Corticotropin-Releasing Factor (CRF): between acute effects and long-
lasting adaptations  
During stress exposure, Corticotropin-Releasing Factor (CRF) is released into the LC by different 
stress-responsive brain regions: the Paraventricular Nucleus (PVN), the Central Nucleus of the 
Amygdala (CeA), the Bed Nucleus of the Stria Terminalis (BNST) and the Barrington’s nucleus 
(Valentino et al., 1992; Valentino, Bockstaele and Van Bockstaele, 2008; McCall et al., 2015). CRF, 
through the activation of CRF1R (Jedema and Grace, 2004; Reyes et al., 2006), a Gs-coupled 
receptor, increases LC tonic discharge rate (Valentino, Foote and Aston-Jones, 1983). The 
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increased tonic firing of LC-NE neurons is associated with impairments in sensory signal 
discrimination, cognitive impairments and increased levels of anxiety (Aston-Jones and Jonathan 
D. Cohen, 2005). At first sight, this might seem a maladaptive response. However, it has been 
hypothesized that an increased LC tonic discharge, therefore high NE level, promotes vigilance and 
facilitates an escape response from threatening situations (Valentino, Bockstaele and Van 
Bockstaele, 2008; Borodovitsyna, Joshi and Chandler, 2018) by dampening top-down inhibition 
from the prefrontal cortex (PFC) to subcortical structures (Birnbaum et al., 1999; Ramos and 
Arnsten, 2007). It is worth noting, however, that the modulatory effect of specific CRF containing 
inputs onto LC neurons might induce more subtle changes that the ones described so far. McCall 
and colleagues (McCall et al., 2015) showed that when CRF+ terminals from the CeA are 
optogenetically activated, roughly half of the responsive LC units increased their firing and the 
other half was significantly inhibited. Although the effect on LC neuron firing rate was not 
homogeneous, this optogenetic stimulation was sufficient to induce an aversive and anxiogenic 
behavioral response (Figure 8). The effects of the photostimulation were rescued by the 
antagonism of CRF1R, demonstrating a direct involvement of CRF.  
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Acutely, CRF increases LC tonic firing signaling through a cAMP-dependent mechanism, an 
intracellular increase of cAMP leads to an inhibition of a K+ conductance and hence to a 
depolarization of the noradrenergic neurons (Jedema and Grace, 2004). Moreover, the acute 
application of CRF on brain slices induces a dose-dependent effect on excitatory spontaneous 
transmission. Lower concentration of CRF1R agonist (50µM CRF) increases the amplitude and 
charge transfer of spontaneous Excitatory Postsynaptic Currents (sEPSCs), while higher 
Figure 8  (A) Schematic showing the viral-genetic strategy used to obtain specific expression of ChR2 in Central Amygdala 
(CeA) CRF+ neurons and the optic fiber implant in the Locus Coeruleus (LC). A CRH-Cre driver mouse line has been used 
for this purpose. (B) Mice injected with ChR2 show a significant Conditioned place aversion compared to mice injected 
with an eYFP control virus. (C) As depicted in the schematic selective illumination of CeA-CRF containing terminals in 
the LC increases anxiety behavior and is aversive. Modified from McCall et al. 2015.  
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concentration of CRF (200µM) leads to a significant decrease in excitatory synaptic transmission 
(Prouty, Waterhouse and Chandler, 2016). Similarly to what has been observed upon bath applying 
CRF on LC brain slices, a single exposure to a combination of stressors (restraint stress coupled to 
predator odor exposure) decreased synaptic transmission efficacy with a reduction in sEPSC 
amplitude and charge transfer. Furthermore, the LC spontaneous discharge rate was higher in 
stressed compared to control subjects. The observed excitability change was not accompanied by 
a change in the neuronal input resistance (Borodovitsyna, Flamini and Chandler, 2018). 
Interestingly, in 5-6 weeks old rats, a single stressor exposure was not only able to induce short 
term modification but also long-lasting effects on LC-NE neurons: a form of experience-dependent 
plasticity. When tested one week after the stressful experience, sEPSCs amplitude -but not 
frequency- was still lower in LC neurons of stressed animals. This points at a long-lasting adaptation 
occurring at glutamatergic synapses upon a single exposure to stress. The effect on synaptic 
transmission was co-occurring together with neuroplastic changes in neuronal excitability: 
similarly to what was observed immediately after stress exposure, spontaneous LC-NE neuron 
discharge rate was higher upon stress exposure. Contrary to the acute study, the input resistance 
and the action potential threshold of LC-NE neurons were affected by a single stress-exposure 
when probed one week later, indicating a possible re-arrangement of the cells’ conductances that 
takes time to be established (Borodovitsyna, Flamini and Chandler, 2018). These findings suggest 
that even short and acute exposure to stressors chronically increase LC-NE firing. This would likely 
lead to changes in the level of NE released in target brain regions which is ultimately crucial in the 
fine modulation and regulation of a variety of behavioral tasks.    
CRF, possibly released in the LC upon stress exposure, is not only able to shape excitatory 
transmission, but it also induces strong morphological changes in noradrenergic neurons by acting 
on the cells’ cytoskeleton (Cibelli et al., 2001; Swinny and Valentino, 2006; Bangasser et al., 2012).  
In immortalized neurons derived from LC neurons, CRF triggers the formation of long and thin 
neurites, which is dependent on cAMP production and ERK signaling cascade (Cibelli et al., 2001). 
A similar effect has also been observed in organotypic slices containing LC cells (Swinny and 
Valentino, 2006). In this study, 12h exposure to CRF induced an increase in the number of LC-NE 
primary processes, in the number of branching points and in the length of the processes. These 
effects were mediated by CRF1R since the application of a non-selective CRF1/CRF2R antagonist 
(Astressin 10µM) prevented the effects on processes morphology, while CRF2R specific 
antagonism (antisauvagine-30, 1µM) was ineffective. Not surprisingly, the cytoskeleton 
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rearrangements were mediated by the activation of the Rho GTPase Rac1. Rac1 is known to 
promote neurite outgrowth and morphology (Ruchhoeft et al., 1999; Woo and Gomez, 2006). As 
expected, the inhibition of Rac1 prevented the stimulatory effect of CRF on neurites outgrowth 
and morphology. In line with these findings, overexpressing CRF neuropeptide increased 
significantly the complexity of LC-NE neuron dendritic arborization (Bangasser et al., 2012).  
In summary, these studies suggest that stress, most likely through CRF release in the LC, induces 
an immediate response and profound long-lasting adaptations in noradrenergic neurons. Overall 
it has been shown that CRF alters synaptic transmission and neuronal excitability, moreover, it 
induces morphological and dendritic rearrangements. These effects are mediated by the activation 
of CRF1R and its downstream signaling cascades, which include cAMP/PKA and MAPK/ERK 
activation. The plastic changes in activity and morphology of LC neurons can profoundly affect 
target brain regions that receive profuse noradrenergic innervation. Changes in NE levels, in turn,  
could promote a “neuroadaptation cascade” in areas crucially regulated by norepinephrine 
signaling, such as the hippocampus (Doze et al., 2011; Kempadoo et al., 2016), the amygdala 
(Kravets et al., 2015; Schiff et al., 2017) and the frontal cortex (Birnbaum et al., 1999; Arnsten, 
2000; Ramos and Arnsten, 2007; Wang et al., 2007). 
Synaptic plasticity in the LC: a field yet to explore 
Albeit the amount of research conducted in the last four decades, few studies on the LC have been 
focused on the plastic properties of its synapses. Recent evidence (including the studied reported 
in the previous paragraph showing how acute stress persistently modulates synaptic transmission 
(Borodovitsyna, Flamini and Chandler, 2018)) suggests that LC synapses can undergo different 
forms of plasticity following diverse stimuli. Synaptic plasticity in LC neurons might be instrumental 
to finely set the gain of LC evoked responses, making more efficient the selection process of salient 
stimuli. At the same time, drugs of abuse can induce maladaptive forms of plasticity that can 
contribute to withdrawal and reinstatement of drug-seeking. Although limited in number, these 
studies demonstrate how flexible and adaptable is the LC system. Nevertheless, the fine molecular 
mechanisms involved in these forms of plasticity and their functional implication are far from being 
clearly elucidated.  
Hereafter I reported two different case studies in which synaptic plasticity has been shown to occur 
in LC-NE cells.  
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LC plasticity driven by auditory stimuli 
To address whether LC neuronal activity is affected by auditory experiences, Martins and Froemke 
(Martins and Froemke, 2015) performed patch-clamp recordings of LC neurons while assessing 
their responsiveness to auditory stimulation. As previously described (see: “LC developmental 
plasticity”), in adult rats pure tones did not evoke any responses in LC cells. Nonetheless, following 
a repetitive pairing of the auditory stimulus with a nociceptive stimulation (foot-shock), LC neurons 
became specifically responsive to the paired tone. Moreover, substituting foot-shock stimulation 
with LC electrical stimulation was enough to induce responses to auditory-stimuli in previously 
unresponsive LC cells. This form of long-lasting auditory driven plasticity was dependent on NMDA 
receptors. Indeed, the antagonism of this glutamatergic receptor with AP-V was sufficient to 
prevent the observed plastic change. This form of plasticity was similar to the potentiation 
previously described in silent synapses of other brain regions (Montgomery, Pavlidis and Madison, 
2001).  
Martins and Froemke, additionally, assessed the role of LC-NE stimulation in modulating the 
cortical sensory representation of auditory stimuli. By performing electrophysiological recordings 
of neurons in the primary auditory cortex (AI), they quantified the tuning curves of AI cells. They 
measured AI tuning curves before and after a pairing protocol in which a defined pure tone was 
paired to electrical or optogenetic stimulation of the LC-NE neurons (LC-tone pairing). The LC-tone 
pairing induced: 1) an initial increase in cortical responses to all tone frequencies lasting 5-10 
minutes or, in other words, a broadened tuning curve; 2) a shift of the best-frequency to the paired 
one; 3) a subsequent return of the tuning curve width to baseline condition, with a maintained 
preference for the paired tone lasting for the whole duration of the recording. At the same time, 
the LC pairing induced a significant increase in both, tone evoked EPSCs and IPSCs in AI cortical 
cells. This was co-occurring with a decrease in spontaneous inhibition without affecting excitatory 
synaptic transmission. The described decrease in spontaneous inhibition, together with an 
unaffected evoked transmission, would act as a simple gain enhancer for all the incoming inputs 
regardless of whether they were precedently paired or not. The authors then aimed at 
understanding whether the observed disinhibition of spontaneous transmission could, on its own, 
account for the tuning-shift observed during the LC-tone pairing. To address this question, they 
measured the responses of AI cortical while antagonizing the GABA-A receptor. The disinhibition 
caused by the GABA-A antagonism was sufficient to progressively tune the synaptic responses to 
a repeated tone and not to other frequency tones. Furthermore, this effect was dependent on 
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NMDA receptor activation in AI cells. Therefore, disinhibition coupled with a repeated tone is 
sufficient to induce long-lasting enhancement of the AI neurons responses to a selective tone 
frequency. NE, consequently, might tune the best-frequency by decreasing the spontaneous 
inhibitory tone in the AI cortex. 
NE in the cortex activates α-adrenergic receptors. These receptors are necessary for the induction 
and maintenance of the best-frequency shift induced by LC-tone pairing: the antagonism of these 
receptors prevented the tuning shift induced by pairing. The authors, thus, hypothesized a 
scenario in which modifications induced in the LC are required for AI cortical plasticity. In this way, 
after the pairing protocol, every other paired tone would induce NE release in the cortex, and this 
would, in turn, be necessary to maintain reliable changes in cortical representations. If this holds 
true, the antagonism of NMDA receptors confined in the LC would prevent subsequent long-lasting 
shifts in the AI neurons tuning curves upon pairing. Accordingly, when AP-V (that has already been 
shown to be necessary for plastic changes in LC) was applied locally in the LC, the enduring effect 
of LC-pairing on AI tuning-shifts was dramatically decreased.  
The authors then tested whether the LC pairing was able to affect auditory perception and 
discrimination. In a cued operant conditioning task, rats had to nose-spoke for food reward in 
response to a specific target tone stimulus, while refraining from responding to foil tones. When 
the target tone was paired to a short-term optogenetic LC-stimulation, the animal’s ability to 
detect auditory stimuli and, therefore, to respond correctly in the behavioral task, was greatly 
increased. In particular: 1) the likelihood of responding to low-intensity stimuli at a given 
frequency, previously unable to be detected, increased; 2) the ability to detect spectrally similar 
tones, initially decreased for the first hours, then gradually increased to reach an above-baseline 
level at 12h after training. This mirrored the effects of LC-tone pairing on the AI cortex: an initial 
broadening of the tuning curve, with a subsequent re-sharpening of the curve to the new best-
frequency. The effect on animals' performance lasted for days after training and it was prevented 
by AP-V infusion in the LC, strongly supporting the importance of LC plastic changes induced by 
NMDA receptor activation. Finally, LC pairing was able to improve behavioral performance in a 
reversal-learning task. Animals first trained to respond to a specific pure tone had to switch to a 
new rewarded frequency tone in a subsequent training session. When animals received a pairing 
between the LC opto-stimulation and the “reversal-tone” on the day of reversal they more readily 
learned the new association between the stimulus and the reward.  
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Martins and Froemke first showed that context associations can be formed in the LC, thanks to 
long-lasting plasticity mechanisms happening in this region. Moreover, the LC NMDA-dependent 
form of plasticity that they described is instrumental for downstream plastic adaptations 
happening in the AI cortex. This “plasticity cascade” ultimately influences behavioral responses, 
shaping the animal’s ability to discriminate and perceive auditory stimuli.  
Martins and Froemke's study, hence, represents the first step in answering whether and how LC 
plasticity occurs and the molecular mechanisms underlying these plastic phenomena. 
A single exposure to drugs of abuse induces plastic changes in LC-NE neurons 
In their recent study, Zhu and colleagues (Zhu et al., 2017) tested the effect of a single 
administration of cocaine on LC glutamatergic transmission. In brain regions containing 
catecholaminergic neurons like the Ventral Tegmental area (VTA), a single cocaine exposure has 
been shown to cause synaptic plastic changes (Ungless et al., 2001; Sarti et al., 2007; Arora et al., 
2011). Cocaine has a high affinity for the norepinephrine transporter (NET) (Trendelenburg, 1991; 
Torres, Gainetdinov and Caron, 2003; Zhou, 2004). NE might, therefore, play an important role in 
cocaine addiction, especially when considering that the administration of α1-adrenergic receptors 
antagonist reduces the hyperlocomotion and the drug-seeking behavior induced by drugs of abuse 
(Wellman et al., 2002; Zhang and Kosten, 2005).  
Zhu and colleagues demonstrated that a single cocaine administration increased the AMPA/NMDA 
ratio in LC excitatory synapses. In cocaine treated animals, but not in vehicle-treated animals, the 
amplitude of EPSC recorded at -70mV (AMPA component) was decreased upon application of a 
selective Ca2+ -permeable AMPA receptor blocker. This suggests that cocaine leads to the insertion 
of new Ca2+ permeable AMPARs, similarly to what has been previously described in the VTA 
(Bellone and Lüscher, 2006; Argilli et al., 2008). Accordingly, the AMPAR current measured in the 
LC neurons of cocaine treated animals showed a stronger inward rectification compared to control 
animals; the rectification index (RI;  
𝐴𝑀𝑃𝐴 𝑐𝑢𝑟𝑟𝑒𝑛𝑡−70𝑚𝑉
𝐴𝑀𝑃𝐴 𝑐𝑢𝑟𝑟𝑒𝑛𝑡+40𝑚𝑉
) was higher in cocaine treated animals, 
further supporting a cocaine-induced insertion on the post-synaptic membrane of GluR2 lacking 
Ca2+ permeable AMPA receptors. The authors ruled out the involvement of pre-synaptic 
adaptations caused by cocaine by measuring the presynaptic quantal glutamatergic release 
(mEPSC) and the paired-pulse ratio (PPR) of the glutamatergic responses, an index of the release 
probability of the pre-synaptic site. These two parameters were unchanged supporting a post- and 
not pre-synaptic functional remodeling of LC excitatory synapses upon cocaine treatment. Finally, 
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to assess whether α1-adrenergic receptors could mediate the effect of cocaine on LC synaptic 
plastic changes, Zhu and colleagues antagonized this class of receptors by in-vivo treating the 
animals with prazosin before cocaine administration. This pharmacological treatment abolished 
the effect of cocaine on both AMPA/NMDA ratio and RI. This suggests that α1 receptors mediate 
the insertion of new GluR2 lacking AMPA receptors, causing the observed potentiation of synaptic 
transmission. 
Zhu’s study points to a synaptic substrate potentially important for the maladaptive adaptations 
induced by cocaine. Moreover, it further supports the plastic properties of LC glutamatergic 
synapses.  
Taken together, the two studies described above show how LC neurons can undergo 
heterogeneous forms of synaptic plasticity. These changes in synaptic strength, that are intimately 
related to experience, can eventually be instrumental for the animal’s behavior or, conversely, 
under adverse circumstances can potentially be detrimental and, thus, be considered maladaptive. 
Although the evidence supporting the importance of LC synaptic plasticity is still scattered, this 
emerging research topic might be important to better understand LC physiology. Neuroplastic and, 
in particular, synaptic plastic changes happening at the level of LC neurons might ultimately affect 
NE release in LC target regions. Changes in NE release can, in turn, modulate plasticity in the 
multiple LC target brain regions. 
Cannabinoid role in regulating LC physiology 
Neuromodulators play a pivotal role across the brain in shaping and/or gating plasticity 
(Hardingham et al., 2013; Blackwell and Jadrzejewska-Szmek, 2014; Nadim and Bucher, 2014; 
Pedrosa, Clopath and Zhang, 2017; Foncelle et al., 2018; Gerstner et al., 2018; Brzosko, Mierau 
and Paulsen, 2019). Neuromodulators released by afferent pathways (i.e. NE, serotonin, 
dopamine, acetylcholine)  and locally released signaling molecules (i.e. endocannabinoids, nitric 
oxide) are both able to influence plasticity (Gu, 2002; Reynolds and Wickens, 2002; Sjöström, 
Turrigiano and Nelson, 2003; Tzounopoulos et al., 2007; Cui et al., 2015, 2016). In particular, the 
endoCannabinoid (eCB) system is involved in many forms of transient (i.e. short-term depression, 
depolarization-induced suppression of inhibition/excitation) and long-lasting plasticity (mainly 
Long-Term Depression), both at excitatory and inhibitory synapses (Gerdeman and Lovinger, 2003; 
Chevaleyre, Takahashi and Castillo, 2006; Castillo et al., 2012). Cannabinoids are known to 
modulate the activity of NE neurons (Gobbi et al., 2005; Muntoni et al., 2006).However, the role 
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of these signaling pathways in regulating LC synaptic plasticity as well as the functional and 
behavioral implication of this modulation remains to be explored.  
Already at the beginning of the nineties, Cannabinoid receptor 1 (CB1r) mRNA and protein were 
found in the LC region (Herkenham et al., 1991; Matsuda, Bonner and Lolait, 1993). More recently, 
immunofluorescence and electron microscopy studies have shown that the CB1r is presynaptically 
located on both glutamatergic and GABAergic terminals that synapse onto NE cells. Interestingly, 
the distribution of CB1r is not exclusively presynaptic; indeed this cannabinoid receptor is also 
present in the somatodendritic compartment of LC-NE cells (Scavone, Mackie and Van Bockstaele, 
2010). In other brain regions such as the cerebral cortex, activation of postsynaptic CB1 auto-
receptors induces auto-inhibition of a subset of interneurons (Bacci, Huguenard and Prince, 2004; 
Marinelli et al., 2008), hence one may speculate that the same self-inhibition might happen in LC 
neurons. Alternatively, postsynaptic CB1r could be optimally located to regulate glutamatergic 
synaptic transmission without affecting the presynaptic release probability. 
 Recently, CB1r has been also found on CRF+ terminals within the LC region. Using Phaseolus 
Vulgaris Leucoagglutinin (PHAL) as an anterograde tracer, Wyrofsky and colleagues demonstrated 
the presence of CB1r on amygdala afferents (R. Wyrofsky, Reyes and van Bockstaele, 2017). The 
release of CRF release is associated with stress response and it induces LC increased excitability 
and firing activity, therefore, CB1r on CRF+ is placed in a critical spot to finely regulate NE release 
following stress exposure. However, the anatomical evidence showing CB1R on CRF+ terminals are 
not flanked by findings revealing the role of the cannabinoid receptor in this location.   
The presence of cannabinoid receptors in the LC is in line with findings showing how cannabinoids 
can profoundly shape LC-NE cells’ activity (for reviews: Carvalho & Van Bockstaele, 2013; Wyrofsky 
et al., 2019). Agonists of the cannabinoid receptors administered systemically or centrally increase 
LC tonic firing rate in anesthetized rats. This effect has been shown to be blocked by the selective 
CB1r antagonist SR 141716A (Mendiguren and Pineda, 2006; Muntoni et al., 2006). Furthermore, 
inhibiting the enzyme fatty acid amide hydrolase (FAAH), the enzyme responsible for the hydrolysis 
of the eCB anandamide (AEA) with its selective blocker URB597, induces an increase in the 
spontaneous firing of LC-NE neurons (Gobbi et al., 2005; Muntoni et al., 2006). Therefore, both 
exogenous cannabinoids and endocannabinoids (eCBs) modulate LC-NE neural activity. Moreover, 
the LC is under tonic eCBs regulation: application of cannabinoid antagonist can slightly but 
significantly decrease LC activity. eCBs play a role in modulating specific inputs, indeed Muntoni 
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(Muntoni et al., 2006) and colleagues showed that the application of CB1r agonists: WIN55212-2 
or tetrahydrocannabinol (Δ⁹THC) attenuates the inhibition on LC tonic discharged induced by the 
electrical stimulation of the GABAergic nucleus prepositus hypoglossi (PrH). Since the PrH provides 
strong inhibitory innervation to the LC (Aston-Jones et al., 1986; Ennis and Aston-Jones, 1989; 
Kaur, Saxena and Mallick, 2001), it has been hypothesized that the counterintuitive positive effect 
of cannabinoid agonists on the LC-NE firing activity might be due to a “suppression of inhibition” 
effect (Muntoni et al., 2006). This suppression of inhibition might be involved in LC neuron 
disinhibition from its tonic GABAergic control of firing discharge, demonstrated in various studies 
(Cherubini, North and Williams, 1988; Shefner and Osmanovic, 1991; Aston-Jones, Zhu and Card, 
2004; Jin et al., 2016; Breton-Provencher and Sur, 2019). This evidence, however, does not rule 
out the possibility that the eCB system in the LC plays an important role in shaping and modulating 





Aims and Relevance 
The LC is a highly integrative neuromodulatory nucleus. Therefore, investigating the synaptic 
physiology of noradrenergic neurons by focusing on how impinging inputs shape LC-NE neuronal 
activity is crucial to better characterize the behavioral importance of this small brainstem region. 
Anatomical evidence highlights how hundreds of brain regions send direct monosynaptic inputs to 
the LC (Schwarz et al., 2015; Breton-Provencher and Sur, 2019). Nevertheless, it remains to be 
established how impinging inputs are integrated and modulated by local neuromodulators at the 
synaptic level. As shown in Martins’ study (Martins and Froemke, 2015), unveiling the experience-
driven synaptic adaptations occurring in a neuromodulatory nucleus such as the LC might shed 
light on a “synaptic plasticity cascade” induced by the release of NE in target brain regions. 
Amongst the brain areas sending projections to the LC, the Prefrontal Cortex (PFC) is considered 
to be one of the major glutamatergic cortical drive for NE neurons (Sara and Hervé-Minvielle, 1995; 
Jodo, Chiang and Aston-Jones, 1998). Whilst anatomical observations indicate direct 
monosynaptic projections from the PFC to LC (PFC→LC), functional evidence for this connectivity 
is still sparse. PFC→LC inputs might convey cognitive and affective information while providing 
“top-down” – or “executive” – control over LC activity. In this context, PFC projection might 
instruct the LC about general features of the environment to guide behavior in previously unseen 
circumstances. Hypothetically, the PFC could entrain LC neurons during goal-directed behavior to 
increase NE release upon the presentation of targets that have been pre-identified by PFC-
dependent cognitive processes. Hence, PFC→LC projections might play an important role in 
preparatory attention and during complex cognitive tasks (Alnæs et al., 2014; Unsworth and 
Robison, 2017). To fully elucidate the functional role of PFC→LC projections, it would be key 
considering not only the properties of the hardwired connections between these two regions but 
also plasticity mechanisms, which can modulate synaptic efficacy. These plasticity mechanisms can 
ultimately lead to changes in postsynaptic firing output upon exposure to relevant salient 
experiences, such as stress exposure, or during postnatal development when PFC complete 
maturation (Van Eden, Kros and Uylings, 1991; Caballero, Granberg and Tseng, 2016; Hodel, 2018). 
Notably, plasticity mechanisms occurring in the LC might be shaped by local neuromodulators, 
such as endocannabinoids (eCBs), and/or by neuromodulators released by long-range impinging 
inputs (long-range neuromodulators), such as Corticotropin-releasing factor (CRF) and Serotonin 
(5-HT), which are known to modulate LC-NE neuronal excitability (see: “Cannabinoid role in 
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regulating LC physiology” and “LC, stress and the role of Corticotropin-Releasing Factor (CRF): 
between acute effects and long-lasting adaptations”).  
To dissect the behavioral role of long-range neuromodulators, perturbing neuronal activity in 
neuromodulatory nuclei is key. Genetically encoded inhibitory optogenetic proteins are useful 
tools to dissect neural circuits without imposing artificial firing patterns. Currently available 
inhibitory optogenetic tools allow short and transient silencing of neurons, but they do not achieve 
long-lasting inhibition.  Thus, there is the need for developing and validating novel optogenetic 
tools to provide sustained and reliable silencing of neural networks (Wiegert et al., 2017).  
In my PhD project, I have been testing the hypothesis that experience-dependent plasticity at 
PFC→LC inputs modulates action control, and that this modulation is shaped by the activity of local 
LC neuromodulators as well as by neuromodulators via long-range projections.  
 To test this hypothesis, I have been developing the following aims: 
1. To define the direct PFC→LC connectivity by providing anatomical, functional and 
behavioral evidence.  
2. To investigate synaptic mechanisms of plasticity at glutamatergic LC synapses, with a 
special focus on PFC→LC synapses. 
3. To elucidate how these mechanisms of plasticity are modified in response to different 
forms of experience (e.g. plasticity induced by context adaptations/salient experiences 
and postnatal developmental plasticity). This will be instrumental in understanding how 
experience-dependent plasticity in the LC affects its NE output, goal-directed control of 
behavior, and the development of stress-related neuropsychiatric conditions in adulthood.  
To develop the project, I combined neurophysiological, pharmacological and optogenetic 
approaches with behavioral paradigms.  Furthermore, I validated a newly engineered genetically 
encoded light-activated potassium channels for long-lasting neuronal silencing of 





Defining the PFC→LC input: in-vivo dissection 
By using in-vivo electrophysiology in anesthetized adult mice [C57BL/6J mice; postnatal day (P) 
60-75], we first investigated whether LC neurons were controlled by PFC projections at the single-
cell level. To this purpose, I trained for few months at the laboratory of François Georges, Institut 
des maladies neurodégénératives (IMN), University of  Bordeaux, where I performed single-unit 
recordings of firing evoked responses in LC neurons upon stimulation of the PFC (100 stimuli 
@0.5Hz 0.5-1.5 mA-500 µs) (Figure 9 A, D). Putative LC neurons were selected based on their 
single-unit wave-form duration (>1 ms; 1.06 ms-2.40 ms), slow tonic firing rate (0.75 Hz-3.55 Hz) 
(Figure 9 B-C), and by their response to nociceptive stimulation (contralateral paw-electrical 
stimulation -  foot shock; 100 stimuli @0.5Hz 1-2 mA-500 µs), as previously described (Muntoni et 
al., 2006) (Figure 9 E). In response to PFC electrical stimulation, we found that 44% of LC cells 
(11/25 single units) were orthodromically activated (Figure 9 B) with a short and reliable excitation 
latency (16.15 ms ± 1.62 ms), as expected for of a direct monosynaptic connection and consistent 
with previous observations in rats (Jodo, Chiang and Aston-Jones, 1998). 
Figure 9 (A) Schematics illustrating the concomitant LC recording and PFC stimulation sites. (B) Pie-chart showing the 
percentage of LC neurons responding to PFC stimulation. (C, left) Scatter-plot of the basal firing rate of LC neurons (1.61 
Hz ± 0.14 Hz, n=25). (right) Scatter-plot showing the distribution of waveform ½ duration (1.48 ms ± 0.07 ms, n=25). (D) 
Representative peri- stimulus histogram (PSTH) and raster-plot of a LC neuron activated by PFC stimulation. (inset) 
representative LC spike. (E) Representative PSTH and raster-plot of a LC neuron activated by Foot shock. 
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PFC→LC optogenetic activation drives Real-Time- and Conditioned-Place Preference 
Next, we sought to assess the behavioral implications of PFC→LC connectivity. In collaboration 
with Dan Covey and Joseph Cheer  (University of Maryland), we tested whether activation of this 
specific input has a positive or negative valence by combining optogenetic with the real-time place 
preference paradigm (Stamatakis and Stuber, 2013; Qi et al., 2014). 
P30-35 C57BL/6J mice were injected with a channelrhodopsin (ChR2) expressing virus combination 
[AAV1/2-CaMKIIa-Cre + AAV5-EF1a-DIO-ChR2(H134R)-eYFP] in the PFC  while implanted with 
optical fibers in the LC, to deliver light stimulation (Figure 10 A). 6 weeks after viral injection, we 
detected a strong expression of the reporter-gene eYFP in the injection site as well as in the PFC 
terminals within the LC and peri-LC regions (Figure 10 B). To asses valence in response to 
stimulation of PFC→LC, animals were then tested in a 3 chambers real-time place-preference 
apparatus (3C-RTPP), in which they received trains of either 10Hz or 30 Hz (10 ms) light stimulation 
when they entered the laser-paired chambers; stimulation was stopped upon animal entry in the 
0Hz chamber. This multifrequency design evaluates the bias for photostimulation and it allows 
comparing the effect of two different photostimulation frequencies at a time (Prus, James and 
Rosecrans, 2009; Qi et al., 2014; Root et al., 2014).  
During day1-habituation session (Pre; 15 min), ChR2-expressing animals did not show preference 
for any of the three chambers ( 𝑡𝑖𝑚𝑒 𝑠𝑝𝑒𝑛𝑡 𝑖𝑛 𝑜𝑛𝑒 𝑐ℎ𝑎𝑚𝑏𝑒𝑟
𝑡𝑜𝑡𝑎𝑙 𝑡𝑖𝑚𝑒
∗100 ; 0Hz = 30% ± 1% versus 10Hz = 31% ± 
1% versus 30 Hz = 34 ± 2% n=7; Tukey p > 0.05). Day2-photostimulation session (Stim1; 30 min) 
significantly increased the time spent in the 10 Hz light-paired chamber (0Hz = 26% ± 3% versus 
10Hz = 37% ± 4% versus 30Hz = 32 ± 3% n=7; p < 0.05). Day3-photostimulation session (Stim 2; 30 
min) resulted in mice exhibiting significant preference for both light-paired chambers (10 and 30 
Hz) (0Hz = 20% ± 1% versus 10Hz = 42% ± 2% versus 30Hz = 33 ± 2% n=7; p < 0.05), although they 
still showed stronger preference for the 10Hz light-paired chamber (n=7; p = 0.02). Thus, 
stimulation of PFC→LC projections induces acute place preference. Furthermore, when tested in 
day4-post-test session (Post; 15 min), during which no photostimulation occurred, mice were still 
biased towards the previously light-paired chambers (0Hz = 22% ± 2% versus 10Hz = 44% ± 3% 
versus 30Hz = 32 ± 2% n=7; ps < 0.05).  This suggests that the activation of PFC→LC pathway 
produces a learned change in behavior (Figure 10 C-D). Locomotor activity did not differ among 




Figure 10 (A, top) Schematic of the viral injection in the PFC and the optic fiber implantation. (A, bottom) Time course 
of the experiment. Animals were injected with AAV1/2-CaMKIIa-Cre + AAV5-EF1a-DIOChR2(H134R)-eYFP and implanted 
with an optic fiber in the LC. 6 weeks after the surgery animal underwent 3chambers real-time place preference (3C-
RTPP). (B) Representative immunofluorescent staining at different magnifications of a brain sagittal session showing the 
expression of Chr2-eYFP in the PFC (green) and the TH positive neurons (red). The dashed line represents the optic fiber 
track placed above the LC. (C) Representative heatmaps across the 4 different sessions. (D) Animals showed preference 
for the laser-paired chambers (2-Way ANOVA; n=7; Stim Frequency main effect, F2,18= 20, p<0.0001). In the Pre-session 
animals did not show any preference for any of the three chambers (2-Way ANOVA; n=7; 0Hz vs 10Hz p=0.9; 0Hz vs 
30Hz p=0.3; 10Hz vs 30Hz p=0.6; Tukey). During Stim1 animals increased the relative time exploring the 10Hz paired 
chamber compared to the others (2-Way ANOVA; n=7; 0Hz vs 10Hz p=0.004; 0Hz vs 30Hz p=0.1; 10Hz vs 30Hz p=0.4; 
Tukey). During Stim2, mice spent more time in the 2 laser-paired chambers (10-30Hz) (2-Way ANOVA; n=7; 0Hz vs 10Hz 
p<0.0001; 0Hz vs 30Hz p=0.0007; 10Hz vs 30Hz p=0.02; Tukey). During Post, animals maintained their preference for 
the photostimulated chambers (2-Way ANOVA; n=7; 0Hz vs 10Hz p<0.0001; 0Hz vs 30Hz p=0.006; 10Hz vs 30Hz p=0.003; 
Tukey). (E) Photostimulation did not affect the locomotor velocity at any stimulation frequency across different sessions 
(2-Way ANOVA; n=7, Stim Frequency main effect, F2,18=2, p=0.1). 
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The 3C-RTPP results indicate that PFC→LC optogenetic activation induces both acute- and 
conditioned place preference, suggesting possible rewarding effect. Next, we asked whether this 
effect was sufficient to drive operant reinforcement in an optogenetic intracranial self-stimulation 
paradigm (o-ICSS) (Figure 11 A) (Lippert et al., 2018; Covey and Cheer, 2019). 
Mice that received the ChR2-viral infusion and optical implantation (Figure 10 A) were trained for 
12 sessions to lever press for laser stimulation [2 sessions x day; Fixed Ratio-1 (FR1)] (Figure 11 A).  
During 30-minute sessions, both levers of the ICSS apparatus remained extended and no other 
cues were presented. Presses on one lever (active) produced immediate laser stimulation (1s, 10 
or 30 Hz), while presses on the other lever (inactive) were collected but had no consequence. We 
found that training of optogenetic stimulation of PFC→LC connection was not sufficient to sustain 
operant reinforcement (< 10 active lever presses per 30 min sessions, n=7; Average responses 
across different sessions: Active10Hz = 3.4 ± 0.5; Active 30Hz = 5.1 ± 0.7; Inactive10Hz = 0.9 ± 0.2;  
Inactive30Hz = 2.1 ± 0.3) (Figure 11 B-C). Mice showed a slight but significant higher number of active 
than inactive lever presses (3-Way ANOVA; n=7, p<0.0001), which might result from a cue effect 
provided by the photostimulation per se. To rule out this possibility, we are currently running o-
ICSS and RTPP experiments in mice injected with the control [AAV1/2-CaMKIIa-Cre + AAV5-EF1a-
DIO-eYFP] virus. 
 
Figure 11  (A) Schematic representing the opto-Intracranial Self Stimulation paradigm (ICSS). Mice have to lever press in 
order to have LC→PFC opto-activation (1s, 10Hz or 30Hz). (B) Time-course of the active lever presses at 10Hz and 30 Hz 
across 12 sessions lasting 30min each (green dots). (C) Time-course of the inactive lever presses at 10Hz and 30 Hz across 
12 sessions lasting 30min each. (B-C) Animals show a bias towards the active lever press, but performance did not change 
across sessions (3-Way ANOVA, n=7; lever main effect, F1,5=37, p<0.0001; session main effect, F5,5=1, p=0.4). Black traces 
represent the performance of each mouse. 
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Altogether these experiments suggest that PFC→LC inputs biases mice behavior.  Upon PFC→LC 
input activation mice not only learn context associations but they can also recall this association. 
These effects point at long-term plasticity processes at this specific input.  
Synaptic mechanisms of plasticity at LC glutamatergic synapses:  ex-vivo brain slice 
recordings 
The synaptic mechanisms of long-term plasticity in the LC are still largely unexplored. With the 
ultimate goal of dissecting plasticity at PFC→LC synapses, we specifically focused on timing-
dependent plasticity, and in particular on t-LTD (Long-Term-Depression). This form of plasticity can 
be studied on ex-vivo brain slice preparations by applying a post-pre STDP paradigm, in which the 
postsynaptic spike precedes the presynaptic stimulation of a critical time window (Caporale and 
Dan, 2008; Feldman, 2012) (Figure 12 A). We targeted t-LTD as at several glutamatergic synapses 
the occurrence of t-LTD depends on the retrograde endocannabinoid (eCB) signaling and activation 
of the presynaptic cannabinoid 1 receptor (CB1), thereby on decreased release probability of 
glutamate (Gerdeman, Ronesi and Lovinger, 2002; Chevaleyre and Castillo, 2003; Chevaleyre, 
Takahashi and Castillo, 2006; Soler-Llavina and Sabatini, 2006; Chevaleyre et al., 2007; Lafourcade 
et al., 2007; Nazzaro et al., 2012) (Figure 12 B). eCB-mediated plasticity is a fundamental means 
by which post-synaptic neuronal activity fine-tunes the synaptic gain at cortical afferents (Melis et 
al., 2004; Gremel et al., 2016; Mateo et al., 2017), thus influencing the transmission of information 
relevant to behavior, including learning and retrieval of contextual memory associations  (Zanettini 
et al., 2011; Maroso et al., 2016; Kruk-Slomka et al., 2017).  
Figure 12 (A) Burst pairing protocol for the induction of the negative-STDP. The protocol consists of 20 bouts of EPSPs 
paired with action potentials, delivered 10 s apart. Each bout consists of five bursts (200 ms apart) each composed of 
three action potentials at 50 Hz followed by one EPSP (negative timing) (see also: “Materials and methods”). (B) 
Schematic representation of the eCB signaling. eCBs are produced postsynaptically then they travel retrogradely to 
decrease the presynaptic release of neurotransmitters acting on CB1R. 
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We initially measured plasticity at non-dissected glutamatergic-LC synapses, which include inputs 
from cortical regions and subcortical regions (e.g. Nucleus Paragigantocellularis, Paraventricular 
Nucleus). Norepinephrine (NE) containing neurons of the LC (NE-LC) were identified by their 
positions - near the IV ventricle-, their soma morphology (20-30µm along their major axis), and 
their tonic firing activity (Williams et al., 1984; Sanchez-Padilla et al., 2014) (Figure 13 B). After 
recording, LC cell identity was confirmed by immunostaining for the marker Tyrosine Hydroxylase 
(TH), a key enzyme for the biosynthesis of catecholamines, including NE (Axelrod, 1971) (Figure 13 
A).  
On ex-vivo brain slices from P60-75 C57BL/6J mice, we recorded excitatory synaptic currents 
(EPSCs) in LC neurons upon the delivery of twin intra-LC stimuli, and in the presence of the 
GABAergic blocker gabazine (10 M). The post-pre STDP protocol (Figure 12 A) resulted in LTD of 
postsynaptic currents (measured at the peak of the first response; 78% ± 6% of baseline n=7; p < 
0.05; Tukey) (Figure 14). We found that t-LTD at glutamatergic-LC synapses is dependent on eCB-
mediated signaling since it was blocked by the CB1R antagonist AM251 (4 µM) (119% ± 8% of 
baseline n=9; p > 0.05; Tukey) (Figure 14 B), as expected (Gerdeman, Ronesi and Lovinger, 2002; 
Chevaleyre and Castillo, 2003; Chevaleyre, Takahashi and Castillo, 2006; Soler-Llavina and Sabatini, 
2006; Chevaleyre et al., 2007; Lafourcade et al., 2007; Nazzaro et al., 2012). We also investigated 
the locus of plasticity expression by measuring paired-pulse ratio (PPR) of the twin synaptic 
responses, before and after the STDP protocol.  t-LTD was associated with slight, but significant, 
increase in PPR, a hallmark of presynaptic plasticity (5-10minPre-STDP = 1.37 ± 0.16 versus 20-
Figure 13 (A, left) Representative immunofluorescent staining of LC containing slice, in yellow are depicted the 
glutamatergic afferents to the LC. Tyrosine Hydroxylase (TH) in green and DAPI in blue. (A, right) TH staining in green 
and patched cell filled with Neurobiotin in red. A patch pipette is depicted in white, while a bipolar stimulator is 
represented in blue. Locus Coeruleus (LC). Fourth ventricle (4V). (B, top) Representative trace of a LC neuron tonic 
firing. (B, bottom) AMPA component of a representative electrically evoked EPSC. 
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25minPost-STDP = 1.47 ± 0.17 ; p < 0.05; Figure 14 C). No changes in PPR were observed in the 
presence of AM251 (5-10minPre-STDP = 1.57 ± 0.16 versus 20-25minPost-STDP = 1.41 ± 0.10; p<0.05; 
Figure 14 D). Thus, these results suggest a presynaptic locus of plasticity expression, which is 





Figure 14 (A, left) Schematic of the experimental setting used to record EPSCs in LC-NE neurons. (A, right) Representation 
of the AM251-mediated CB1R antagonism. (B) In LC-NE cells, t-LTD was induced by the post-pre timing pairing (solid 
circles). In these neurons, bath perfusion of AM251 (4µM; empty horizontal bar) during the STDP was sufficient to prevent 
the t-LTD (empty circles) (LC adult; n=7 versus LC adult + AM251; n=9, p=0.03; Mann-Whitney test). (C) Scatter plot 
indicating the paired-pulse ratios of the last 5 min of baseline and 20-25 min after STDP. PPR was expressed as the ratio 
between the amplitude of the second (p2) and the first averaged EPSCs (p1) (5-10minPre-STDP versus 20-25minPost-STDP, 
p=0.04; 2tailed paired t-test). (D) AM251 Scatter plot indicating the paired-pulse ratios of the last 5 min of baseline and 
20-25 min after STDP (5-10minPre-STDP versus 20-25minPost-STDP, p=0.13; 2tailed paired t-test). (C-D) Insets represent 
averaged recordings (30 traces) before (black) and after (blue) the delivery of the STDP protocol (blue vertical bar). Dots 
represent single paired values. The average value ± s.e.m. is represented by the green symbols.  
(B) In these figures, and in the analogous plots that follow throughout the manuscript, data are presented as a time course 
(mean ± SEM) of normalized EPSC amplitudes. The EPSC time courses were obtained in presence of 10 µM gabazine, and 
in whole cell configuration. Scatter plot summarizes the ratios of synaptic responses 20-25min after (a) and 5-10min before 
(b) the STDP. Insets represent superimposed averaged recordings (30 traces) before (black) and after (blue) the delivery 




For synaptic plasticity to have functional consequences, it must ultimately influence firing activity 
in the postsynaptic neuron. To test whether eCB-tLTD affects the LC-NE neuronal output, we 
recorded excitatory evoked postsynaptic potentials (EPSPs). We delivered trains of ten stimuli (20 
Hz) and set the stimulation intensity so that  50% of EPSPs would result in action potentials (APs) 
(Figure 15 A). Change in the amplitude of the first EPSP positively correlated with the STDP-induced 
change in APs number (Figure 15 B), thus indicating that variation in synaptic strength translates 
into changes in output-firing in the post-synaptic NE neurons.  
 
eCBs regulate synaptic plasticity at Prefrontal Cortex (PFC) inputs 
So far, we provided evidence that eCB signaling, through the activation of CB1R, is involved in 
the induction of t-LTD at glutamatergic input to the LC. To dissect whether this plasticity 
mechanism occurs at PFC→LC synapses, we probed the LC-NE circuit with optogenetics. We 
bilaterally injected an adeno-associated viral (AAV) vector encoding ChR2-eYFP under the control 
of the CaMKIIa promoter [AAV5-CaMKIIa-ChR2(H134R)-eYFP] into the PFC of P30-35 C57BL/6J 
mice (Figure 16 A). 5-7 weeks after the injection, we obtained strong expression of the reporter 
fluorophore eYFP in the injection site as well as in PFC terminals in LC and peri-LC regions. On ex-
vivo LC slices, short blue light pulses through the microscope objective (1 ms at 470 nm) elicited 
EPSCs (EPSCs-OptoPFC) in NE-neurons. We investigated post-pre STDP at PFC→LC synapses by 
Figure 15 (A) Schematic represents the ten stimuli provided at a frequency of 20Hz. Sample traces showing a decrease 
in the APs number upon the delivery of the post-pre STDP. (B) Sample traces before (black) and after (blue) the post-
pre STDP. Graph showing the correlation between normalized synaptically-driven firing and normalized EPSP peak 
(Pearson correlation, r = 0.71; p =0.04). Insets represent superimposed averaged recordings (30 traces) before (black) 
and after(blue) the delivery of the STDP protocol (blue vertical bar). 
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monitoring EPSCs-OptoPFC before and after the induction protocol. During the post-pre pairing 
paradigm, the pre-synaptic EPSP was obtained by optogenetic stimulation of cortical terminals. In 
this experimental setting, the OptoPFC-STDP induced a t-LTD of PFC→LC synapses (65 % ± 7 % of 
baseline n=7; p < 0.05; Tukey), thus recapitulating the LTD obtained at non-dissected glutamatergic 
synapses upon electrical stimulation (Figure 16 B). Consistent with this, PFCt-LTD was dependent 
on eCB signaling since it was prevented in the presence of the CB1R antagonist AM251 (91 % ± 8 
% of baseline n=9; p > 0.05; Tukey) (Figure 16 B).  
  
Figure 16 (A, left) Schematic of the injection site and (right) AAV5-CaMKIIa-ChR2(H134R)-eYFP expression targeting the 
PFC (inset), the LC and the peri-LC region. eYFP(green), TH (grey). (B, top, left) Schematic of the recording configuration 
in LC-NE neurons. (B, bottom, left) Time course and (B, bottom, right) scatter plot showing the LTD induced by the Post-
pre pairing (solid circles), and (B, top, right) representative current traces. The CB1R antagonism by AM25 (4µM; empty 
horizontal bar) blunted the LTD elicited by the OptoPFC-STDP (empty circles) (LC adult; n=7 versus LC adult + AM251; 
n=9, p=0.04; Mann-Whitney test).  
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Modulation of synaptic plasticity at PFC→LC inputs 
We demonstrated that the eCB signaling is required for the induction of LC t-LTD in response to 
either electrical or optogenetic STDP paradigms, on ex-vivo brain slices. We next assessed the 
engagement of this plasticity mechanism in-vivo. To this purpose, we investigated how eCB-LTD is 
modified in response to two different forms of in-vivo experience: (I) exposure to context 
adaptations and salience experiences; (II) postnatal development, specifically the adolescence to 
adulthood transition.   
(I) Experience salience modulates t-LTD at PFC → LC synapses 
The PFC mediates behavioral responses to environmental changes (Fogelson et al., 2009; 
Lenartowicz, Escobedo-quiroz and Cohen, 2010; Waskom and Wagner, 2017; Werchan and Amso, 
2017). Also, in brain regions other than the LC, the eCB system acts as a dynamic regulator of 
adaptations to the environmental context and changes in CB1R function correlate with the salience 
of an experience (Wamsteeker, Kuzmiski and Bains, 2010; Cusulin et al., 2014). We therefore 
assessed how t-LTD at PFC → LC is modulated by context habituation and by exposure to a novel, 





Figure 17 (A) Schematic showing the behavioral protocol used. Following 5 days of context habituation (C-HAB), animals 
underwent either an extra session of C-HAB or a novel stress exposure (Stress; restraint stress coupled to fox urine 
odor). Anxiety levels were scored in an open-field arena, then animals were sacrificed to evaluate c-fos activation in the 
LC. (B, left) Representative immunofluorescent c-fos staining of LC obtained by animals that underwent C-HAB or Stress. 
TH (green), c-fos (red), DAPI (blue), the arrows indicate c-fos+-TH+ neurons. (B, right) Percentage of TH+-c-fos+ neurons 
in C-HAB and Stressed animals (C-HAB n= 6 versus Stress n=4; p<0.0001; 2sided unpaired t-test). (C, left) Representative 
traces show motor behavior in C-HAB and Stressed animals. (C, middle) Scoring of the corner time (C-HAB, n= 18 versus 
Stress, n= 13; p<0.0001, 2sided unpaired t-test). (C, right) Scoring of the distance travelled (C-HAB, n= 18 versus Stress, 




We subjected mice expressing ChR2 in the PFC→LC terminals (Figure 16 A) to either 6 days of 
context habituation (c-HAB group) or to 5 days of context habituation followed by simultaneous 
exposure to physical restraint and predator odor (Stress group;  day 6; Figure 17 A) (Borodovitsyna, 
Flamini and Chandler, 2018; Borodovitsyna, Joshi and Chandler, 2018). 24 later, both groups 
underwent behavioral testing in an open-field arena (OFT) to measure anxiety-like behavior (Tye 
et al., 2011; Seibenhener and Wooten, 2015; Borodovitsyna, Flamini and Chandler, 2018). To 
confirm the activation of LC neurons by stress compared to control conditions, a subset of mice 
from each cohort was sacrificed 1 hr. after the OFT. Brain sections containing the LC were prepared 
and co-immunostained for TH, while the expression of c-Fos was used as a proxy for neuronal 
activation (Bullitt, 1990; Perrin-Terrin et al., 2016). Compared to C-HAB, we found that stress 
exposure significantly reduced the total distance traveled (C-HAB = 21.5 m ± 1.7  m, n= 18 versus 
Stress = 11.3 m ± 1.1 m, n=13; p < 0.0001) and increased the time spent in the corners (C-HAB = 
233 s ± 17 s, n= 18 versus Stress = 343 s ± 18 s, n= 13; p<0.0001), indicative of anxiety-like behavior 
(Figure 17 C). This occurred in parallel to higher expression of c-Fos in the Stress group compared 
to C-HAB, as indicated by the significant difference in percentage of c-fos+/Th+ cells between the 
two cohorts (C-HAB = 22.1 % ± 3.75 %, n = 6 versus Stress = 70.5 % ± 0.3 % n = 4; p < 0.0001)(Figure 
17 B).  
Finally, we investigated the modulation of t-LTD at PFC→LC synapses in a second subset of C-HAB 
or Stress mice, 1 day after OFT.  We found that OptoPFC-STDP was impaired by context habituation 
(90 % ± 7 % of baseline, n=13; p > 0.05; Tukey) and restored upon stress salience (61 % ± 6 % of 
baseline n=6; p < 0.05; Tukey) (Figure 18). Together, these results indicate that, in the LC, changes 





 (II) eCB-mediated plasticity at LC glutamatergic synapses is developmental regulated during the 
adolescent to adulthood transition. 
Not only the eCB system shapes excitatory synaptic plasticity in LC neurons of adult mice (this 
study) but it plays a key role in modulating the developmental trajectories of the PFC during 
adolescent brain maturation (Ellgren et al., 2008; Heng et al., 2012; Meyer, Lee and Gee, 2018). 
This raises the possibility that eCB-mediated plasticity at PFC→LC synapses is developmentally 
regulated during the adolescent to adulthood transition. As an initial step to test this hypothesis, 
we investigated t-LTD at non-dissected glutamatergic synapses in the LC of young (P23-P28) mice 
in response to intra-LC electrical stimulation (Laviola et al., 2003; Brust, Schindler and Lewejohann, 
2015). Differently from adult mice (Figure 14 D), the post-pre STDP protocol resulted in LTP of 
postsynaptic currents (148 ± 17% of baseline; n=7; p < 0.05; Tukey) (Figure 19 B). Notably,  this 
form of plasticity was still dependent on eCB signaling as it was sensitive to CB1R antagonism 
(AM251, 4 µM; 98 ± 10% of baseline n = 8; p > 0.05; Tukey) (Figure 19 B). Although no significant 
changes in PPR were associated with LTP induction (5-10minPre-STDP = 1.76 ± 0.16 versus 20-25minPost-
STDP = 1.45 ± 0.11; p = 0.058) (Figure 19 C), we observed a trend towards a decreased in PPR, 
which would be consistent with increased glutamate release, thereby with LTP.  
Figure 18 Schematic of the experimental setting used to record EPSCs-OptoPFC in LC-NE neurons. Time course and scatter 
plot showing that C-HAB (green dots) impairs t-LTD at PFC→LC synapses. Stress (orange dots) restores the t-LTD. The 
shadowed line shows the time course of plasticity from the LC OptoPFC group (Figure 15) (1WA; F2,23=5.1; p=0.015; LC 
OPTOPFC C-HAB versus LC OPTOPFC Stress, p=0.023; LC OPTOPFC C-HAB versus LC OPTOPFC naïve, p=0.037; Dunnet). Insets 
represent superimposed averaged recordings (30 traces) before (black) and after (blue) the delivery of the STDP 




Figure 19 (A, left) Schematic of the experimental setting used to record EPSCs in LC-NE neurons. (A, right) 
Representation of the AM251-mediated CB1R antagonism. (B) In LC-NE neurons of young animals, t-LTP was induced 
by the post-pre timing pairing (solid circles). In these neurons, bath perfusion of AM251 (4µM; empty horizontal bar) 
during the STDP was sufficient to prevent the t-LTP (empty circles) (LC young; n=7 versus LC young + AM251; n=8, 
p=0.006; Mann-Whitney test). (C) Scatter plot indicating the paired-pulse ratios of the last 5 min of baseline and 20-25 
min after STDP. PPR was expressed as the ratio between the amplitude of the second (p2) and the first averaged EPSCs 
(p1) (5-10minPre-STDP versus 20-25minPost-STDP, p=0.058; 2tailed paired t-test). (D) AM251 Scatter plot indicating the 
paired-pulse ratios of the last 5 min of baseline and 20-25 min after STDP (5-10minPre-STDP versus 20-25minPost-STDP, 
p=0.70; 2tailed paired t-test). (C-D) Insets represent averaged recordings (30 traces) before (black) and after (blue) the 
delivery of the STDP protocol (blue vertical bar). Dots represent single paired values. The average value ± s.e.m. is 
represented by the red symbols. 
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Previous studies described uncanonical forms of eCB-mediated LTP (Cachope et al., 2007; Lin et 
al., 2011; Xu, Zhang and Chen, 2012; Cui et al., 2016; Wang et al., 2016; Maglio et al., 2017; Cui, 
Perez and Venance, 2018; Xu et al., 2018). Nevertheless, the majority of these plastic phenomena 
rely upon GABAergic disinhibition mechanism (Carlson, Wang and Alger, 2002; Chevaleyre and 
Castillo, 2004; Lin et al., 2011; Xu, Zhang and Chen, 2012; Silva-Cruz et al., 2017). This is not the 
case in our experimental settings, as recordings were performed in the presence of a GABAA 
receptor antagonist (Gabazine 10 µM).  Change in synaptic plasticity rules (i.e. the switch between 
t-LTD and t-LTP in response to the same stimulating protocol) may also depend upon the activity 
of long-range neuromodulators (Cachope et al., 2007; Yang and Dani, 2014; Brzosko et al., 2017; 
Xu et al., 2018; Brzosko, Mierau and Paulsen, 2019), which might differ between young and adult 
mice. In the LC, intra-LC electrical stimulation is likely to recruit projections from the Central 
Nucleus of the Amygdala (CeA), which releases Corticotropin-releasing factor (CRF) (Van 
Bockstaele, Colago and Valentino, 1998; McCall et al., 2015). In the LC-NE neurons, CFR binds the 
CRF1 receptor (CRF1R) (Jedema and Grace, 2004; Reyes et al., 2006), which is coupled to Gs-
signaling pathways.  Activation of CRF1R has been shown triggering synaptic potentiation in other 
brain regions (Blank et al., 2002; Pollandt et al., 2006; Krishnan et al., 2010). We, therefore, 
reasoned that the functional interplay between CRF release and eCB mobilization in response to 
Figure 20 (A, left) Representation of the NBI 35965-mediated CRF1R. (A, bottom) antagonism Perfusion of the CRF1R 
selective antagonist NBI 35965 (1 µM; empty horizontal bar) prevented the STDP-LTP in young animals (LC young; n=7 
versus LC young + NBI 35965; n=6, p=0.005; Mann-Whitney test). (B) NBI 35965 (1 µM; solid horizontal bar) was 
unaffecting on the adult animal LTD (LC adult; n=7 versus LC adult + NBI 35965; n=7, p=0.60; Mann-Whitney test). (A-B) 
The shadowed line shows the time course of plasticity from the young animal group of Figure 19 (B) and the adult animal 
group of Figure 14 (B).  
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presynaptic activity could be developmentally regulated in the LC. To test this, we blocked the 
activity of CRF1R during the post-pre STDP protocol by using the selective antagonist NBI 35965 
(Million et al., 2003; Kosoyan, Grigoriadis and Tache, 2005) (Figure 20).  CRF1R antagonism was 
sufficient to impair t-LTP induction (NBI 35965, 1 µM (Ma et al., 2013); 89% ± 6% of baseline; n=6; 
p > 0.05; Tukey) (Figure 20 A) in young mice whereas it had no effects on t-LTD induced in adult 
animals (71% ± 9% of baseline; n=7; p < 0.05; Tukey) (Figure 20 B).  
OptoPFC-STDP induces eCB-LTD at PFC→LC synapses of young animals 
In young animals, to investigate whether the LTP observed at non-dissected excitatory LC 
synapses also occurs at dissected PFC→LC synapses, we injected an adeno-associated viral (AAV) 
vector encoding ChR2-eYFP under the control of the CaMKIIa promoter [AAV9-CaMKIIa-
ChR2(H134R)-eYFP] into the PFC of P0-3 C57BL/6J mice; we opted to the AAV serotype 9 for 
infection of mouse pups as we observed that this virus type has a higher infection yield compared 
to AAV serotype 5 at this post-natal age. (Passini et al., 2003) (data not shown). At P23-28, we 
detected eYFP expression in the PFC injection, in the peri-LC area, and in the LC (Figure 21 A). 
Differently from electrical STDP that resulted in LTP of synaptic responses (Figure 19 B), the 
OptoPFC-STDP induced t-LTD at PFC→LC projections of young mice (61% ± 7% of baseline; n=8; p < 
0.05; Tukey) (Figure 21 B).  On-going experiments are investigating the role of eCBs in this form 
PFCt-LTD as well as the mechanisms underlying the dichotomous behavior of non-dissected and 
dissected PFC→LC synapses in response to electrical and opto-STDP paradigms, respectively (see 
Project implementation and Discussion). 
Collectively, this evidence suggests that eCB-mediated plasticity is developmentally regulated 
during the adolescent to adulthood transition, thus further supporting the engagement of this 



















Figure 21 (A, left) Schematic of the injection site and (right) AAV9-CaMKIIa-ChR2(H134R)-eYFP expression targeting the 
PFC (inset), the LC and the peri-LC region. eYFP (green), TH (grey). (B, top, left) Schematic of the recording configuration 
in LC-NE neurons. (B, bottom, left) Time course and (B, bottom, right) scatter plot showing the LTD induced by the Post-
pre pairing (solid circles) (RM1WA; F7,20 = 1.66; p = 0.047; n = 8; Tukey), and (B, top, right) representative current traces.  
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Project Implementation  
The main findings of our study can be summarized as 
1) Optogenetic activation of PFC→LC inputs supports the expression of place preference together 
with learning and retrieval of context associations (Figure 10). 
2) Plasticity at PFC → LC projections relies on eCB-mediated signaling capacity (Figure 16), which 
is dynamically regulated by context adaptations and salience experiences (Figure 18; Figure 21).  
 
Project implementation requires establishing synaptic causalities between eCB-mediated 
modulation of PFC→LC inputs and place conditioning as well as elucidating how this modulation 
affects the LC noradrenergic output during naturalistic forms of behavior that are dependent on 
the PFC (i.e. working memory, social interaction, task switching, etc.).   
Establishing a direct role of CB1R at PFC→LC synapses in the expression and acquisition of place 
preference 
• To establish the involvement of eCB-mediated modulation of PFC→LC inputs in the 
expression of real-time place preference and/or in the learning conditioned place preference (3C-
RTPP test), we are currently applying an “occlusion” strategy.  Specifically, if eCBs/CB1R-mediated 
signaling is engaged during the place preference paradigm the subsequent ex-vivo induction of 
eCB-LTD at PFC→LC synapses will be disfavored, at least immediately after the behavioral testing. 
The occurrence of eCB-LTD will be evaluated either upon the Stim1 session, for assessing the 
contribution of eCB signaling in the expression of real-time place preference or following the post-
stimulus session for testing its contribution in learning or retrieving of contextual memory 
associations.  
 
• To test whether it is sufficient to block the function of CB1R to prevent the expression 
and/or acquisition of place preference induced by stimulation of PFC→LC synapses during the 3C-
RTPP paradigm, we will delete CB1R in the PFC by using a conditional approach. The PFC-CB1R 
deletion will be obtained by injecting the CRE and ChR2 virus combination [AAV1/2-CaMKIIa-Cre + 
AAV5-EF1a-DIOChR2(H134R)-eYFP] in the PFC of homozygous CB1 floxed animals  (CB1 Flox/Flox; 
Cnr1tm1Ltz) (Marsicano et al., 2002)  implanted with optical fibers in the LC, as before (Figure 10 A). 
This viral approach will allow deleting CBR1 in the PFC, thus also at PFC→LC projections. Although 
this viral strategy will result in CB1R deletion in all PFC target regions, by optogenetic stimulating 
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PFC→LC terminals during 3C-RTPP paradigm we will gain behavioral insights into the role of CB1R 
expressed at this specific input.  
Investigating the role of CB1R at PFC→LC inputs in a PFC-dependent naturalistic behavior: the 5-
choice serial reaction time task 
While the 3C-RTPP is an effective behavioral paradigm to evaluate the positive or negative 
valence associated with the activation the PFC→LC inputs, it implies the artificial optogenetic 
stimulation of these projections, possibly enforcing eCB-release from LC neurons. To get insights 
on the physiological role of eCB-mediated modulation of PFC→LC inputs we will test how deletion 
of CB1R at this input will affect a behavioral task that relies on PFC activation. To achieve CB1R 
deletion the PFC→LC projections we will implement an intersectional viral approach (Kakava-
Georgiadou et al., 2019) in which CB1R deletion is dependent on a retrograde CRE-expressing FLP-
dependent virus injected in the LC (retroAAV-EF1a-FRT-CRE) and a Flp recombinase expressing 
virus injected in the PFC of CB1 Flox/Flox mice. CB1R PFC→LC-deleted mice (PFC→LC-CB1R-KO) 
will be tested in the 5-choice serial reaction time task (5-CSRTT), which involves PFC functional 
activity and noradrenergic signaling  (Liu et al., 2009; Economidou et al., 2012; Fitzpatrick et al., 
2018). 
Collectively, these experiments will stride towards a better understanding of the behavioral role 
of the eCB system at the PFC→LC inputs, thus overcoming inferences associated with optogenetic 
stimulation of this pathway. 
Exploring NE dynamics upon CB1R deletion 
Our data indicate the eCB system modulates PFC→LC synapses (Figure 16; Figure 21). We 
hypothesize that eCB-mediated LTD at PFC to LC inputs represents a key a feedback mechanism to 
regulate the reciprocal connectivity between the  PFC and the LC, as this plasticity mechanism 
would limit the cortical drive of the LC, ultimately shaping the spatial and temporal dynamic profile 
of NE release in the cortex. This type of regulation might be critical in the trade-off between 
exploration and exploitation (Aston-Jones and J. D. Cohen, 2005; Jepma et al., 2010), for example 
upon stress exposure, or for tuning the behavioral responses to salience experiences. 
 To assess how CB1R expressed at PFC→LC inputs shape NE release in LC target regions, we will 
image the signal dynamic of a genetically encoded NE sensor (GRABNE; Feng et al., 2019) by using 
fiber photometry in freely-moving mice.   Our findings indicate that photoactivation of the PFC→LC 
pathway sustains learning and retrieval of contextual associations (Figure 10). Therefore, we will 
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image NE signal not only in the PFC but also in the Hippocampus (Preston and Eichenbaum, 2013), 
because of its role in contextual memory  (Smith and Bulkin, 2014). We expect to observe 
deregulation of NE levels in target regions upon the deletion of CB1R at PFC→LC connection. Since 
eCB signaling modulates neuronal activity on-demand, we expect to find deregulation of NE levels 
together with impairment in behavioral performances only when PFC→LC-CB1R-KO mice are 
engaged in a task that strongly requires PFC→LC connection activation. Therefore, we will test 
how the eCB system finely tunes LC activity during the 5-CSRTT, which requires frontal-cortex 
entrainment (Robbins, 2002; Benn and Robinson, 2014). 
Validation of a novel optogenetic tools to manipulate neuromodulatory projections to the LC: the 
genetically encoded light-activated K+ channel (BLINK2) 
Results obtained during project development indicate that experience-dependent plasticity at 
PFC→LC inputs is shaped by the activity of local LC neuromodulators (i.e. eCB) as well as by 
neuromodulators via long-range projections (i.e. CRF). With the ultimate goal of resolving the 
behavioral function of long-range neuromodulatory projecting to the LC at cellular resolution, I 
devoted part of my PhD to validate novel optogenetic tools for sustained neuronal silencing. In 
collaboration with Anna Moroni (Department of Biosciences, University of Milano, Italy), we 
developed a viral-based strategy for the neuron-specific expression of a newly engineered, 
genetically encoded light-activated K+ channel (BLINK2).  
In Alberio & Locarno et al., (2018), by means of electrophysiological and optogenetic approaches 
(ex-vivo and in-vivo) we have tested the ability of BLIN2 of silencing neurons in different neuronal 
subtypes (Alberio & Locarno, et al., Nature Methods, 2019; see also Appendix). The combination 
of large unitary conductance and prolonged light-off activity of BLINK2 allows cellular inhibition in 




BLINK2 in brief  
Given the universal role of K+ conductances in the termination of action potentials and their major 
contribution to the resting potential, there is interest in engineering light-gated K+ channels. The 
Laboratory of Anna Moroni previously engineered BLINK version 1 (BLINK1)  (Cosentino et al., 
2015), in which a LOV2 photoreceptor domain (Christie, 2007; Christie et al., 2012) reversibly 
controls a K+ channel (KcvPBCV1) (Plugge et al., 2000) in response to blue light (455 nm) (Cosentino 
et al., 2015). BLINK1 has favorable properties for optogenetics: a low light requirement that avoids 
tissue heating and damage, a large unitary conductance (>100 pS) to counteract excitatory 
currents, and a lack of inactivation during prolonged illumination. In vivo experiments with 
zebrafish embryos highlighted the use of BLINK1 as an inhibitory tool. However, BLINK1 has low 
surface expression, especially in mammalian neurons, which hampers its wider use. To improve 
the surface expression of BLINK, signal sequences that promote forward trafficking in eukaryotic 
K+ channels (Gradinaru et al., 2010) have been added to the BLINK1 C-terminal. Specifically, BLINK2 
has the same topology as BLINK1 and the C terminus of the KAT1 sequence that ends with the 
binding motif 673YFSDN677 for 14-3-3 proteins, a class of adaptors that promote KAT1 surface 










Figure 22 (A, left) Diagram indicating the virus injection site. (middle) sample confocal image showing expression of the 
AAV1/2-hSyn-BLINK2-IRES-eGFP virus in the mouse DRN (green, GFP; gray, DAPI). Scale bars, 200 µm or 40 µm (inset). 
AQ, aqueduct. Right, representative current-clamp recording of tonic firing activity in DRN GFP+ neurons. (B, left) 
representative whole-cell current-clamp recordings of the firing response before and after 60 s (top) and 30 s (bottom) 
of blue light stimulation (top, n = 11; bottom, n = 8). (middle) Effect of 60 s (top) and 30 s (bottom) of blue light 
stimulation (blue bar) on the firing rate (5-s binning). (right) summary plots indicating the mean firing discharge rate 
2 min before light (Beforelight; baseline) and 2 min after light-off (Afterlight 0–2′) (60 s, Beforelight versus Afterlight 0–2′, n = 11, 
p < 0.0001, 2sided paired t-test; 30 s, Beforelight versus Afterlight 0–2′, n = 8, p = 0.004, 2sided paired t-test). c, Left, 
representative cell-attached voltage-clamp recordings of firing responses before and after 60 s of blue light stimulation 
(blue bar) (n = 11 independent recordings). (middle) Time course of the effect of 60 s of blue light stimulation (blue bar) 
on the firing rate (5-s binning). Right, summary plot indicating the mean discharge rate 2 min before light (Beforelight) 
and at 2 (Afterlight 0–2′) and 5 (Afterlight 5′–7′) min after the end of light exposure (n = 11; RM1WA, F10,2 = 22, p = 0.0007; 
Beforelight versus Afterlight 0–2′, p = 0.002; Beforelight versus Afterlight 5′–7′, p = 0.003; Afterlight 0–2′ versus Afterlight 5′–7′, p = 0.02; 
Tukey). Blue light (470 nm, 8.7 mW/mm2). 
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BLINK2 validation on ex-vivo brain slices 
To test neuronal silencing by BLINK2 in brain slices, we injected the AAV-hSyn-BLINK2- IRES-eGFP 
virus in the dorsal raphe nucleus (DRN) of the midbrain (Figure 22 A). We selected the DRN for the 
tonic activity of its neurons and for the known neuromodulatory projections to the Locus 
Coeruleus (LC) (Segal, 1979; Kim et al., 2004). BLINK2-expressing neurons (GFP+) recorded at the 
soma in the dark showed basal tonic firing (0.2–7 Hz, Figure 22 A), similar to the activity in 
untransfected acute DRN slices (Mlinar et al., 2016; Giorgi et al., 2017). After transfection with a 
control GFP-expressing virus (AAV1/2-hSyn-eGFP), none of the recorded cells (n=7) showed 
inhibition of firing activity (Figure 23).  
Figure 23 (A, left) Diagram of injection site in the DRN. (right) Sample confocal image showing expression of the AAV1/2-
hSyn-eGFP virus in the DRN (green, GFP; gray, DAPI). Scale bars, 200 µm or 40 µm (inset). AQ, aqueduct. (B, top, left) 
Representative cell-attached voltage clamp recording of firing response before and after 60-s blue light illumination 
(blue bar) (n = 7). (B, top, right) Expanded view of the recording period defined by the red dotted box. (B, bottom, left) 
Time course of the effect of 60-s blue light stimulation (blue bar) on discharge firing rate (5-s binning). (B, bottom, right) 
Summary plots indicate mean firing discharge rate 2 min prior to light (Beforelight) and 2 min after lights-off (Afterlight 0-2’) 
(Beforelight, 3.4 ± 0.8 Hz; Afterlight 0-2’, 4.1 ± 1.0 Hz n = 7, 2sided paired t-test) 
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Passive and active properties of BLINK2-expressing cells were indistinguishable from those of 
controls in the dark (Figure 24), which indicates that the channel is closed in the dark. After 
exposure to 60 s or 30 s of blue light (470 nm, 8.7 mW/mm2), light-responsive neurons 
hyperpolarized and stopped firing within 2 min after the light was switched off (for 60-s exposure 
(n = 11), 1.32 ± 0.17 Hz Beforelight and 0.005 ± 0.003 Hz Afterlight 0-2′ ; for 30-s exposure (n = 8), 1.39 
± 0.2 Hz Beforelight and 0.016 ± 0.007 Hz Afterlight 0-2′) (Figure 22 A). The firing did not recover for at 
least 20–30 min after stimulation (data not shown). We reasoned that dialysis of intracellular 
constituents during whole-cell recordings might represent a caveat, and therefore we analyzed 
the discharge rate of tonically active GFP+ neurons in a cell-attached configuration. Although light 
stimulation (60 s) substantially reduced the firing discharge rate (Beforelight, 1.3 ± 0.3 Hz; Afterlight 
0-2′, 0.03 ± 0.01 Hz), we observed a slight recovery of activity (Afterlight 5′-7′, 0.18 ± 0.05 Hz) in 7 out 
of 11 cells in the dark (n = 11; repeated measures one-way ANOVA, F10,2 = 22, p = 0.0007; post 
hoc, Beforelight versus Afterlight 0-2′, p = 0.002; Beforelight versus Afterlight 5′-7′, p = 0.003; Afterlight 0-2′ 
versus Afterlight 5'-7′, p = 0.02; multiple comparison and Tukey’s p-value correction) (Figure 22 C).   
Figure 24 (A, left) Representative current traces. (A, right) Membrane resistance (Rm) was measured in response to –
5mV steps in voltage clamp configuration and did not significantly change between BLINK2 and CTRL group (Rm, BLINK2 
386 ± 35 MΩ, n = 14; CTRL, 308 ± 35 MΩ, n = 15; p = 0.12, 2sided unpaired t-test). (B, left) Representative current clamp 
traces in response to fixed current injections. Action potential firing was generated by 2-ms current pulses at 1.2 nA. 
(right) resting membrane potential (R.M.P.) and action potential threshold did not differ between BLINK2 and CTRL 
groups (R.M.P.: BLINK2, –50.6 ± 1.8 mV n = 7; CTRL, –50.9 ± 1,8 mV, n = 15, p = 0.90,  2sided unpaired t-test; Threshold: 
BLINK2, –31.1 ± 2.3 mV, n = 8; CTRL, –35.4 ± 1.9 mV, n = 15, p = 0.18, 2sided unpaired t-test). Action potential threshold 
was determined from the second derivative of the spike waveform. 
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To compare BLINK2 to the opsin-based chloride pump eNphR3.0, we coinjected AAV1-hsyn-Cre 
and AAV5-EF1α-DIO-eNpHR3.0-eYFP viruses into the DRN (Figure 25 A). In YFP+ cells, 60 s of yellow 
light (585 nm, 17 mW/mm2) induced rapid (<5 s) silencing of firing activity (Figure 25 B); this 
inhibitory effect faded within the illumination period. The firing rate returned to control levels 
within 2 min of dark onset (Beforelight, 2.7 ± 0.8 Hz; Light, 1.3 ± 0.7 Hz; Afterlight 0-2′, 2.3 ± 0.9 Hz) 
(Figure 25 C). To provide a quantitative comparison between the eNpHR3.0-mediated and BLINK2-
Figure 25 (A, top) Diagram represents virus injection site (AAV1-hSyn-Cre + AAV5-EF1α-DIO-eNpHR3.0-eYFP). (A, 
bottom) Confocal image showing expression of eNpHR3.0-eYFP in the mouse DRN (green, YFP; gray, DAPI; scale bar, 200 
µm; AQ, aqueduct). (B, top) Representative cell-attached voltage clamp recording of firing response before and after 60 
s of yellow light illumination (yellow bar). (B, bottom) Time course of the effect on the discharge rate of 60 s of yellow 
light stimulation (yellow bar) on this representative recording; red horizontal bar represents the threshold (Th) defined 
as the mean discharge rate minus two times the s.d.; mean firing rate is calculated on values (5-s binning) computed 
over 1 min prior to light illumination (see also “Materials and method”). (C, left) Average time course of the effect of 60 
s of yellow light stimulation (yellow bar) on firing discharge rate (5-s binning). (C, right) Summary plots indicate mean 
firing discharge rate 2 min prior to light (Beforelight), during 1 min of light (Light) and 2 min after light (Afterlight 0-2’) (n = 
9; RM1WA, F8,2 = 6, p = 0.019; Beforelight versus Light, p = 0.047; Beforelight versus Afterlight 0-2’, p = 0.62; with multiple 
comparison and Dunnett). (D) Bar graph indicating the duration of neuronal silencing (time below threshold; Timeth) 
induced by eNpHR3.0 or BLINK2 activation (Timeth: BLINK2 versus eNpHR3.0, p = 0.03, 2sided Mann–Whitney test). The 
Timeth of BLINK2 has been calculated from the dataset included in Figure 22. Data are presented as mean ± s.e.m. 
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mediated effects, we calculated the duration of firing inhibition as the ‘time below threshold’ (see 
also “Materials and methods”), which was 71 ± 28 s for eNpHR3.0 (n = 9) and 420 ± 148 s for 
BLINK2 (n = 10) (Figure 25 D). Thus eNpHR3.0-induced inhibition was faster than that of BLINK2 
and did not persist in the dark.  
 
Target manipulation of long-range neuromodulatory projections to the LC   
We have previously shown that BLINK2 is suitable for somatic neuronal inhibition (Alberio & 
Locarno et al., 2018). We are currently validating this tool for synaptic silencing, in order to 
manipulate neuromodulatory projections to the LC originating from the Central Amygdala and 
from the Dorsal Raphe Nucleus.  
1) Central Amygdala: 
We will investigate the involvement of CRF released by Central Amygdala (CeA) projections to the 
LC (CRF-CeA→LC) in the induction of t-LTP occurring at non-dissected glutamatergic synapses of 
young animals in response to electrical STDP (Figure 19). We have shown that this form of LTP is 
sensitive to pharmacological antagonism of CRF1R (Figure 20). This raises the possibility that the 
electrical STDP obtained by intra-LC stimulation results in CRF release from CFR-containing fibers 
impinging on the LC, this would promote LTP by activating the Gs-coupled CRF1R. Many brain 
regions targeting the LC (e.g. BNST, CeA, PVN) can be the source of CRF required for LTP. Amongst 
those regions, the CeA provides a strong and dense input to the LC (Schwarz et al., 2015; Breton-
Provencher and Sur, 2019). By using BLINK2, we will test whether inhibiting CeA-CRF+ neurons, 
thereby CRF release in the LC, is sufficient to prevent LTP observed at glutamatergic synapses of 
young animals upon electrical STDP.  To this purpose, we will inject in the CeA of P 0-3 CRF-Cre 
mice (B6(Cg)-Crhtm1(cre)Zjh/J), a DIO (double-inverted-floxed) AAV vector coding for BLINK2 (AAV-
hSyn-DIO-BLINK2-IRES-eGFP; currently under production). Ex-vivo electrophysiological 
experiments will be performed in which the electrical post-pre STDP will be coupled to optogenetic 
inhibition of CRF-CeA→LC terminals. We expect optogenetic inhibition of CRF release to 




2) Dorsal-Raphe Nucleus (DRN) 
We have shown that BLINK2 is suitable for inhibition of DRN neurons (Alberio & Locarno et al., 
2018)(Figure 22). We will therefore exploit this optogenetic tool to explore the role of serotonergic 
regulation of LC-NE neurons. While anatomical evidence supports a connection between DRN and 
LC (Segal, 1979; Kim et al., 2004), how these inputs shape LC activity is still unaddressed.  
Furthermore, it is not clear whether tonic release of serotonin (5-HT) in the LC modulates NE-
neurons firing.  
First, we will investigate how tonic release of 5-HT from DRN projections affects LC-NE discharge 
rate. To this purpose, we will take advantage of a TpH2-Cre driver mouse line (Tg(Tph2-
icre/ERT2)6Gloss/J; Bartsch, Weber and Scho, 2011) to achieve BLINK2 expression specifically in 
5HT-DRN neurons by injecting the AAV-hSyn-DIO-BLINK2-IRES-eGFP virus (currently under 
production) in the DRN of adult mice. We will then perform ex-vivo electrophysiology experiments 
in which we will record tonic firing activity of LC-NE neurons upon local photoinhibition of DRN-
5HT terminal fields.  
Not only these experiments will help to understand how CRF released by the CeA or 5-HT released 
by the DRN modulates the physiology of LC-NE neurons, but they will pave the way for future 
investigations regarding the role of DRN→LC projection in major depression or the role of CeA→LC 
projection in stress-induced maladaptations. In this context, BLINK2 would be useful to circumvent 
the paradoxical effects arising from the activation of commonly used inhibitory opsins (Wiegert et 





Although the role of Norepinephrine (NE) in Locus Coeruleus (LC) target regions has been 
extensively investigated (reviewd by Sara, 2009), it is still unclear how impinging inputs 
dynamically shape Locus Coeruleus neuronal activity to affect NE release. In the light of anatomical 
evidence supporting the highly integrative nature of LC-NE neurons (Szabadi, 2013; Schwarz et al., 
2015; Breton-Provencher and Sur, 2019), studying synaptic physiology of these cells could provide 
useful insights for the understanding of how NE neurons affect behavior. Amongst the numerous 
brain regions projecting to the LC, the Prefrontal Cortex (PFC) is of particular interest, first because 
it bears a strong cortical drive to this noradrenergic nucleus (Jodo, Chiang and Aston-Jones, 1998) 
and secondly as it might provide top-down control over the sub-cortical LC during cognition and 
stress response (Sara and Bouret, 2012). 
 
In-vivo and ex-vivo dissection of PFC→LC connectivity 
By performing in-vivo electrophysiological recordings in mice, we demonstrated that pulse 
stimulation of the PFC generates orthodromic spikes in 44% of LC neurons. Similar excitatory 
influence of PFC stimulation on LC neurons has been previously described in rats (Jodo, Chiang and 
Aston-Jones, 1998). In contrast, other studies suggested an inhibitory influence of the PFC on LC 
neurons (Sara and Hervé-Minvielle, 1995; Breton-Provencher and Sur, 2019). In Sara and Hervé-
Minvielle's study (Sara and Hervé-Minvielle, 1995), local inactivation of the PFC resulted in 
increased LC tonic activity. The authors suggested that PFC provides inhibitory control over LC 
neurons by activating local GABAergic interneurons. However, the authors did not directly assess 
the effect of PFC stimulation on LC activity. Accordingly, Breton-Provencher and Sur  (Breton-
Provencher and Sur, 2019) demonstrated that activating PFC terminals in the LC region induces 
pupillary constriction, which can be used as a readout of LC activity (Joshi et al., 2016; Zerbi et al., 
2019). Nonetheless, pupil size is regulated also by other neuromodulators such as acetylcholine 
(Larsen and Waters, 2018) and dopamine (Van Slooten et al., 2018). 
In-vivo, we found latency of LC responses to PFC stimulation (≈ 15 ms), which is consistent with 
direct monosynaptic connectivity between these two regions. Ex-vivo, we demonstrated that 
shedding light on PFC-ChR2-expressing terminals resulted in optogenetically evoked excitatory 
postsynaptic currents in LC-NE neurons. Our work, together with previous anatomical evidence 
(Breton-Provencher and Sur, 2019), supports a direct PFC→LC monosynaptic connection. Further 
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experiments are needed to conclusively demonstrate the direct synaptic connectivity between 
these two brain areas. To this purpose, we are currently testing whether opto-induced 
depolarization of PFC terminal fields in the LC region results in EPSCs even when neuronal firing is 
pharmacologically blocked by Tetrodotoxin (TTX) (Yamawaki et al., 2016).  
 
Behavioral relevance of PFC→LC projections 
Our results suggest that activation of PFC→LC projections results in mice acquiring place 
conditioning, indicative of appetitive learning and retrieval of contextual memory associations. To 
the best of our knowledge, this is the first evidence showing behavioral implications of PFC→LC 
input activation. 
Previous studies have demonstrated that LC neurons are responsive to appetitive as well as to 
aversive stimuli (Foote, Aston-Jones and Bloom, 1980; Gary Aston-Jones and Bloom, 1981). 
However, optogenetic/chemogenetic activation of LC-NE neurons (McCall et al., 2015; Zerbi et al., 
2019), or activation of CRF+ Central Amygdala (CeA)→LC projections (McCall et al., 2015), 
promotes anxiety-like behavior (e.g. more time spent in the corners of an open field, more time 
spent in the closed arms of an elevated plus-maze), and induces strong and reliable aversion. 
Therefore, optogenetic excitation of the  LC as a whole, or activation of CRF+ terminals impinging 
on the LC, is sufficient to recapitulate the stress-induced increase in anxiety levels (e.g. decreased 
animal’s exploratory behavior, increased freezing). Contrary to what it has been previously shown, 
we did not find any aversive effect of PFC→LC projections stimulation. The different impact of 
neuromodulatory CRF+-CeA→LC stimulation versus glutamatergic PFC→LC-(see: “Results”) 
activation in generating aversive state may reside in the level and mode of excitation exerted by 
these two inputs on LC neurons. LC firing responses evoked by CRF show lower maximum 
magnitude of activation (measured as the increase in discharge rate frequency), slower onset, and 
longer duration than glutamate-induced ones (Jedema and Grace, 2004; Valentino, Bockstaele and 
Van Bockstaele, 2008). Furthermore, CRF biases LC activity towards high tonic firing mode, 
whereas glutamate release induces phasic LC activation (Valentino, Bockstaele and Van 
Bockstaele, 2008). While CRF, and CRF-mediated stress stimuli, have been shown to activate the 
overall LC neuronal population (see: “Results”, and  Rassnick et al., 1998; McDevitt et al., 2009; 
McCall et al., 2015; Borodovitsyna, Flamini and Chandler, 2018), we found that PFC stimulation 
orthodromically activated only 44% of LC neurons. Also, our in-vivo results show an increase in LC 
spike probability upon PFC pulse stimulation with short onset. Contrary to CRF-CeA→LC 
78 
 
projections activation (McCall et al., 2015), PFC pulse stimulation did not result in long-lasting tonic 
entrainment of NE-neurons (see: “Results”). Taken together, the behavioral differences observed 
upon activating CRF-CeA→LC projections or the PFC→LC terminals could be explained by a 
different spatio-temporal dynamic of  NE signal in LC  target regions in the two different 
experimental settings. Indeed, while high NE levels are associated with stressful situations (Finlay, 
Zigmond and Abercrombie, 1995; Morilak et al., 2005), moderate concentrations of NE favors 
behavioral performance in tasks requiring focused attention by decreasing distractibility (Arnsten 
and Contant, 1992; Aston-Jones and J. D. Cohen, 2005). Levels of NE in the brain and behavioral 
performance accuracy are known to follow an inverted-U shape relationship [or Yerkes-Dodson 
relationship (Yerkes and Dodson, 1908; Teigen, 1994)]. Specifically low levels of NE, corresponding 
to low arousal, correlate to drowsiness and non-alertness. Performances are optimal with 
moderate levels of NE, which favors the exploitation of task-related sources of reward; this 
condition might be recapitulated by the activation of PFC→LC connection, which may engage only 
a minority of LC neurons, and for a shorter period of time.  On the other side of the spectrum, high 
levels of LC activity, as induced by stressors or CRF, deteriorate cognitive performances and allow 
exploration of the environment to escape potentially dangerous situations (Aston-Jones and J. D. 
Cohen, 2005; Luksys, Gerstner and Sandi, 2009). This view can be complemented when considering 
that LC neurons receiving input from the PFC might have a distinct output-projection pattern 
compared to the rest of LC cells. The LC might be divided into functional subpopulations playing 
divergent behavioral roles accordingly to their input-output profile. Supporting this view, in other 
brain regions involved in emotional processing, such as the Amygdala, a “minority population” of 
neurons could support the opposite behavioral phenotype from the structure as a whole, based 
on by their output-profile (Tye et al., 2011; Tye, 2018). Accordingly, previous studies showed a 
functional dichotomy between LC neurons with distinct projection pathways. LC efferent 
ascending pathway is able to exacerbate spontaneous pain while LC efferent descending pathway 
positively modulates analgesia (Hirschberg et al., 2017). Future studies are needed to address the 
output pathway of LC neurons receiving projections from the PFC. 
In the RTPP testing, we found that optogenetic stimulation of the PFC→LC inputs is sufficient to 
learn conditioned place preference, thus suggesting that activation of this input has a positive 
valence. Nevertheless, stimulation of the PFC→LC projections does not support operant 
reinforcement when assessed in an opto-ICSS paradigm (o-ICSS); this speaks against a rewarding 
effect of PFC→LC input activation. Although during o-ICSS mice showed preference for the lever 
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paired with light stimulation of PFC→LC terminals (active lever) over the inactive lever, the number 
of responses on the active lever were very low, especially when compared to response rates 
observed during o-ICSS of structures belonging to the reward system (Mateo et al., 2017; Brocka 
et al., 2018; Covey and Cheer, 2019). It is therefore possible that other factors, rather than PFC→LC 
stimulation, may shape preference for the active lever. Since we have not performed yet control 
experiments in animals that do not express ChR2, we cannot exclude that mice were pressing for 
unspecific effects induced by photostimulation. Current experiments in mice injected with a 
control virus are on-going to validate our findings.  
To explain why activation of PFC→LC inputs results in conditioned place preference without being 
rewarding, one might consider that the role of NE in valence processing is controversial (Tye, 
2018). The LC is believed to encode for the salience of an event more than for its valence (Berridge 
and Waterhouse, 2003; Vazey, Moorman and Aston-Jones, 2018). Hence, we can speculate that 
mice showed place preference during the RTPP paradigm because of perceiving novelty, or 
increased saliency, associated with photostimulation rather than for the positive valence of this 
experience. Consistent with this, rodents display a tendency to explore novel environments 
(Bardo, Neisewander and Pierce, 1989; Bevins and Besheer, 2005) and to interact with novel 
objects (Bevins et al., 2002; Kennedy et al., 2016). This suggests that novel environments/objects 
can be perceived as appetitive. Indeed, the appetitive qualities of novelty can induce conditioned 
place preference; animals repeatedly exposed to novel objects in the same environment display 
learned preference for the environmental cues previously paired with the novel objects (Bevins, 
2001; Bevins and Besheer, 2005). Therefore, the formation of place preference upon PFC→LC 
input stimulation might be reminiscent of novelty-induced conditioned place preference.  
NE has been recently suggested to boost incidental memory (Hauser et al., 2019). Incidental 
memory - or non-intentional memory- is the formation of memory when subjects are not asked to 
remember. In behavioral paradigms assessing incidental memory, subjects are engaged in a 
specific task when non-task-relevant information is presented. It follows that subjects menage to 
recall the non-task-relevant information without prior effort made to memorize it (Kontaxopoulou 
et al., 2017). Photoactivation of PFC→LC input during the RTPP might support the formation of 
incidental memories by increasing the arousal state of the animal and increasing the awareness of 
environmental cues. Therefore, PFC→LC activation might facilitate the encoding and/or retrieval 




Behavioral relevance of long-term synaptic plasticity at PFC→LC projections 
The evidence that mice form contextual associations upon PFC→LC input stimulation and can 
recall the experience of this association points at long-term plasticity processes occurring at this 
specific input. It is worth noting that mechanisms of synaptic plasticity at PFC→LC synapses, or 
more in general in the LC, have not been explored so far.  
In this study, we assessed long-term synaptic plasticity ex-vivo in the LC by applying a post-pre 
STDP paradigm, which resulted in eCB-mediated t-LTD of PFC→LC inputs, consistent with a wealth 
of experimental evidence obtained in other brain regions (Crozier et al., 2007; Heifets and Castillo, 
2009; Li and Burrell, 2011; Cui et al., 2015; Bosch-Bouju et al., 2016; Cavaccini et al., 2018; Cui, 
Perez and Venance, 2018; Foncelle et al., 2018; Xu et al., 2018).  As already introduced in the 
“Project Implementation” paragraph, we targeted this form of plasticity because retrograde eCB 
signaling at PFC→LC synapses may represent a key feedback mechanism to regulate the 
connectivity between the PFC and the LC, ultimately shaping the spatial and temporal dynamic 
profile of NE release in target brain regions, thereby affecting action control.  
We also found that the eCB-mediated signaling capacity in the LC reflects experience-dependent 
plasticity at PFC→LC synapses. Indeed, while repeated exposure to the same context impairs 
PFCLTD, a single exposure to a novel salient stressor is able to re-open this form of plasticity. Our 
result goes in line with what has been previously observed in other stress-responsive brain regions 
(Cusulin et al., 2014). We still need to provide evidence that PFCLTD re-opened by stress salience is 
eCB-mediated. Whether and how other salient events, such as positive experiences, are able to 
re-open LTD at LC→PFC synapses is a matter of future investigation.  
As a further demonstration of LC synapses’ plastic properties, we found that postnatal 
development plays a crucial role in determining the post-pre STDP outcome. The same electrical 
post-pre STDP protocol that induces eCB-LTD at adult non-dissected glutamatergic synapses 
resulted in eCB-mediated LTP at excitatory synapses of young animals. This form of synaptic 
potentiation requires activation of CRF1R-mediated signaling, which has been shown to modulate 
post-synaptically the biosynthesis of eCB (Megan Gray et al., 2015; Natividad et al., 2017). Thus, 
eCBs and CRF appear acting in concert to regulate synaptic plasticity at LC glutamatergic synapses 
of young animals. This is in line with the evidence that our optogenetic post-pre STDP paradigm, 
which does not engage neuromodulatory afferent fibers, including CRF-releasing projections to 
the LC, results in  LTD at dissected LC→PFC inputs of young mice. Reminiscent of higher synaptic 
strength of CRF-releasing afferents in young compared to adult LC,  we hypothesize that activation 
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of CRF+-containing terminals arising from CeA during the electrical STDP might lead to potentiation 
of PFC→LC synapses. To demonstrate our hypothesis, in young animals we will either 
chemogenetically activate CeA-CRF+ terminals during the opto-STDP or we will optogenetically 
suppress (for instance by using BLINK2) CeA-CRF release during the electrical STDP. In the first 
case, we expect to induce potentiation of PFC→LC synapses, while in the latter we should prevent 
the LTP at non-dissected glutamatergic synapses. Additionally, future experiments will aim at 
better characterizing the molecular interplay between CRF1R and eCB system in young mice’s LC 
neurons. Finally, we will try to address whether the divergent LC synaptic substrates between 
young and adult animals play a role in determining different stress susceptibility observed during 
adolescence (Casey, Jones and Hare, 2008).  
In summary, we found that PFC→LC stimulation supports learning and/or retrieval of contextual 
memory associations. Consistent with the occurrence of plasticity processes at LC synapses, long-
lasting modulation of PFC→LC projections relies on eCB-mediated signaling capacity, which is 
dynamically shaped by context adaptations and stress salience experiences. We also found that 
eCB-mediated plasticity at PFC → LC synapses is regulated during postnatal development, thus 
unveiling divergent synaptic substrates that might be relevant to explain some of the different 




Materials and methods 
Animals 
Male C57BL/6J [postnatal day 23-28 (young) or postnatal day 60-75 (adult)] were used in this 
study. Male mice were kept in standard cages with food and water ad libitum at 22 ± 1 °C under 
artificial 12/12-h light (7-19) /dark cycle. 
In-vivo electrophysiology 
Stereotaxic surgeries for electrophysiology were performed under 1.0–1.2% isoflurane (in 50% 
air/50% O2; 1 L/min) anesthesia. Stimulation and recording electrodes were, respectively, 
stereotaxically placed into the LC (AP -5.4 mm/bregma; ML 0.8 mm/midline; DV (-2.6)-(-
3.5) mm/brain surface) and in the the PFC (AP 1.8 mm/bregma; ML 0.5 mm/bregma; DV -1.25 
mm/brain surface).  
A glass micropipette (1–2 μm, 10–12 mΩ) filled with 2.0% pontamine sky blue in 0.5 m sodium 
acetate was used for recording. The extracellular potential was recorded with an Axoclamp-2B 
amplifier and filter (300/0.5 Hz). Single-neuron spikes were collected on-line (CED 1401, SPIKE 2, 
Cambridge Electronic Design). 
Bipolar electrical stimulation of the PFC was conducted with a concentric electrode (Phymep, 
France) and a stimulus isolator (500 μs duration, 0.5–1.5 mA; Digitimer, UK). Electrical Footshock 
stimulation was conducted with silver wires connected to the hindlimb footpad (500 μs duration, 
0.5–2 mA; Digitimer, UK). During electrical stimulation of the PFC or Foot shock stimulation, 
cumulative peristimulus time histograms (PSTH, 100 stimuli @ 0.5Hz, 5 ms bin width) of LC activity 
were generated for each neuron recorded. Cells were considered responsive to the stimulation 
when in at least 2 consecutive bins after the stimulation the spike count was higher than the 
average baseline spike count ± 2.5 standard deviations. 
At the end of each recording, the recording pipette placement was marked with an iontophoretic 
deposit of pontamine sky blue dye (−20 μA, 30 min). To mark the electrical stimulation site, +50 μA 
was passed through the stimulation electrode for 90 s. Afterward, brains were removed and snap-
frozen in a solution of isopentane stored at −80 °C. Brains were then coronally sliced and mounted 
on glass slides. The recording and electrical stimulation locations were verified under a transmitted 





Mice were anesthetized under isoflurane, intracardially perfused with a dissecting artificial 
cerebrospinal fluid (aCSF) solution containing: 87mM NaCl, 2.5mM KCl, 1,25mM NaH2PO4, 7Mm 
MgCl2, 75mM Sucrose, 25mM NaHCO3, 25mM D-glucose, 0,5mM CaCl2, saturated with a carbogen 
mix 95%O2 5%CO2. Mice were subsequently decapitated; their brains were kept in the same ice-
cold dissecting aCSF used during cutting for the successive vibratome slicing procedure. Horizontal 
slices containing pons sections (200 µm thickness) or coronal slices containing the DRN (250 µm 
thickness) were obtained using a Vibratome 1000S (Leica) then transferred to aCSF containing: 
115 mM NaCl, 3.5 mM KCl, 1.2 mM NaH2PO4, 1.3 mM MgCl2, 2 mM CaCl2, 25 mM NaHCO3 and 
25 mM D-glucose, aerated with 95% O2 and 5% CO2. Slices were incubated for 20 min at 32°C, then 
kept at 22-24 °C. During electrophysiological experiments, slices were continuously superfused 
with aCSF at a rate of 2mL/min at 28-30°C.  
LC recordings 
Whole-cell patch-clamp recordings were performed on LC-NE neurons in horizontal slices. Neurons 
were visualized under IR-DIC (infrared differential interference contrast) and selected by their 
anatomical location, their morphology and, after patching, by their electrophysiological properties 
(Zhang et al., 2010). The intracellular solution contained: 130 mM KMeSO4, 5 mM KCl, 5 mM NaCl, 
10 mM HEPES, 0.1 mM EGTA, 2 mM MgCl2, 0.05 mM CaCl2, 2 mM Na2-ATP and 0.4 mM Na3-GTP 
(pH 7.2-7.3, 280-290 mOsm/kg). The excitatory postsynaptic currents (EPSPs) were induced at 0.1 
Hz in the presence of the GABAA receptor antagonist gabazine (10 mM) by local electrical 
stimulation using a theta electrode connected to a constant current insulator unit (Digitimer Ltd.) 
or by optogenetic stimulation of prefrontal cortex afferents using short blue light pulses (1 ms at 
470 nm) of LED light delivered through the microscope objective (CoolLED, pE-100, Andover, 
Hampshire, United Kingdom). To induce plasticity a negative STDP paradigm was used: 20 EPSPs 
bouts paired with bAPs, delivered 10 s apart. Each bout consisted of five bursts (200 ms apart), 
each composed of three bAPs at 50 Hz followed by one EPSP (negative timing). The onset of the 
EPSPs followed the peak of the last postsynaptic action potential in the burst by 10 ms (Δt =-10 
ms). During plasticity induction, the postsynaptic neuron was held at -70mV in between bAPs. Data 
were excluded when the access resistance (Ra) changed > 20%. Data are reported without 
corrections for liquid junction potentials. Data were acquired using a Multiclamp 700B amplifier 
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controlled by pClamp 10 software (Molecular Device), filtered at 2.4 kHz and sampled at 10 kHz 
(voltage clamp), or filtered at 10 kHz and sampled at 20 kHz (current clamp) with a (Digidata 1322, 
Molecular Device). 
Data analysis 
The occurrence and magnitude of synaptic plasticity were evaluated by comparing EPSC 
normalized amplitudes from the last 5 min of baseline recordings with the values between 20–25 
min after conditioning. The plasticity loci (pre- vs postsynaptic) were deduced from the change in 
the paired-pulse ratio (PPR) after the delivery of the stimulation protocol in the same time periods. 
DRN recordings 
Electrophysiology recordings were performed on coronal brain slices containing the DRN. The DRN 
was first visualized under infrared differential interference contrast to allow for subsequent 
identification of GFP+ or YFP+ neurons by epifluorescence microscopy. Patch pipettes (4–6 MΩ) 
were filled with a solution containing 135 mM NaCl, 10 mM HEPES, pH 7.2–7.3, for cell-attached 
recording or 130 mM KMeSO4, 5 mM KCl, 5 mM NaCl, 10 mM HEPES, 2 mM MgCl2, 0.1 mM EGTA, 
0.05 mM CaCl2 , 2 mM Na2ATP and 0.4 mM Na3GTP, pH 7.2–7.3 (280–290 mOsm/kg), for whole-
cell recordings. Cell-attached experiments were performed in the voltage-clamp configuration 
with GFP+ or YFP+ neurons held at the potential that gave a holding current of 0pA, whereas 
whole-cell experiments were performed in the current-clamp configuration, without current 
injection. Light (470 nm for BLINK2 activation, 8.7 mW/mm2; 585 nm for eNpHR3.0 activation, 17 
mW/mm2) emitted by an LED (CoolLED) was delivered to the specimen through the microscope 
objective (IR-ACHROPLAN 40× /0.8-NA (numerical aperture); Zeiss). Data were acquired with a 
Multiclamp 700B amplifier controlled by pClamp 10 software (Molecular Devices) filtered at 10 
kHz and sampled at 50 kHz (current clamp and voltage clamp) (Digidata 1322; Molecular Devices). 
We generated time-course plots by averaging the discharge firing rate every 5 s; values were 
normalized to 1 min of baseline recording before light illumination. All data are reported without 
corrections for liquid junction potentials. Data where the access resistance (Ra) changed by > 20%, 
were excluded from further analyses. To identify light-responsive cells, we applied a threshold-
based criterion: the threshold (Th) was set as the mean discharge rate minus 2 standard deviations, 
and the mean firing rate was calculated on values (5-s binning) computed over 1 min prior to light 
illumination. Cells were considered light-responsive when their mean discharge rate fell below Th, 
or to zero, in at least two consecutive 5-s bins. ‘Time below threshold’ (Timeth) was measured as 
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the interval between the time point at which the discharge rate fell below Th in at least two 
consecutive 5-s bins and the time point at which the discharge rate increased above Th in at least 
two consecutive 5-s bins. 
Substances 
Triton-X, NaCl, KCl, NaH2PO4, MgCl2, CaCl2, NaHCO3, D-glucose, Sucrose, KMeSO4, HEPES, MgCl2, 
Na2-ATP, Na3-GTP, 2,4,5-trimethylthiazole (TMT), Paraformaldehyde (PFA), were purchased from 
Sigma Aldrich. Gabazine (SR 95531 hydrobromide), AM251 were purchased from HelloBio. NBI 
35965 was purchased from Tocris Bioscience. TH-antibody was purchased from Merck-Millipore. 
GFP-antibody was purchased from AbCam. C-fos antibody was purchased from Cell Signaling 
Technology, Inc. Neurobiotin was purchased from (DBA, Italy). DAPI and Streptavidin conjugated 
with Alexa 568 (Termofisher Scientific). 
Animal surgeries 
Adult viral injections 
C57BL/6J mice (postnatal day 30-45) were anesthetized with isoflurane (4-5% for induction, 1-2% 
for maintenance) and O2 mix. Subsequently, mice were mounted on a stereotaxic frame 
(Stoelting). To target the PFC 0.5-0.6 µL of AAV5.CamKII.hChR2.EYFP (AddGene, viral prep #26969-
AAV5) or a combination of AAV1.hSyn.Cre (AddGene, viral prep #105553-AAV5) and 
AAV5.Ef1α.DIO.hChR2.EYFP (AddGene, viral prep # 20298-AAV5) was delivered at the following 
stereotaxic coordinates from bregma: AP +1.94; ML ±0.4; DV -2.4., the virus volume was delivered 
at a 0.1 µL/min rate using a syringe (WPI, Nanofil 10µL) connected to a Micro Pump (WPI, UMP3 
UltraMicroPump). Electrophysiological recordings were performed at least 5 weeks after the 
surgery. To deliver BLINK2 or eNpHR3.0 to the DRN, we injected 0.5 µ l (titer 1013 GC/mL) of 
AAV1/2-hSyn-Blink2-IRES-eGFP, AAV1/2-hSyn-eGFP or a 1:1 mixture of AAV1-hsyn-Cre 
(pENN.AAV.hSyn.Cre.WPRE.hGH, a gift from James M. Wilson (Perelman School of Medicine, 
University of Pennsylvania); Addgene viral prep # 105553-AAV1) and AAV5-EF1α -DIO-eNpHR3.0-
eYFP (Stanford Virus Core) into the DRN (mediolateral, + 1.15 mm, anteroposterior, –4.4 mm, 
dorsoventral, –3.6 mm under an angle of 20° from bregma; or mediolateral, + 0.5 mm, 
anteroposterior, –4.36 mm, dorsoventral, –3 mm from bregma). Ex-vivo electrophysiology was 
performed at least 2 weeks after surgeries. 
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P0-P3 viral injections 
C57BL/6J mice (postnatal day 0-3) were anesthetized through hypothermia and mounted on a 
stereotaxic apparatus (Stoelting). A small AAV9.CamKII.hChR2.EYFP volume (0.25 µL) was injected 
into the PFC (stereotaxic coordinates from bregma: AP +0.5; ML ±0.1; DV-0.9) at a 0.1 µL/min rate 
using a syringe (WPI, Nanofil 10µL) connected to a Micro Pump (WPI, UMP3 UltraMicroPump). 
Electrophysiological recordings were performed between postnatal day 23 and 28. 
Optical ferrules implantation 
Animals that were injected AAV1.hSyn.Cre (AddGene, viral prep #105553-AAV5) and 
AAV5.Ef1α.DIO.hChR2.EYFP (AddGene, viral prep # 20298-AAV5) underwent, during the same 
surgical procedure, optic fiber implantation in the LC. Briefly, an optical fiber (200 um core, 0.48 
NA, Thorlabs) was implanted bilaterally above the LC injection site (AP -5.45, ML 1.0, DV -3.65, 
from bregma with a 6° ML angle). Optic fiber ferrules were then permanently affixed with dental 
cement (Metabond, Parkell, Inc). Mice were allowed 6 weeks to recover from surgery and to allow 
viral expression. 
Behavioral paradigms 
Real-Time -and conditioned- Place Preference  
A three-chamber conditioned place preference apparatus was used for the real-time place 
preference test (Anymaze, Stoelting). The apparatus consisted of three chambers (20 × 18 × 35 cm) 
with distinct walls patterns and floors. The animal’s position was monitored via a CCD camera. 
Mice expressing ChR2 at the PFC level and with optic fibers implanted in the LC area were used for 
real-time place preference. On each of the four days, mice were connected to an optical fiber and 
allowed to access the three chambers of the apparatus freely. On Pre-session, mice were 
connected to an optical fiber with no laser (15-min session). Mice showing side preference were 
excluded. On Stim1 and Stim2 (30-min session), two chambers were assigned as the stimulation 
chambers (counterbalanced across all mice). Whenever the mouse was within the stimulation 
chambers the laser was on (473 nm, 1 mW, 10 ms pulse length duration at 10 Hz and 30Hz in 
different chambers) (Figure 26). On Post-session (15-min session), the mice were allowed to freely 
explore the three chambers without optical stimulation. 
IntraCranial Self Stimulation (ICSS) 
Mice expressing ChR2 at the PFC level and with optic fibers implantation in the LC were used for 
ICSS. Animals were placed into the operant chamber featured with two levers. They were trained 
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on a fixed ratio (FR1) reinforcement schedule; each time the mouse pressed the active response 
lever, the computer delivered a 1-s 10 Hz or a 1-s 30Hz pulse of light stimulation (473 nm, 1 mW, 
10 ms pulse length duration)(Figure 26). The inactive lever presses were not associated with any 
consequence. Animals underwent 2 training sessions per day, each session lasted 30 min. Six ICSS 
training sessions were associated with 10Hz opto-stimulation, the remaining 6 were associated 
with 30Hz opto-stimulation. We recorded both active and inactive lever presses during the 6 days. 
 
Figure 26 Schematics of the optogenetic stimulation protocols used for the ICSS and Place Preference paradigms. 
Context habituation and stress exposure 
Mice were habituated to the context and handled by the experimenter for 5-10 min per day for 5 
days prior to experimentation. Mice were also habituated to a plastic chamber where stress or 
control conditions took place. To induce acute stress, mice were placed in a rodent restrainer for 
15 min, the restrainer was then placed inside a sealed anesthesia induction chamber. A piece of 
filter paper was placed inside the chamber and saturated with 100 µL predator odor (2,4,5-
trimethylthiazole, TMT, Sigma-Aldrich). 
Open Field Test 
Immediately after the last context habituation session (C-HAB) or the stress exposure (Stress), 
animals were tested for their anxiety levels in an open field test (OFT). The OFT apparatus consisted 
in a 30cmx30cmx40xm dark plastic box. Mice were allowed to freely explore the apparatus for 10 
minutes, during which their activity was filmed with an infrared camera situated above the maze. 
1h after the conclusion of each test, mice were sacrificed for c-fos staining. Alternatively, mice 
used for electrophysiology were sacrificed 24h after the test. Behavior was scored using AnyMaze 
behavioral tracking software (Stoelting). 
Immunofluorescence 
Tyrosine Hydroxylase (TH) immunostaining 
To confirm the LC-NE identity of the recorded neurons, the patched cells were filled with 
Neurobiotin (0.3mg/mL, DBA Italia) and processed post-hoc for their immunoreactivity for the TH 
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marker. Following the electrophysiological recordings, brain slices were kept for 24-48h in 4% 
paraformaldehyde in 0.1M Phosphate Buffer 7.4pH (PB). Brain slices were then rinsed 3 times in 
PB saline (PBS) for 15min and then permeabilized and blocked (PBS containing 3% Bovine serum 
albumin (BSA) [w/v]; 0.3% Triton-X [v/v]). Slices were then incubated at 4°C overnight in the same 
permeabilization and blocking medium containing the anti-TH rabbit polyclonal antibody (1:500, 
Merk-Millipore). Brain sections were then rinsed 3x15min in PBS and incubated 4h RT in the 
permeabilization and blocking buffer containing Alexa568-streptavidin (1:1000, Thermofisher) to 
label the Neurobiotin filled patched cells. Subsequently, slices were rinsed 3x15min in PBS and 
incubated 2h RT in the permeabilization and blocking medium containing Alexa488 conjugated 
secondary antibody (1:500, Thermofisher). After rinsing the slices 3x15 min, the nuclei were 
stained with DAPI solution (1:500 in PBS, Sigma-Aldrich), rinsed again, mounted on glass slides, 
and coverslipped with ProLong Gold antifade reagent (Invitrogen). 
C-fos immunostaining 
Briefly, mice were transcardially perfused with 25mL Phosphate Buffer Saline (PBS) and 25mL 4% 
paraformaldehyde in 0.1M phosphate buffer (PFA). Brains were extracted, post-fixed in PFA 4%, 
cryoprotected (sucrose 20%), and sliced in the coronal plane to generate brain sections containing 
LC. Free-floating sections were rinsed in 0.1M PBS three times, blocked in 4% bovine serum 
albumin (BSA), incubated in anti-TH chicken polyclonal antibody (1:500, Merk-Millipore) and rabbit 
anti-c-Fos (1:500, Cell Signaling Technology) @ 4°C overnight, rinsed again 3 times in 0.1M PBS, 
incubated in AlexaFluor 568 goat anti-chicken (1:500, Invitrogen) and AlexaFluor 488 goat anti-
rabbit (1:500, Invitrogen) secondary antibodies, washed in 0.1M PBS, and incubated. After rinsing 
the slices 3x15 min, the nuclei were stained with DAPI solution (1:500 in PBS, Sigma-Aldrich), rinsed 
again, mounted on glass slides, and coverslipped with ProLong Gold antifade reagent (Invitrogen). 
From each brain, 5 images of LC-containing slices were acquired with an inverted Leica TCS SP5 
confocal microscope. Th+ cells and Th+ c-fos+ were counted using ImageJ software.  
Statistics  
Appropriate parametric statistics were used to test our hypothesis unless data did not meet the 
assumptions of the intended parametric test (normality test). In that case, appropriate 
nonparametric tests were used. Power analysis assumptions were as follows: power, 0.9; alpha, 
0.5; two-tailed and expected difference 50% greater than the observed s.d. Data were analyzed by 
one-way repeated measures ANOVA for comparisons within a group, by one-way ANOVA for 
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between-group comparisons. Two-way and three-way- ANOVA were used in case we compared 
respectively two or three independent factors (GraphPad Prism 7 software). Post hoc analysis 
(Tukey or Dunnet, as indicated) was performed only when ANOVA yielded a significant main effect. 
Two groups were tested for statistical significance by two-population t-test and Mann–Whitney U 
nonparametric test (GraphPad Prism 7 software). Statistical details of experiments are shown in 
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Remote manipulation of ion channels by light is a powerful method to control neuronal activities. Light-gated proton (archaerhodopsin)1 and chloride pumps (halorhodopsin)2–4 
and anion-selective channelrhodopsins (ACRs)5–8 are established 
optogenetic tools for the inhibition of neuronal activity. Given their 
fast on and off kinetics, pumps are well suited for millisecond-pre-
cision applications2,9,10, but they have limitations when long-lasting 
inhibition (for seconds to minutes) is required. Under prolonged 
activity, pumps substantially affect ion-concentration gradients 
across the plasma membrane11,12 and eventually lead to paradoxical 
effects with activation instead of inactivation13. Longer inhibition 
can be achieved with ACRs that have a slow off kinetics8,14; however, 
their effectiveness depends directly on the chloride reversal poten-
tial −(E )Cl , which can vary among neurons. Immature neurons15 
and axon initial segments16 of mature neurons can have a positively 
shifted −ECl , which will promote activation rather than inhibition 
after ACR channel opening.
Given the universal role of K+ conductance in the termination 
of action potentials and its major contribution to the resting poten-
tial, there is interest in engineering light-gated K+ channels. We 
previously engineered BLINK1, in which a LOV217,18 photoreceptor 
domain reversibly controls a K+ channel (KcvPBCV1)19 in response to 
blue light (455 nm)20. BLINK1 has favorable properties for optoge-
netics: a low light requirement that avoids tissue heating and dam-
age, a large unitary conductance (> 100 pS) to counteract excitatory 
currents, and a lack of inactivation during prolonged illumination. 
In vivo experiments with zebrafish embryos highlighted the use 
of BLINK1 as an inhibitory tool. However, BLINK1 has low sur-
face expression, which hampers its wider use. We present here an 
improved version of the channel, BLINK2, which showed higher 
surface expression in neurons compared with that of BLINK1, as 
well as efficient inhibition of firing in three animal models: zebraf-
ish, rat and mouse. Unique to BLINK2 is its post-illumination activ-
ity, which lasts tens of minutes. This property is advantageous for 
achieving long neuronal inhibition without toxic exposure to pro-
longed illumination, for instance, in the case of neuropathic pain or 
in behavioral animal experiments. As proof of principle, we show 
that BLINK2 activation by light reduced pain for more than 30 min 
in a rat model and inhibited the touch-evoked escape response in 
zebrafish. This durable light-off activity of BLINK2 paves the way 
for optogenetic interventions in chronic applications.
Results
Improving surface expression of BLINK1. We improved BLINK1 
trafficking to the plasma membrane by adding C-terminal signal 
sequences that promote forward trafficking in eukaryotic K+ chan-
nels21. We tested, alone and in combination, the endoplasmic reticu-
lum export motif and trafficking signals of Kir2.121 and the 14-3-3 
binding sites of TASK1-322 and KAT123–25. We coexpressed the con-
structs (Supplementary Table 1) with GFP in HEK293T cells and 
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thetic potassium channel, BLINK2, which showed good expression in neurons in three species. The channel is activated by 
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(> 30 min) reduction in pain sensation.
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measured light-regulated currents by patch clamp. We evaluated 
two parameters: expression efficiency (the percentage of GFP+ cells 
with a measurable BLINK1-like K+ current) and light regulation 
(the percentage of cells with no K+ current in the dark). Most clones 
showed an increase in expression efficiency to > 25%, compared 
with 8% for BLINK1 (Fig. 1a). High expression efficiency, however, 
resulted in a loss of light regulation. In clone 4, for instance, the 
addition of Kir2.1 trafficking signal increased the expression effi-
ciency to about 40% but decreased light regulation from 100% to 
~70%, thus making the construct unsuitable as an optogenetic tool. 
Only clone 9, which we renamed BLINK2, showed improved expres-
sion efficiency (~28%) and 100% light regulation. BLINK2 (Fig. 1b) 
has the same topology as BLINK1 and the C terminus of KAT1 
(amino acids 506–677, KAT1 numbering) (Supplementary Table 1). 
This KAT1 sequence ends with the binding motif 673YFSDN677 for 
14-3-3 proteins, a class of adaptors that promote KAT1 surface 
expression25. Figure 1c shows exemplary whole-cell recordings from 
a BLINK2-transfected COS7 cell in which dark/light transition acti-
vated a particularly high current, which is normally in the range of 
200–500 pA. In the dark, we measured low currents in BLINK2-
transfected cells that were similar to those in untransfected or 
GFP-transfected cells (Supplementary Fig. 1), indicating that the 
channel was closed. Inhibition by BaCl2 showed that the dark cur-
rent was an endogenous potassium conductance of COS7 cells. 
3 min of blue light illumination (455 nm, 90 μ W/mm2) elicited a 
voltage-independent current increase, which reverted after 5 min of 
darkness (Fig. 1c,d). We estimated a ton of 2.7 min (n = 5) and a toff of 
7.4 min (n = 6) (Fig. 1e,f).
BLINK2 is activated specifically by blue light (Supplementary 
Fig. 2). We measured BLINK2 single-channel currents in cell-
attached recordings (Fig. 1g). Blue light gradually increased channel 
activity within 2 min. A return to darkness reduced channel activity 
after 1 min. The unitary conductance of the light-activated channel is 
about 130 pS (102 mM K+out). Comparison of the i/V relationship of 
BLINK2 with those of BLINK1 and KcvPBCV1 (Supplementary Fig. 3) 
showed that BLINK2 retained a large unitary conductance (> 100 pS 
in 100 mM K+)20,26.
We determined the dynamics of BLINK2 open probability (Po) 
during light/dark transitions from cell-attached recordings (Fig. 1h; 
n = 4). An increase in Po was measurable after only 30 s of light expo-
sure and increased further during 60 s of illumination. Deactivation 
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Fig. 1 | Engineering and characterization of BLINK2. a, Surface expression and light regulation of BLINK1 derivatives. Expression efficiency (EE) was 
defined as the percentage of cells with measurable BLINK1-like current. Light regulation (LR) represents the percentage of cells that did not show dark 
current. Clones are numbered according to Supplementary Table 1. b, Cartoon representation of BLINK2 showing the KcvPBCV1 channel (gray), LOV2 domain 
(orange), N-terminal myristoylation and palmitoylation sites (zigzagging black lines) and a fragment of Arabidopsis thaliana KAT1 protein (GenBank 
AED95356.1) (red) for binding of 14-3-3 proteins (blue). c, Whole-cell recordings from a COS7 cell transfected with BLINK2 in response to voltage steps 
from + 60 to –140 mV in the dark (top black traces), 5 min after the start of blue light illumination (blue traces) and 5 min after returning to darkness 
(bottom black traces). Similar results were obtained in n =  9 cells from 10 independent experiments. d, I/V relationship from measurements in c in the dark 
(black solid circles), in blue light (blue circles) and after a return to dark conditions (open black circles). e,f, Activation kinetics of BLINK2 current in blue 
light (e) and after deactivation in the dark (f). Currents were recorded at –100 mV and normalized to t =  5 and t =  0 min for activation and deactivation, 
respectively (r.u., relative units). Data were fitted with a single exponential (solid line). g, Single-channel recordings from cell-attached measurement of 
BLINK2 in COS7 cells. The traces show the current response to a voltage step from 0 mV to + 40 mV in a dark-adapted cell (top black trace), after 1.5 and 
2 min of blue light (blue traces) and 1 min after turning the light off (bottom black trace). Similar results were obtained in n =  4 cells from 4 independent 
experiments. h, Open probability (Po) changes of BLINK2 single channels in response to dark/light transitions. Recordings were done at + 40 mV in the 
cell-attached configuration. Blue arrows indicate the time of light on (upward-facing arrow) and light off (downward-facing arrow). Data shown are 
the mean ±  s.d. of the time at which measurements were performed in 4 experiments. In all experiments reported in this figure, the blue light (455 nm) 
intensity was 90 μ W/mm2.
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the current kept increasing over a short time window in the dark, 
and in another case we measured residual channel activity 20 min 
after the light was turned off. Single-channel data confirmed that 
the light-induced macroscopic current (Fig. 1c) was generated by 
the large conductance BLINK2 channel. The slow deactivation 
kinetics in the dark suggests that BLINK2 can be used as a tool for 
sustained inhibition after cessation of illumination.
BLINK2 localization in rat hippocampal primary neurons. We 
infected rat primary hippocampal neuronal cultures with an adeno-
associated virus (AAV) expressing BLINK2 (AAV-hSyn-BLINK2-
IRES-eGFP). An immunofluorescence-based antibody assay27 
showed that BLINK2 was expressed at the cell surface with a punc-
tate staining pattern (Fig. 2a). We found no immunofluorescence 
for an intracellular protein (MAP2) in nonpermeabilized cells, 
which demonstrates the reliability of our assay and the specificity 
of BLINK2 membrane staining (Supplementary Fig. 4a). The per-
centage of cells surface-stained for BLINK2 versus the total number 
of GFP+ cells (n = 14) was 66.14% ± 3.23% (all values are ± s.e.m. 
unless stated otherwise).
BLINK2 intracellularly colocalized with the Golgi marker GM130 
in the soma and in dendritic Golgi outposts (Fig. 2b), which sug-
gests that it is sorted along the secretory pathway. The average value 
for surface versus total staining was 32.73% ± 2.34% (n = 27). Thus, 
about one-third of BLINK2 protein expressed by a neuron reaches 
the plasma membrane. To determine the localization of BLINK2 in 
axonal and somatodendritic domains, we used the MAP2 marker. 
BLINK2 clusters were detectable in the dendritic compartment 
(MAP2+) but not in the axon (MAP2–) (Fig. 2c). We further assessed 
colocalization of BLINK2 clusters with the presynaptic marker 
Bassoon and the postsynaptic protein PSD-95. BLINK2 clusters 
partially colocalized with the synaptic markers Bassoon and PSD-95, 
indicating the presence of BLINK2 in some synapses (Supplementary 
Fig. 4b). The percentage of synapses in which BLINK2 localized was 
26.35% ± 6.16% (n = 8 cells from two independent experiments) for 
Bassoon staining and 20.04% ± 2.98% (n = 7 cells from two inde-
pendent experiments) for PSD-95 staining. In conclusion, our data 
show that BLINK2 is transported along the secretory pathway and 
expressed at the plasma membrane in hippocampal neurons, prefer-
entially in the somatodendritic compartment.
Ex vivo recordings from mouse brain. To test neuronal silencing 
by BLINK2 in brain slices, we injected the AAV-hSyn-BLINK2-
IRES-eGFP virus in the dorsal raphe nucleus (DRN) of the mid-
brain (Fig. 3a). BLINK2-expressing neurons (GFP+) recorded at 
the soma in the dark showed basal tonic firing (0.2–7 Hz; Fig. 3a), 
similar to the activity in untransfected acute DRN slices28–30. After 
transfection with a control GFP-expressing virus (AAV1/2-hSyn-
eGFP), none of the recorded cells (n = 7) showed inhibition of 
firing activity (Supplementary Fig. 5a,b). Passive and active proper-
ties of BLINK2-expressing cells were indistinguishable from those 
of controls in the dark (Supplementary Fig. 6a,b), which indicates 
that the channel is closed in the dark. Furthermore, the number of 
GFP+ cells did not vary 2, 4 and 8 weeks after infection, thus indi-
cating that BLINK2 expression does not interfere with cell viability 
(Supplementary Fig. 7).
After exposure to 60 s or 30 s of blue light (470 nm, 8.7 mW/mm2), 
light-responsive neurons hyperpolarized and stopped firing within 
2 min after the light was switched off (for 60-s exposure (n = 11), 
1.32 ± 0.17 Hz Beforelight and 0.005 ± 0.003 Hz Afterlight 0-2′; for 30-s 
exposure (n = 8), 1.39 ± 0.2 Hz Beforelight and 0.016 ± 0.007 Hz 











GFP/Surface BLINK2 GFP/BLINK2 Surface BLINK2/BLINK2
Fig. 2 | BLINK2 expression in rat hippocampal neurons. a, BLINK2 expression. Left, BLINK2 at the cell surface (magenta). Center, total BLINK2 (turquoise). 
Right, merged image. GFP is shown in yellow. Scale bar, 10 μ m. Similar results were obtained in n =  27 cells from 3 independent experiments. b, From left 
to right, staining for MAP2, Golgi marker GM130 (magenta) and BLINK2 (turquoise), and merged images. The rightmost images are cropped views of the 
regions outlined by boxes in the other images in the row; red arrowheads indicate colocalization between BLINK2 and GM130. Scale bars, 10 μ m. Similar 
results were obtained in n =  15 cells from 3 independent experiments. c, GFP (yellow), MAP2 (turquoise) and BLINK2 (white) in dendrites (MAP2+) and 
axons (MAP2–). Scale bars, 5 μ m. Similar results were observed in n =  16 cells from 3 independent experiments. All images were acquired from cultured rat 
hippocampal neurons infected with AAV1/2-hSyn-BLINK2-IRES-eGFP. Neurons in c were also transfected with a GFP expression plasmid.
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after stimulation (data not shown). We reasoned that dialysis of 
intracellular constituents during whole-cell recordings might rep-
resent a caveat, and therefore we analyzed the discharge rate of 
tonically active GFP+ neurons in a cell-attached configuration28,31. 
Although light stimulation (60 s) substantially reduced the firing 
discharge rate (Beforelight, 1.3 ± 0.3 Hz; Afterlight 0-2′, 0.03 ± 0.01 Hz), 
we observed a slight recovery of activity (Afterlight 5′-7′, 0.18 ± 0.05 Hz) 
in 7 out of 11 cells in the dark (n = 11; repeated measures one-way 
ANOVA, F10,2 = 22, P = 0.0007; post hoc, Beforelight versus Afterlight 0-2′, 
P = 0.002; Beforelight versus Afterlight 5′-7′, P = 0.003; Afterlight 0-2′ versus 
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Fig. 3 | BLINK2-mediated silencing of tonic firing activity in mouse DRN neurons. a, Left, diagram indicating the virus injection site. Middle, sample 
confocal image showing expression of the AAV1/2-hSyn-BLINK2-IRES-eGFP virus in the mouse DRN (green, GFP; gray, DAPI). Scale bars, 200 µ m or  
40 µ m (inset). AQ, aqueduct. n =  21 mice. Right, representative (n =  19 from 11 mice) current-clamp recording of tonic firing activity in DRN GFP+ neurons. 
b, Left, representative whole-cell current-clamp recordings of the firing response before and after 60 s (top) and 30 s (bottom) of blue light stimulation 
(duration indicated by horizontal blue bars) (top, n =  11 independent recordings in 5 mice; bottom, n =  8 independent recordings in 6 mice). Middle, time 
course of the effect of 60 s (top) and 30 s (bottom) of blue light stimulation (blue bar) on the firing discharge rate (5-s binning). Right, summary plots 
indicating the mean firing discharge rate 2 min before light (Beforelight; baseline) and 2 min after light-off (Afterlight 0–2′) (60 s, Beforelight versus Afterlight 0–2′, 
n =  11, P <  0.0001, t =  7.9, df =  10, two-sided paired t-test; 30 s, Beforelight versus Afterlight 0–2′, n =  8, P =  0.004, t =  4.2, df =  7, two-sided paired t-test). c, Left, 
representative cell-attached voltage-clamp recordings of firing responses before and after 60 s of blue light stimulation (blue bar) (n =  11 independent 
recordings; n =  10 mice). Middle, time course of the effect of 60 s of blue light stimulation (blue bar) on the firing discharge rate (5-s binning). Right, 
summary plot indicating the mean firing discharge rate 2 min before light (Beforelight) and at 2 (Afterlight 0–2′) and 5 (Afterlight 5′–7′) min after the end of light 
exposure (n =  11; repeated measures one-way ANOVA, F10,2 =  22, P =  0.0007; post hoc, Beforelight versus Afterlight 0–2′, P =  0.002; Beforelight versus Afterlight 5′–7′, 
P =  0.003; Afterlight 0–2′ versus Afterlight 5′–7′, P =  0.02; multiple comparison and Tukey’s P value correction) (*P <  0.05, **P <  0.01, ****P <  0.0001). Data in time 
course plots are presented as mean ±  s.e.m. Blue light was delivered through the microscope objective (40×  at 470 nm, 8.7 mW/mm2).
NATuRE METHoDS | VOL 15 | NOVEMBER 2018 | 969–976 | www.nature.com/naturemethods972
ArticlesNature Methods
To compare BLINK2 to the opsin-based chloride pump eNphR3.0, 
we coinjected AAV1-hsyn-Cre and AAV5-EF1α -DIO-eNpHR3.0-
eYFP viruses into the DRN (Supplementary Fig. 8a). In YFP+ cells, 
60 s of yellow light (585 nm, 17 mW/mm2) induced rapid (< 5 s) 
silencing of firing activity (Supplementary Fig. 8b); this inhibitory 
effect faded within the illumination period. The firing rate returned 
to control levels within 2 min of dark onset (Beforelight, 2.7 ± 0.8 Hz; 
Light, 1.3 ± 0.7 Hz; Afterlight 0-2′, 2.3 ± 0.9 Hz; Supplementary Fig. 8c). 
To provide a quantitative comparison between the eNpHR3.0-medi-
ated and BLINK2-mediated effects, we calculated the duration of fir-
ing inhibition as the ‘time below threshold’ (a detailed definition is 
presented in the Methods section), which was 71 ± 28 s for eNpHR3.0 
(n = 9) and 420 ± 148 s for BLINK2 (n = 10) (Supplementary Fig. 8d). 
Thus eNpHR3.0-induced inhibition was faster than that of BLINK2 
and did not persist in the dark.
In vivo validation of BLINK2. Next we validated BLINK2 for in vivo 
application in a zebrafish model. In a touch-evoked escape-response 
assay, embryos are gently touched on the tail to elicit an escape-type 
swimming episode. We reasoned that BLINK2 photoactivation 
would prevent or impair this behavior. In blue light, 2-d-old larvae 
injected at the one-cell stage with BLINK2 RNA showed an altered 
escape response to touch compared with that of controls; we did not 
observe a significant difference between experimental and control 
specimens when we repeated the experiment in the dark (GFP dark, 
4.2% ± 4.2%; BLINK2 dark, 10.4% ± 5.3%; GFP light, 7.2% ± 3.7%; 
BLINK2 light, 46.4% ± 5.2%) (P = 0.028 and 0.0023 for BLINK2 dark 
versus light and GFP light versus BLINK2 light, respectively). The 
percentage of affected larvae (Supplementary Fig. 9a) was similar to 
that reported for BLINK120, with the exception that a subpopulation 
of BLINK2 embryos (13 of 91 embryos) required more touches than 
2 dpf
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Fig. 4 | BLINK2 expression and functional silencing in zebrafish. a, Left, immunohistochemistry in 3-dpf (days post-fertilization) embryos, showing a 
hair cell of the inner ear labeled for membrane-targeted GFP (green in the merged image) and the BLINK2 channel (magenta in the merged image), both 
expressed under the control of brn3c:gal4. Right, neuromast cells from the same Tg(brn3c:gal4;UAS:mGFP) line labeled in the same way. Embryos were 
counterstained with DAPI (blue). Scale bars, 10 µ m. Similar results were obtained in 3 independent experiments. b, Immunohistochemistry on whole 
2-dpf embryos showing cell bodies and part of the axons of primary motor neurons stained by membrane-targeted GFP (green) and BLINK2 (magenta). 
White arrows indicate BLINK2 immunoreactivity at the plasma membrane and axonal tract. Genotypes are as indicated. GFP was expressed in subsets 
of motor neurons only. Scale bars, 10 µ m. Similar results were obtained in 3 independent experiments. c, Touch-evoked escape response assay (TEER) in 
Tg(mnx1:gal4;UAS:BLINK2) and Tg(UAS:BLINK2) embryos. Embryos were assayed after a 20-min activation of the channel with blue light. Swim duration, 
distance and average speed were 2.03 ±  0.28 s, 35.80 ±  5.65 mm and 17.49 ±  1.50 mm/s, respectively, in control animals and 1.10 ±  0.16 s, 16.62 ±  2.38 mm 
and 16.60 ±  1.75 mm/s in BLINK2-expressing animals. Traces for 10 escape episodes are shown for each condition. n =  26 larvae for Tg(UAS:BLINK2) and 
n =  15 larvae for Tg(mnx1:gal4;UAS:BLINK2). Data are presented as the average (center line) ±  s.d.; P values are, respectively, 0.019, 0.017 and 0.071.  
d, TEER assay in the same animals as in c after 1 h of rest in the dark. Swim duration, distance and average speed were 3.18 ±  0.50 s, 77.12 ±  13.42 mm and 
24.03 ±  0.79 mm/s, respectively, in control animals and 2.67 ±  0.44 s, 57.03 ±  8.90 mm and 22.08 ±  0.63 mm/s in BLINK2-expressing animals. P values are, 
respectively, 0.48, 0.29 and 0.099. *P ≤ 0.05 (two-sided t-test). n.s., not significant.
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BLINK1 embryos in order for an observable response to be elicited 
(Supplementary Fig. 9b). The light-driven effect on escape devel-
oped with a half-time of 15–20 min and reverted in the dark with 
a similar kinetics (Supplementary Fig. 9c). The mutation Q513D, 
which accelerates dark recovery in the isolated LOV2 domain32, did 
not affect the kinetics of BLINK2 (Supplementary Fig. 9c).
Transgenic zebrafish line expressing BLINK2. Expression of 
BLINK2 under the control of UAS regulatory sequences in a 
transgenic zebrafish line allowed targeting of the channel in 
genetically defined populations of neurons through crossing with 
Gal4 reporter lines33.
We expressed BLINK2, together with a membrane-bound fluo-
rophore (mGFP), in hair cells of the zebrafish ear and lateral line 
neuromasts by crossing our specimens into the brn3c:gal4 back-
ground (Tg(brn3c:gal4;UAS:BLINK2;UAS:mGFP)). Whole-mount 
immunohistochemistry with anti-BLINK2 showed expression of 
the channel preferentially at the level of the apical cilia in hair cells 
(Fig. 4a). Its expression in neuromasts seemed most prominent in 
the cell body in GFP+ cells.
To express BLINK2 in primary motor neurons of the spinal cord, 
we crossed the UAS:BLINK2 carrier zebrafish into the mnx1:gal4 
background34 to obtain Tg(mnx1:gal4;UAS:BLINK2) embryos. We 
injected transgenic embryos from this cross with a construct con-
taining the mnx1 promoter35 driving lynGFP, which encodes a mem-
brane-bound fluorophore36, in order to visualize cell membranes 
and allow localization of the channel in this cell type. Whole-mount 
immunohistochemistry revealed channel puncta at the level of the 
membrane in motor neuron cell bodies and at the axon (Fig. 4b).
To functionally test silencing of neurons by BLINK2, we 
exposed Tg(mnx1:gal4;UAS:BLINK2) embryos to light from a 
blue LED (447 nm, 80 μ W/mm2) for 20 min and then carried out 
the touch-evoked escape-response assay. The evoked behavior 
relies on spinal cord primary motor neurons and was affected by 
activation of the channel (Fig. 4c). We dissected the response into 
three parameters: duration, distance and average speed (Fig. 4c). 
Tg(mnx1:gal4;UAS:BLINK2) embryos exhibited a reduced escape 
duration and distance but a conserved instant maximum speed as 
compared with that of Tg(UAS:BLINK2) embryos, which indicates 
that BLINK2 did not inactivate muscles. We then left embryos for 
1 h in the dark to allow BLINK2 channel-closing before we repeated 
the behavioral assay. The embryos with closed BLINK2 channels 
performed as the controls did, with no significant difference in their 
escape behavior (P = 0.48, 0.29 and 0.099 for duration, distance and 
average speed, respectively; two-sided t-tests) (Fig. 4d). This dem-
onstrates that BLINK2 activation in this specific neuronal popula-
tion was sufficient to reversibly impair function with a measurable 
behavioral defect.
BLINK2 stimulation relieves chemotherapy-induced neuro-
pathic pain in a rat model. A property of BLINK2 is its prolonged 
activity after cessation of light exposure, which can last for several 
minutes (Figs. 1 and 3). Therefore BLINK2 is a candidate tool for 
optogenetic applications that require long-lasting inhibition, such 
as pain relief in peripheral neural circuits.
As proof of concept, we tested the effect of BLINK2 on neuro-
pathic pain in rats. We expressed BLINK2 in dorsal root ganglia 
(containing the primary afferent neurons) by in vivo transfection 
via intrathecal injection. Twenty-four hours after injection, YFP and 
BLINK2 were expressed in sensory neurons in L4–L6 dorsal root 
ganglia (Fig. 5a) and nerve terminals of the glabrous skin (Fig. 5b). 
We then tested BLINK2-mediated silencing of nociceptive neu-
rons in a preclinical model of chemotherapy-induced neuro-
pathic pain. Rats injected with paclitaxel develop tactile allodynia 
(Fig. 5c), which is caused by ectopic firing of sensory neurons 
and increased nociceptive signal transmission37. Opening of a K+  
channel should hyperpolarize the nociceptive neurons and pre-
vent firing of action potentials.
After inducing tactile allodynia, we injected rats intrathecally 
with a BLINK2 plasmid for in vivo transfection. We expected pro-
tein expression and physiological consequence to peak about 24 h 
after injection38. On the day after plasmid injection, we illumi-
nated BLINK2 by exposing the left paw to blue light for 1 min. The 
right paw was not illuminated and was used as an internal control. 
Illumination of the left paw reduced nociception for at least 30 min, 
as indicated by an increased threshold for paw withdrawal after 
touch, which resolved after 3 h (Fig. 5c). We observed this effect 
only in the left paw; the right paw did not show an increased paw 
withdrawal threshold. This measured the force needed to elicit a 
response in the rats (Fig. 5c). Rats injected with an empty plasmid 
were insensitive to blue light (Fig. 5c). These experiments show that 
a specific effect of blue light is to trigger BLINK2 activation and 
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Fig. 5 | BLINK2-mediated reversal of chemotherapy-induced neuropathic 
pain in rats. a, Fluorescent micrographs of 12-µ m sections of adult dorsal 
root ganglia from animals that received intrathecal (i.t.) injection of 
BLINK2–YFP expression plasmid, immunostained 24 h after injection for 
YFP and BLINK2 (bottom row). In the images in the top row, no primary 
antibody control was used to visualize YFP fluorescence. Presented 
data are from three independent animals that yielded similar results. 
b, Fluorescent micrographs of 12-µ m sections of glabrous skin from 
animals that received i.t. injection of BLINK2–YFP expression plasmid, 
immunostained 24 h after injection for PGP9.5 (nerve terminals) or 
BLINK2. White arrows indicate the nerve terminals in the glabrous 
skin stained with PGP9.5 or BLINK2. Presented data are from three 
independent animals that yielded similar results. c, Paw withdrawal 
thresholds for rats with chemotherapy-induced neuropathic pain 
(paclitaxel) and i.t. injection of BLINK2 plasmid (4.5 μ g per rat; n =  6). 
Blue light illumination was applied for 1 min to the left paw only. *P <  0.05 
for the left paw compared with the right paw. P =  0.0001 (two-way 
ANOVA with Student–Neuman–Kuels post hoc test). Data were analyzed 
by nonparametric two-way ANOVA, where time was the within-subject 
factor and treatment was the between-subjects factor. Data are presented 
as the average ±  s.e.m.
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Discussion
We have shown that the light-gated K+ channel BLINK2 is an inhib-
itory tool in long-lasting optogenetic experiments. Because BLINK2 
is not activated by wavelengths greater than 500 nm, it can be com-
bined with green-excitable labels and tools with minimal cross-talk.
Compared with BLINK120, BLINK2 shows slower activation 
and deactivation kinetics (on the order of minutes). The lasting 
inhibition is presumably due to the high channel conductance 
that prevents depolarizing inputs even if only a small number of 
channels remain active. We observed more severe inhibition in 
whole-cell experiments than in cell-attached experiments, which 
we presently do not understand and which may depend on the 
dilution of cytosolic factors during prolonged whole-cell mea-
surements. However, the full recovery observed in our in vivo 
experiments indicates that the system is in principle reversible 
and does not cause severe stress to the cells. BLINK2 should have 
minimal effects on cells, as it exploits an inherent mechanism for 
hyperpolarization, namely, K+ efflux. We expect that BLINK2 will 
provide inhibition in all cell types and in many model organisms. 
Moreover, the combination of large unitary conductance and 
prolonged light-off activity allows cellular inhibition in a time 
range inaccessible to other inhibitory tools, such as the opsin-
based chloride pump eNpHR3.0. In our experimental condi-
tions, eNpHR3.0 inhibited firing transiently for no longer than 
tens of seconds.
BLINK2 is suitable for in vivo experiments that require very 
long inhibition times. BLINK2 may be used to dissect the role of 
genetically defined neuronal populations in behavioral experi-
ments or for silencing of neurons during the development of neu-
ral circuits, where it is necessary to silence neurons for hours or 
days. This may be achievable with BLINK2 by light pulses of low 
frequency and intensity, which should prevent the unwanted tis-
sue heating often associated with prolonged inhibition by other 
optogenetic tools39.
The slow post-illumination recovery of BLINK2 is a beneficial 
property for silencing peripheral neural circuits in the control of 
neuropathic pain. This is a high-priority issue in therapeutics 
because of inadequate responses to drug therapy40. In our hands, 
reduced pain sensation in a rodent model did not require constant 
light but was achieved with a brief transdermal light pulse and 
without the need for fiber-optic implantation. This avoids nega-
tive consequences of high-intensity illumination such as local tissue 
heating41 and facilitates potential clinical translation.
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Methods
Engineering of channel constructs. Constructs in Fig. 1a were prepared by 
overlapping PCR42. The IDs of the sequences used are as follow: AsPhototropin1 
(Avena sativa), GeneBank AAC05083.1; mKir2.1 (Mus musculus), NCBI gene 
16518; mTASK1 (M. musculus), NCBI gene 16527; mTASK3 (M. musculus), NCBI 
gene 223604; KAT1 (Arabidopsis thaliana), NCBI gene 834666.
QuikChange Lightning (Agilent Technologies) was used to introduce point 
mutations. BLINK2 used in all experiments except those in transgenic zebrafish 
contained the mutation Q513D in the LOV2 domain32 (AsPhot1 numbering).
Electrophysiology in cell lines. Cell culture and transfection protocol. 
HEK293T or COS7 cells were cultured in Dulbecco’s modified Eagle’s medium 
(Euroclone) supplemented with 10% FBS (Euroclone), 100 IU/ml penicillin, 
100 μ g/ml streptomycin and stored in a 37 °C humidified incubator with 
5% CO2. Transfections were performed with TurboFect transfection reagent 
(Thermo Scientific) according to the supplier’s protocol: BLINK2 inserted in 
pcDNA3.1+ was cotransfected with a plasmid encoding GFP and incubated in the 
dark. For viral infection we added the virus directly to the cell culture medium. 
Currents were recorded after 2–3 d in GFP+ cells.
Patch-clamp recordings. One to two days after transfection, cells were dispersed 
by trypsin–EDTA treatment and seeded on 35-mm plastic petri dishes to allow 
single-cell measurements. GFP+ cells were selected for patch-clamp measurements. 
Membrane currents were recorded in the whole-cell configuration with a Dagan 
3900A amplifier and digitized with a Digidata 1322A controlled by pCLAMP 
9.2. The pipette resistance was about 2 MΩ . The pipette solution contained 
10 mM NaCl, 130 mM KCl, 2 mM ATP–magnesium salt, 1 mM EGTA and 5 mM 
HEPES–KOH buffer, pH 7.2. The extracellular bath solution contained 100 mM 
KCl, 80 mM d-mannitol, 1.8 mM CaCl2, 1 mM MgCl2 and 5 mM HEPES–KOH 
buffer, pH 7.4. K+ concentrations were 101.7 mM for the extracellular solution 
and 133.7 mM for the pipette solution. The calculated Nernst reversal potential 
for K+ is –6.89 mV. The voltage protocol consisted of 20-mV steps from + 60 to 
–140 mV. For cell-attached measurements, the pipette resistance was 2 MΩ and 
the pipette solution was the same as the extracellular solution. Transfected cells 
were kept in the dark before the assays, and all preliminary operations were 
performed under red light illumination (MRH2060–20T, LUXEON Rebel LEDs 
Red-Orange (617 nm)). Blue light illumination was provided by an LED (Royal 
Blue, 455 nm, High-Power LED; Thorlabs) or monochromatic light from a 75-W 
Xenon Arc lamp (PTI DeltaRem X, Photon Technology International) delivered 
through the 60× objective of a fluorescent Nikon Eclipse Ti-U microscope with an 
oil-immersion lens. In both cases, the light intensity measured with a power meter 
(Thorlabs) at the position of the sample was about 90 μ W/mm2.
Statistical analysis. Significance was calculated by one-way ANOVA and Tukey post 
hoc test using GraphPad Prism for Windows (GraphPad Software, La Jolla, CA, 
USA; https://www.graphpad.com).
Viral expression of BLINK2. Cloning of AAV plasmids. BLINK2 cDNA was 
amplified from Q513D pGEMT-BLINK2 by PCR with primers containing BglII 
recognition sites (A^GATC). With the use of BglII restriction, pAAV1/2-hSyn-
IRES-eGFP was linearized and BLINK2 cDNA was subsequently ligated into the 
linearized vector to produce pAAV1/2-hSyn-BLINK2-IRES-eGFP.
Virus production. HEK293T cells (ATCC, UK) were cultured in Iscove’s modified 
Dulbecco’s medium (Sigma-Aldrich, Germany) supplemented with 10% (v/v) 
FCS (Sigma-Aldrich) and penicillin–streptomycin–glutamine (Sigma-Aldrich) 
in 5 × 150 mm dishes. After 80% confluency was reached, cell were transfected 
in serum-free medium with the helper plasmids pRV1, pH21 and pDFΔ 6 and 
pAAV1/2-hSyn-BLINK-IRES-eGFP or pAAV1/2-hSyn-IRES-eGFP at a molar ratio 
of 1:1 with CaCl2. On the next day, the medium was replaced with serum-containing 
medium, and 48 h after transfection cells were harvested, pelleted and resuspended 
in lysis solution (150 mM NaCl, 20 mM Tris, pH 8). Next, cells were subjected to a 
freeze–thaw cycle, and after the addition of NaDOC (0.5% v/v), the solution was 
incubated with Benzonase (Sigma-Aldrich; 50 units/ml) for 60 min at 37 °C. After 
centrifugation (3,000g at 4 °C for 10 min), the supernatant was frozen. The next day, 
we carried out ion-exchange chromatography with 1-ml HiTrapQ columns (GE 
Healthcare, UK). Viral particles were washed and eluted with solutions of 20 mM 
Tris, pH 8, with increasing NaCl concentrations (100–500 mM NaCl). Eluate was 
transferred to an Amicon Ultra-4 filter (Millipore, USA) to concentrate the viral 
particles and exchange the buffer for PBS. The purified virus was then aliquoted 
and stored at − 80 °C. The titer was determined by real-time quantitative PCR 
on a 7900HT Fast Real-Time PCR system (Applied Biosystems Inc., USA) using 
primers against GFP (forward, AAGCTGACCCTGAAGTTCATCTGC; reverse, 
CTTGTAGTTGCCGTCGTCCTTGAA) and the GoTaq RT-qPCR kit  
(Promega, USA).
BLINK2 immunolocalization in rat primary neurons. Cell cultures and 
transfections. Hippocampal neuronal primary cultures were prepared from 
embryonic day 18–19 (E18– E19) rat hippocampi as previously described43. All the 
experiments were approved by the Institutional Animal Care and Use Committee 
of University of Milan and by the Italian Ministry of Health (#326/2015). Neurons 
were transfected at 7 days in vitro (DIV7) via the calcium-phosphate precipitation 
method with 4 μ g of plasmid DNA for GFP for the experiments assessing the 
axonal and dendritic distribution of BLINK2 reported in Fig. 2c. Neurons were 
infected with AAV1/2-hSyn-BLINK2-IRES-eGFP at DIV10 and fixed at DIV12 for 
the immunocytochemistry assays.
Immunocytochemistry. For colocalization experiments, cells were fixed with 4% 
paraformaldehyde (PFA)–4% sucrose in PBS solution at 4 °C and washed several 
times with PBS. Cells were permeabilized with 0.1% Triton X-100 in PBS for 
15 min at room temperature and then blocked with 5% BSA in PBS for 45 min 
at room temperature. Cells were then labeled with antibodies for intracellular 
epitopes overnight at 4 °C. Cells were washed and incubated with secondary 
antibodies for 1 h at room temperature. Cells were washed in PBS and mounted on 
glass slides with Fluoromount mounting medium (Sigma-Aldrich, USA).
To evaluate surface and total staining of BLINK2, neurons were fixed with 
4% PFA–4% sucrose in PBS solution at 4 °C, and then incubated with anti-BLINK2 
8D6 custom-made monoclonal antibody. This antibody, originally raised against 
the potassium channel Kcv, recognizes BLINK channels too20,44. To visualize 
surface expression, we blocked cells with 5% BSA in PBS and incubated them 
with an Alexa Fluor 555–conjugated secondary antibody. Afterward, cells were 
permeabilized with 0.1% Triton X-100 for 10 min, and intracellular expression was 
determined after incubation with 8D6 antibody and labeling of the total receptor 
fraction with an Alexa Fluor 405–conjugated secondary antibody.
Fluorescence images were acquired with the Zeiss Confocal LSM510 Meta 
system with a sequential acquisition setting at 1,024 × 1,024 pixel resolution; for 
each image two to four 0.5-μ m sections were acquired and a z projection was 
obtained45. Images were acquired with signals in a linear range and without any 
saturated pixel, for reliable quantification and appropriate comparison of all 
experimental conditions.
For quantification of surface and total expression intensities, images were 
acquired with the same settings. The average intensity of surface fluorescence 
staining was determined after cell tracing and was normalized to the total intensity 
to correct for differences in expression. We obtained surface ratios by dividing the 
background-subtracted fluorescence intensities.
Antibodies. We used antibodies to MAP2 (Millipore; AB5222), GM130 (BD 
Bioscience; 610822) and GFP (Millipore; AB16901). Alexa Fluor fluorescently 
labeled antibodies were purchased from Thermo Fisher.
Ex vivo electrophysiology. Animals. All procedures involving animals were carried 
out in accordance with the Italian Ministry of Health’s directives (D.lgs 26/2014) 
regulating animal research. Animal experiments were designed in accordance with 
the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines, with 
a commitment to refinement, reduction and replacement, so as to minimize the 
number of mice used. C57BL/6J male mice were maintained in standard cages with 
food and water ad libitum at 22 ± 1 °C under an artificial 12/12-h light/dark cycle.
Stereotaxic injections. C57BL/6J male mice (4–6 weeks old) were anesthetized 
with a mixture of isoflurane (1–2%) and O2. Mice were positioned in a stereotaxic 
frame (Kopf Instruments) and their body temperature was maintained at 37 °C. We 
injected 0.5 µ l (titer 1013) of AAV1/2-hSyn-Blink2-IRES-eGFP, AAV1/2-hSyn-eGFP 
or a 1:1 mixture of AAV1-hsyn-Cre (pENN.AAV.hSyn.Cre.WPRE.hGH, a gift 
from James M. Wilson (Perelman School of Medicine, University of Pennsylvania); 
Addgene viral prep # 105553-AAV1) and AAV5-EF1α -DIO-eNpHR3.0-eYFP 
(Stanford Virus Core) into the DRN (mediolateral, + 1.15 mm, anteroposterior, 
–4.4 mm, dorsoventral, –3.6 mm under an angle of 20° from bregma; or 
mediolateral, + 0.5 mm, anteroposterior, –4.36 mm, dorsoventral, –3 mm from 
bregma) at a speed of 0.1 µ l/min. Ex vivo electrophysiology was performed at least 
2 weeks after surgeries.
Immunofluorescence. Mice were killed 2, 4 or 8 weeks after the injection. 
Anesthetized mice were transcardially perfused with PBS followed by 4% PFA. 
Brains were dissected and post-fixed in 4% PFA overnight at 4 °C. 50-μ m coronal 
sections were obtained with a vibratome (Leica Microsystems). Antigen retrieval 
was performed as follows: sections were incubated for 30 min at 80 °C in 50 mM 
sodium acetate solution. Then the slices were washed three times in a PBTriton 
0.1% solution. Sections were incubated with chicken anti-GFP (Abcam; 1:500) 
primary antibody overnight at 4 °C and then rinsed in PBTriton 0.1%. Alexa 
Fluor 488–conjugated goat anti-chicken IgG (1:500; Life Technologies) was used 
overnight at 4 °C as the secondary antibody. The next day, sections were washed 
three times with PBTriton 0.1% solution and counterstained with DAPI. High-
power confocal images in the injection site of the DRN region were obtained on a 
Nikon A1 confocal microscope with a 10× or 40× plan-apochromat.
Slice preparation. Mice were killed under isoflurane anesthesia, after which 
their brains were dissected out and transferred to ice-cold modified artificial 
cerebrospinal fluid (aCSF) containing 110 mM choline chloride, 2.5 mM KCl, 
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1.25 mM NaH2PO4, 7 mM MgCl2, 0.5 mM CaCl2, 25 mM NaHCO3, 25 mM  
d-glucose and 11.6 mM ascorbic acid, saturated with 95% O2 and 5% CO2. Coronal 
slices containing the DRN (250-µ m thickness) were prepared with a Vibratome 
1000S slicer (Leica) and transferred to aCSF containing 115 mM NaCl, 3.5 mM 
KCl, 1.2 mM NaH2PO4, 1.3 mM MgCl2, 2 mM CaCl2, 25 mM NaHCO3 and 25 mM 
d-glucose, aerated with 95% O2 and 5% CO2. After 20 min of incubation at 32 °C, 
slices were kept at 22–24 °C. During electrophysiological experiments, slices were 
continuously superfused with aCSF at a rate of 2 ml/min at 28 °C.
Electrophysiological recordings. Electrophysiology recordings were performed on 
coronal brain slices containing the DRN. The DRN was first visualized under 
infrared differential interference contrast to allow for subsequent identification of 
GFP+ or YFP+ neurons by epifluorescence microscopy. Patch pipettes (4–6 MΩ )  
were filled with a solution containing 135 mM NaCl, 10 mM HEPES, pH 7.2–7.3, 
for cell-attached recording or 130 mM KMeSO4, 5 mM KCl, 5 mM NaCl, 10 mM 
HEPES, 2 mM MgCl2, 0.1 mM EGTA, 0.05 mM CaCl2, 2 mM Na2ATP and 0.4 mM 
Na3GTP, pH 7.2–7.3 (280–290 mOsm/kg), for whole-cell recordings.  
Cell-attached experiments were performed in the voltage clamp configuration 
with GFP+ or YFP+ neurons held at the potential that gave a holding current of 0 
pA (ref. 31.), whereas whole-cell experiments were performed in the current-clamp 
configuration, without current injection. Light (470 nm for BLINK2 activation, 
8.7 mW/mm2; 585 nm for eNpHR3.0 activation, 17 mW/mm2) emitted by an 
LED (CoolLED) was delivered to the specimen through the microscope objective 
(IR-ACHROPLAN 40× /0.8-NA (numerical aperture); Zeiss). Data were acquired 
with a Multiclamp 700B amplifier controlled by pClamp 10 software (Molecular 
Devices) filtered at 10 kHz and sampled at 50 kHz (current clamp and voltage 
clamp) (Digidata 1322; Molecular Devices). We generated time-course plots by 
averaging the discharge firing rate every 5 s; values were normalized to 1 min 
of baseline recording before light illumination. All data are reported without 
corrections for liquid junction potentials. Data where the access resistance (Ra) 
changed by > 20% were excluded from further analyses.
To identify light-responsive cells, we applied a threshold-based criterion: the 
threshold (Th) was set as the mean discharge rate minus 2 s.d., and the mean  
firing rate was calculated on values (5-s binning) computed over 1 min prior 
to light illumination. Cells were considered light responsive when their mean 
discharge rate fell below Th, or to zero, in at least two consecutive 5-s bins. ‘Time 
below threshold’ (Timeth) was measured as the interval between the time point 
at which the discharge rate fell below Th in at least two consecutive 5-s bins and 
the time point at which the discharge rate increased above Th in at least two 
consecutive 5-s bins.
Statistics. Appropriate parametric statistics were used to test our hypothesis, unless 
data did not meet the assumptions of the intended parametric test (normality 
test). In that case, appropriate nonparametric tests were used. Power analysis 
assumptions were as follows: power, 0.9; alpha, 0.5; two-tailed and expected 
difference 50% greater than the observed s.d. Data were analyzed by one-way 
repeated measures ANOVA for comparisons within a group, and by one-way 
ANOVA for between-group comparisons (GraphPad Prism 6 software). Post 
hoc analysis (Tukey or Dunnet, as indicated) was performed only when ANOVA 
yielded a significant main effect. Two groups were tested for statistical significance 
by two-population t-test and Mann–Whitney U nonparametric test (GraphPad 
Prism 6 software). Statistical details of experiments are shown in the results, figures 
and figure legends. Data are reported as mean ± s.e.m., unless stated otherwise.
Zebrafish experiments. Zebrafish husbandry. The zebrafish were housed and 
maintained at 28.5 °C according to standard procedures45. Experiments were done 
in compliance with European and French animal welfare guidelines.
Microinjections. Zygotes were injected with mnx1:lynGFP constructs to 
label single primary motor neuron membranes in the spinal cord in the 
Tg(mnx1:GAL4;UAS:BLINK2) background.
Transgenic BLINK2 zebrafish generation. To express BLINK2 under the control 
of the Gal4 trans-activator in stable transgenic zebrafish, we cloned the BLINK2 
coding sequence in a p10UAS vector containing a cmcl2:eGFP cassette to 
visualize transgenic animals by heart GFP fluorescence using standard molecular 
biology techniques46. The plasmid also contained Tol2 flanking sites for efficient 
transgenesis in zebrafish and was named p10UAS:BLINK2-tol2;cmcl2:eGFP. 
This plasmid was injected at the one-cell stage with tol2 mRNA via standard 
transgenesis protocols47. Transgenic F1 larvae were identified by heart GFP 
expression, and BLINK2 gene insertion was verified by genomic PCR.
Whole-mount immunohistochemistry. Embryos at 48 h post-fertilization (hpf) 
were fixed overnight at 4 °C in 4% PFA diluted in PBS, then thoroughly rinsed 
in PBST (PBS with 0.1% Triton X-100). The fixed embryos were incubated with 
1 mg/ml collagenase for 20 min, then rinsed in PBST before 1 h of incubation with 
block solution (PBS with 1% BSA, 2% normal goat serum, 1% DMSO, 0.1% Triton 
X-100). The embryos were then incubated sequentially with the primary antibodies 
(anti-GFP (1:300; Genetex), anti-RFP (1:200; AbCam), anti-BLINK2 (8D6) and 
DAPI (1:500; Life Technologies)) in fresh block solution, thoroughly rinsed in 
PBST and incubated with secondary antibodies (goat anti-rabbit Alexa Fluor 488 
and goat anti-mouse Alexa Fluor 568 (both from Life Technologies)) also diluted in 
fresh blocking solution.
Microscopy. Embryos were embedded in 1% low-melting-point agarose in a glass-
bottom tissue culture dish (Fluorodish; World Precision Instruments, USA).
Inner ear cells were imaged on an inverted laser scanning confocal microscope 
with spectral detection (LSM700; Zeiss) with a long-working-distance oil-
immersion 25× /0.8-NA W GLY DIC LD LCI PL APO (UV) VIS-IR (420852-9870) 
lens. Acquisitions were done via the Zen software (Zeiss).
Spinal cord primary motor neurons were imaged on a Roper confocal spinning 
disk head mounted on a Zeiss upright microscope, using a long-working-distance 
water-immersion 40× /1-NA W DIC PL APO VIS-IR (421462-9900) lens. 
Acquisitions were done with a CoolSNAP HQ2 CCD (charge-coupled device) 
camera (Photometrics, USA) through the MetaMorph software (Molecular 
Devices, USA).
Touch-evoked escape response assay. Embryos at 48 hpf were staged, dechorionated 
and exposed to a blue LED light (Royal-Blue LED, λ 447 ± 10 nm, LUXEON Rebel 
LED) for 20 min (λ = 447, 80 μ W/mm2) to activate the BLINK2 channel. The 
embryos were then placed in the center of an open petri dish filled with embryo 
medium. The escape response was elicited by a light touch on the tail with blunt 
forceps, and the resulting swimming episode was recorded with an Olympus  
FE-5000 camera at 30 Hz. The embryos were then left in the dark for 1 h to allow 
the inactivation of BLINK2, and the assay was subsequently performed again to 
test for recovery of locomotion. The videos were analyzed in ImageJ (NIH) using 
the Manual Tracking plugin (Fabrice Cordelières, Institut Curie-Orsay, France).
Statistics. Data were compiled in GraphPad Prism (Windows version 6.01) and  
t-tests were run to determine significance, set at P ≤ 0.05.
Rat pain model and intrathecal injection of BLINK2. Animals. Pathogen-free 
adult male and female Sprague Dawley rats (150–200 g; Envigo) were housed in 
temperature-controlled (23 ± 3 °C) and light-controlled (12-h light/12-h dark 
cycle; lights on 07:00–19:00) rooms with standard rodent chow and water available 
ad libitum. The Institutional Animal Care and Use Committee of the College of 
Medicine at the University of Arizona approved all experiments. All procedures 
were conducted in accordance with the Guide for Care and Use of Laboratory 
Animals published by the National Institutes of Health and the ethical guidelines 
of the International Association for the Study of Pain. Animals were randomly 
assigned to treatment or control groups for the behavioral experiments. Animals 
were initially housed three per cage but were individually housed after the 
intrathecal cannulation on a 12-h light-dark cycle with food and water ad libitum. 
All behavioral experiments were performed by experimenters who were blinded to 
the experimental groups and treatments
Paclitaxel-induced neuropathy model. Rats were given paclitaxel (P-925-1;  
Goldbio) based on the protocol described by Polomano et al.48. In brief, 
pharmaceutical-grade paclitaxel (Taxol) was resuspended at a concentration of 
2 mg/ml in 30% 1:1 Cremophor EL:ethanol, 70% saline and given to the rats at 
2 mg/kg intraperitoneally every other day for a total of four injections (days 0, 2, 4 
and 6), resulting in a final cumulative dose of 8 mg/kg. No abnormal spontaneous 
behavioral changes in the rats were noted during or after the treatment.  
Animals developed mechanical hyperalgesia within 10 d after the first  
paclitaxel injection.
Implantation of intrathecal catheter. For intrathecal drug administration, rats 
were chronically implanted with catheters as described49. Rats were anesthetized 
with halothane and placed in a stereotactic head holder. The occipital muscles 
were separated from their occipital insertion and retracted caudally to expose 
the cisternal membrane at the base of the skull. Polyethylene tubing was passed 
caudally from the cisterna magna to the level of the lumbar enlargement. Animals 
were allowed to recover and were examined for evidence of neurologic injury. 
Animals with evidence of neuromuscular deficits were excluded.
In vivo transfection of BLINK2 plasmid. For in vivo transfection, the BLINK2 
plasmid was diluted to 0.3 µ g/µ l in 5% sterile glucose solution as done previously38. 
Then, Turbofect in vivo transfection reagent (R0541; Thermo Fisher Scientific, 
Waltham, MA) was added according to the manufacturer’s instructions. Finally, 
15 µ l of the plasmid complexes were injected intrathecally in Sprague Dawley rats.
Testing of allodynia. The assessment of tactile allodynia (i.e., a decreased threshold 
for paw withdrawal after probing with normally innocuous mechanical stimuli) 
consisted of testing the withdrawal threshold of the paw in response to probing 
with a series of calibrated fine (von Frey) filaments. Each filament was applied 
perpendicularly to the plantar surface of the paw of rats held in suspended wire 
mesh cages. We determined the withdrawal threshold by sequentially increasing 
and decreasing the stimulus strength (the ‘up and down’ method), and we analyzed 
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data using the nonparametric method of Dixon, as described by Chaplan et al.50, 
with results expressed as the mean withdrawal threshold.
Illumination of the paw was performed with blue LED light (Royal-Blue LED, 
λ 455 ± 9 nm, LUXEON Rebel LED) for 1 min (35.6 µ W/mm2). The light was 
measured at a distance of 1–1.5 cm from the paw.
Immunohistofluorescence and epifluorescence imaging. L4–L6 dorsal root ganglia 
were dissected from adult rats and then fixed with 4% PFA overnight at 4 °C. Dorsal 
root ganglia were next transferred into a 30% sucrose solution and left at 4 °C until 
sinking of the tissues could be observed (~3 d). Tissues were cut at 12-µ m  
thickness with a Bright OTF 5000 microtome cryostat (Hacker Instruments and 
Industries, Inc.), fixed onto charged glass slides and kept at –20 °C until use. 
Prior to antibody staining, slides were dried at room temperature for 30 min and 
rehydrated in PBS for 5 min. For glabrous skin staining, slides were incubated 
in ice-cold methanol for 5 min and left to dry at room temperature. The slices 
were permeabilized and saturated with PBS containing 3% BSA, 0.3% Triton 
X-100 solution for 30 min at room temperature, and then antibodies diluted in 
PBS, 3% BSA were added overnight at room temperature. Primary antibodies 
used were anti-GFP (AB3080; Millipore), anti-PGP9.5 (NB600-1160; Novus 
Biologicals) and anti-Blink2 8D6. The slices were then washed three times in PBS 
and incubated with PBS, 3% BSA containing secondary antibodies (Alexa Fluor 
488 goat anti-rabbit or Alexa Fluor 594 goat anti-mouse secondary antibodies 
(Life Technologies)) for at least 3 h at room temperature. After three washes (PBS, 
10 min, room temperature), DAPI was used to stain the nuclei of cells. Slides were 
mounted and stored at 4 °C until analysis. Immunofluorescent micrographs were 
acquired on a Nikon Eclipse Ti-U (Nikon Instruments Inc.) with a Plan Apo  
10× /0.45-NA objective controlled by NIS Elements software (version 4.51; Nikon 
Instruments). The freeware image-analysis program ImageJ (https://imagej.nih.
gov/ij/) was used to remove background and generate merged images. All images 
were obtained with identical acquisition parameters by individuals blinded to the 
staining conditions.
Statistical analyses. Behavioral threshold values were statistically analyzed for 
each foot separately, and the significance of differences was assessed between the 
averages of at least two pre-injection tests and the mean obtained for each post-
injection test. In all tests, baseline data were obtained before and after paclitaxel 
treatment. Within each treatment group, post-administration means were 
compared with the contralateral values by nonparametric two-way ANOVA, where 
time was the within-subjects factor and treatment was the between-subjects factor, 
followed by post hoc pairwise comparisons (Student–Newman–Keuls method). 
A P value of < 0.05 indicated statistical significance between treatment and 
nontreatment groups. Data were analyzed and plotted with Graphpad Prism 7.
Reporting Summary. Further details on research design are available in the Nature 
Research Reporting Summary linked to this article.
Data availability
Raw data generated and analyzed during the current study are available from the 
corresponding author on reasonable request. Data have been deposited under the 
following accession codes: AddGene 117075; GenBank submission MH937726. 
Source data for Fig. 1 and Supplementary Fig. 9 are available online.
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Sample size Figure 1- Patch clamp on cell cultures: we use as a sample size, usually between 6-10 cells for patch experiments. These numbers are 
adequate for the kind of measurements, based on the fact that the signal to noise ratio is very high (at least >4). 
 
Figure 2 ans Suppl. Figure 2: Staining of hippocampal primary cultures: No statistical analyses have been performed. With regards to the 
quantitative analysis of  surface/total staining, cells were chosen randomly from four to eight different coverslips (two to three independent 
experiments) and representative images are shown. 
 
Figure 3, Supplementary Figures 5-7:  Patch clamp experiments in DRN brain slices- Sample size is chosen according to the "sample size 
calculator" implemented in the software Sigma-plot 12.0 taking into account the minimal detectable difference in means, the expected 
standard deviation, the desired power (0.80), the alpha value (0.05) and the statistic test applied (t-student test or 1WAY ANOVA). Estimated 
values used in the calculator were taken from a previous study on pharmacogenetic manipulations of serotonergic neurons: "D.J. Urban et al. 
Neuropsychopharmacology (2016) doi:10.1038/npp.2015.293"  
 
Figure 4: Sample size is chosen according to our experience  with behavioral experiments. Because genotyping was not known before 
behavioral testing we tested enough larvae to have at least n>10 for each condition. 
 
Figure 5: For in vivo pain studies, We used n=6 samples based on power analysis and previous experience. 
 
Supplementary Figure 8: In each experiment, fertilized eggs were collected and randomly distributed into several subgroups, to be injected 
with either GFP RNA or wt and mutated forms of BLINK RNAs. Sample size was thus varying depending on clutches of eggs (usually 30-60 per 
group). Sample size was defined based on our experience in order to have statistically relevant numbers of embryos, but also to avoid 
overcrowded Petri dishes for escape response assays in order to better detect individual responses. 
 
Data exclusions Figure 1: Patch experiments on cell cultures: The criteria for discarding cells was if seal 
resistance remained > 1 gigaOhm throughout the experiment or not. 
 
Figure 2: Staining of hippocampal primary cultures: we have excluded dead neuronal cells and cells showing a certain suffering due to the 
transfection. 
 
Figure 3, Supplementary figures 5-7: cells were excluded based when the access resistance changed >20%, as described in the "Materials and 
Methods" or when defined as statistical outliers according to the "Identify Outliers" implemented in Prism7.0 using the ROUT method. 
 
Figure 4, 5: No data exclusion   
 
Supplementary Figure 8: Embryos showing grossly abnormal morphology, due to unspecific developmental problems/poor egg quality were 
excluded from touch-response assays. GFP-injected embryos were used as a control for unspecific developmental problems: when control 





Replication Figure 1: Patch experiments on cell cultures were performed once or twice in a week, cells were patched 12-24h after (transient) transfection. 
Each condition/protocol was tested at least in 3 independent experiments, each time the number of cells  tested was > 5, usually 10-15. 
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Staining of hippocampal primary cultures: not relevant  to our study 
 
Figure 3, Supplementary figures 5-7: data were collected from 3 to 8 animals for each condition to ensure biological reproducibility.  
 
 
Figure 4: data were reproduced  in three independent experiments giving always comparable results. Results of one experiments are 
reported. 
 
Supplementary Figure 8: In vitro transcribed RNAs from each construct were injected several times in independent clutches of eggs. Inhibitory 
effect of blue light exposure on touch-evoked escape response of BLINK-injected embryos, as well as reversibility in the dark, were thus 
verified in several individuals derived from several clutches of eggs, injected with several batches of in vitro transcribed RNAs.
Randomization Figure 1: Patch clamp experiments on cell cultures: not relevant as the operator cannot influence the outcome of the measurement 
Figure 3, Supplementary figures 5-7: not relevant 
Figure 4: not relevant  to our study 
Figure 5: For in vivo pain studies, rats were ramdomly assigned to treatments and groups 
 
Supplementary Figure 8: Fertilized eggs were randomly distributed into groups prior to microinjection 
Blinding Figure 1:Patch clamp experiments on cell cultures: not relevant as the operator cannot influence the outcome of the measurement 
Figure 2:Staining of hippocampal primary cultures: not relevant  to our study 
Figure 3, Supplementary figures 5-7: not relevant 
Figure 4: The genotyping of each larva was determined after behavioral response was recorded. Genotyping and beahvioral recording were 
performed by two independent investigators 
Figure 5: For in vivo pain studies, experimenter was blinded to the groups and treatments.  
 
Supplementary Figure 8: Investigators were not blinded to group allocation. Assays were always performed first on control group (GFP-
injected embryos), to monitor the quality of the clutches.
Reporting for specific materials, systems and methods
Materials & experimental systems





Animals and other organisms
Human research participants
Methods





Antibodies used Figure 2-5: anti-BLINK2:  8D6, custom made monoclonal antibody  
Figure3, Supplementary figure 5,7, anti-eGFP: antibody name ab13970, chicken polyclonal antibody anti eGFP 
Figure 5: anti-GFP (Cat# AB3080, Millipore, Billerica, MA), anti-PGP9.5 (Cat# NB600-1160, Novus Biologicals, Littleton, CO)  
Validation 8D6 was validated for the Kcv channel expressed in several organisms and on the native Kcv in the PBCV-1 virus (Romani et al, 
2013 J Gen Virol. 2013 Nov; 94(Pt 11): 2549–2556. doi: 10.1099/vir.0.055251-0); 8D6 was further validated against BLINK1 
expressed in HEK 293T cells (Cosentino et al.,  2015,  Science 348(6235):707-10. doi: 10.1126/science.aaa2787). 
Other primary antibodies used in Fig.2 are commercial antibodies frequently used in the literature (e.g. GM130 see Saraceno et 
al. 2014, PSD-95 see Marcello et al., 2007) 
 




Anti-GFP and anti PGP9.5 were validated by the company and widely used in the litterature.
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) HEK 293 T: obtained from ATCC (RRID:CVCL_0063)  
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Cell line source(s) COS7, obtained from Gerhard Thiel lab, TU-Darmstadt, originally bought by ATCC
Authentication both lines were  authenticated by ATCC 




HEK293 cells (but not HEK293T) are listed in the ICLAC database for possible contamination by HeLa cells. We think that for 
our purposes, i.e. virus amplification and heterologous expression of  a synthetic light-activated channel conductance,  such a 
contamination should not matter.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals Figure 2: E18 embryos from Sprague–Dawley rats for primary hippocampal neuron cultures were used. All the experiments were 
approved by the Institutional Animal Care and Use Committee of University of Milan and by the Italian Ministry of Health 
(#326/2015). 
 
Figure 3, Supplementary figures 5-7: Mus Musculus, C57BL/6J, males, P45-P70 
 
Figure 4: Experiments with zebrafish embryos/larvae were conducted within the first 5 days post fertilization, when zebrafish are 
not considered as animals yet and are thus not subject to the European or local directives on animal research. 
 
Figure 5: adult male Sprague–Dawley rats (250 g; Envigo) 
Wild animals No wild animals were used in this study
Field-collected samples No field-collected samplese were used in this study
